var title_f27_23_28016="Erythema annulare centrifugum - dark skin";
var content_f27_23_28016=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F59741&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F59741&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Superficial erythema annulare centrifugum",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 324px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Erythematous annular plaques with \"trailing scale\" are classic features of superficial erythema annulare centrifugum.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f27_23_28016=[""].join("\n");
var outline_f27_23_28016=null;
var title_f27_23_28017="Patient information: Scleroderma (The Basics)";
var content_f27_23_28017=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div>",
"   &nbsp;",
"  </div>",
"  <div id=\"basicsTopicMinWidth\">",
"   <div id=\"basicsTopicRight\">",
"    <div id=\"placeholder\">",
"    </div>",
"   </div>",
"   <div id=\"basicsTopicLeft\">",
"    <div id=\"topicTitle\">",
"     Patient information: Scleroderma (The Basics)",
"    </div>",
"    <span class=\"view\">",
"     View in",
"     <a class=\"lang\" href=\"./es-419/scleroderma-the-basics?source=topic_page\">",
"      Spanish",
"     </a>",
"    </span>",
"    <a class=\"contributor contributor_credentials\" href=\"./authors-and-editors/patient-information\">",
"     Written by the doctors and editors at UpToDate",
"    </a>",
"    <div id=\"topicText\">",
"     <p class=\"headingAnchor\" id=\"H110678437\">",
"      <span class=\"h1\">",
"       What is scleroderma?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Scleroderma means &ldquo;hard skin.&rdquo; Doctors use the term scleroderma for conditions that affect the skin and tissues that support the organs inside your body. This tissue is called &ldquo;connective tissue.&rdquo;",
"     </p>",
"     <p>",
"      There are 2 main types of scleroderma. &ldquo;Localized&rdquo; scleroderma affects the skin and tissue just under the skin. &ldquo;Systemic&rdquo; scleroderma can affect the skin and organs inside your body, including the heart, lungs, kidneys, and the digestive system. The digestive system includes all the structures and organs that handle and process food, such as the stomach and intestines.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H110678452\">",
"      <span class=\"h1\">",
"       What are the symptoms of scleroderma?",
"      </span>",
"      &nbsp;&mdash;&nbsp;The most common symptoms of localized scleroderma include:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Streaks or bands of hard, waxy skin on an arm, leg, or the face",
"       </li>",
"       <li>",
"        Patches of hard, dry, smooth skin, usually on the belly, chest, and back",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      The affected areas can be itchy or painful.",
"     </p>",
"     <p>",
"      The symptoms of systemic scleroderma include:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        A condition called &ldquo;Raynaud phenomenon&rdquo; that causes the fingers and toes to turn white or purple-blue in response to cold or stress",
"       </li>",
"       <li>",
"        Puffy skin that slowly becomes hard and thicker than normal",
"       </li>",
"       <li>",
"        Joints that become stiff, because the skin around them isn&rsquo;t able to stretch as well as it used to",
"       </li>",
"       <li>",
"        Small white lumps in or under the skin on the fingers - These are called &ldquo;skin deposits.&rdquo; They contain calcium and might also be called &ldquo;calcinosis.&rdquo;",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      Less common symptoms that can happen when other organs are affected include:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Acid reflux - This is when the acid that is normally in your stomach backs up into your esophagus, the tube that carries food from your mouth to your stomach.",
"       </li>",
"       <li>",
"        Trouble swallowing",
"       </li>",
"       <li>",
"        Diarrhea",
"       </li>",
"       <li>",
"        Shortness of breath",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H110678467\">",
"      <span class=\"h1\">",
"       Are there tests for scleroderma?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Yes. Your doctor or nurse might be able to tell if you have it by learning about your symptoms and doing an exam. But you might need other tests, including:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Blood tests",
"       </li>",
"       <li>",
"        Skin biopsy &ndash; For this test, a doctor takes a small sample of your skin. Another doctor then looks at the skin cells under a microscope to check for signs of scleroderma.",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H110678482\">",
"      <span class=\"h1\">",
"       How is scleroderma treated?",
"      </span>",
"      &nbsp;&mdash;&nbsp;The treatment depends on the type of scleroderma you have and your symptoms.",
"     </p>",
"     <p>",
"      Treatments for localized scleroderma include:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Light therapy &ndash; For this treatment, doctors use a machine that gives off a special type of light. They point the light at the affected part of your body.",
"       </li>",
"       <li>",
"        Medicines &ndash; These include prescription skin creams and pills.",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      Treatments for systemic sclerosis include:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Tests every few weeks or months to check your blood pressure and check how well your kidneys and lungs are working",
"       </li>",
"       <li>",
"        Prescription medicines to treat symptoms in different parts of the body",
"       </li>",
"       <li>",
"        Surgery to remove calcinosis",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H110678497\">",
"      <span class=\"h1\">",
"       Is there anything I can do on my own to feel better?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Yes. You can use special creams with &ldquo;lanolin&rdquo; (a greasy substance found in wool) to help keep your skin soft. If itching is a problem, you can take over-the-counter antihistamines, such as",
"      <a class=\"drug drug_patient\" href=\"UTD.htm?24/60/25537?source=see_link\">",
"       diphenhydramine",
"      </a>",
"      (sample brand name: Benadryl&reg;).",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H110678512\">",
"      <span class=\"h1\">",
"       What if I want to get pregnant?",
"      </span>",
"      &nbsp;&mdash;&nbsp;If you have scleroderma, you might have a harder time getting pregnant than women without the disease. You also might be more likely to have a miscarriage (this is when a pregnancy ends before a woman has been pregnant for 20 weeks).",
"     </p>",
"     <p>",
"      During pregnancy, some of your symptoms (such as Raynaud phenomenon) might get better. But other symptoms (such as heartburn) might get worse. If you have kidney problems caused by scleroderma, pregnancy can be very dangerous and even life threatening.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H110678527\">",
"      <span class=\"h1\">",
"       What will my life be like?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Because scleroderma affects the way you look and, in some cases, your ability to do everyday things, the disease can cause stress and worry. Your doctor can refer you to a counselor or a local scleroderma support group for advice on coping with the condition.",
"     </p>",
"    </div>",
"    <div id=\"reviewProcess\">",
"     <span>",
"      All topics are updated as new evidence becomes available and our",
"      <a class=\"policy policy_editorialpolicy\" href=\"/home/editorial-policy\">",
"       peer review process",
"      </a>",
"      is complete.",
"     </span>",
"    </div>",
"    <div id=\"topicRetrievedDate\">",
"     <span class=\"emphasis\">",
"      This topic retrieved from UpToDate on:",
"     </span>",
"     Apr 20, 2013.",
"    </div>",
"    <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"     <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"      Find",
"     </a>",
"     <a class=\"toolbutton printicon\" href=\"UTD.htm?27/23/28017?view=print\" title=\"Print This Topic\">",
"      Print",
"     </a>",
"     <a class=\"toolbutton emailicon etacLink\" href=\"#\" title=\"Email This Topic\">",
"      Email",
"     </a>",
"    </div>",
"    <div id=\"disclaimer\">",
"     The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions.",
"The use of UpToDate content is governed by the",
"     <a class=\"legal legal_termsofuse\" href=\"/home/terms-use\" target=\"_blank\">",
"      UpToDate Terms of Use",
"     </a>",
"     . &copy;2013 UpToDate, Inc. All rights reserved.",
"    </div>",
"    <div id=\"topicVersionRevision\">",
"     Topic 83677 Version 1.0",
"    </div>",
"   </div>",
"   <!--  basicsTopicLeft -->",
"  </div>",
"  <!-- basicsTopicMinWidth -->",
" </div>",
" <!-- topicContent -->",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1004-183.1.191.153-863D5741FF-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f27_23_28017=[""].join("\n");
var outline_f27_23_28017=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H110678437\">",
"      What is scleroderma?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H110678452\">",
"      What are the symptoms of scleroderma?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H110678467\">",
"      Are there tests for scleroderma?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H110678482\">",
"      How is scleroderma treated?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H110678497\">",
"      Is there anything I can do on my own to feel better?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H110678512\">",
"      What if I want to get pregnant?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H110678527\">",
"      What will my life be like?",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f27_23_28018="LS LSC";
var content_f27_23_28018=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F72766&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F72766&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Lichen sclerosus (LS) with lichen simplex chronicus",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 285px; height: 360px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Figure 8 involvement of vulvar LS with scarring of the vulva and loss of all the normal architecture. All areas are lichenified with fissuring of the thick periclitoral area and labiocrural fold.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: F William Danby, MD, FRCPC, FAAD&nbsp;and Lynne J Margesson, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f27_23_28018=[""].join("\n");
var outline_f27_23_28018=null;
var title_f27_23_28019="Resisted wrist flexion";
var content_f27_23_28019=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F77615&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F77615&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 476px\">",
"   <div class=\"ttl\">",
"    Resisted wrist flexion",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 456px; height: 363px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    With the elbow flexed at 90 degrees, the forearm is firmly grasped. The patient is asked to make a \"light\" fist and to flex the wrist against the resistance of the examiner's second hand. As this maneuver is performed, the examiner should emphasize the relationship of the wrist motion to the aggravation of elbow pain. The diagnosis of medial epicondylitis is strongly suggested by local tenderness of the medial epicondyle plus elbow pain aggravated by resisted wrist flexion.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Bruce C Anderson, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f27_23_28019=[""].join("\n");
var outline_f27_23_28019=null;
var title_f27_23_28020="Gentamicin (ophthalmic): Patient drug information";
var content_f27_23_28020=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Gentamicin (ophthalmic): Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?3/21/3412?source=see_link\">",
"     see \"Gentamicin (ophthalmic): Drug information\"",
"    </a>",
"    and",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?36/36/37443?source=see_link\">",
"     see \"Gentamicin (ophthalmic): Pediatric drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F8107111\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Garamycin&reg;;",
"     </li>",
"     <li>",
"      Gentak&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F8107112\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Diogent&reg;;",
"     </li>",
"     <li>",
"      Garamycin&reg;;",
"     </li>",
"     <li>",
"      Garasone;",
"     </li>",
"     <li>",
"      Gentak&reg;;",
"     </li>",
"     <li>",
"      Gentocin;",
"     </li>",
"     <li>",
"      PMS-Gentamicin",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10031205\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691501",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to stop or treat eye infections.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10031204\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2702197",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to gentamicin or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10031209\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10031210\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698045",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Eye irritation.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10031212\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699057",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Big change in balance.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699086",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sudden change in eyesight, eye pain, or irritation.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10031207\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2705385",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         Eye drops:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696185",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Use as you have been told, even if you are feeling better.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694913",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       For the eye only.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694635",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not wear contact lenses at any time while using this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694779",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not touch the container tip to the eye, lid, or other skin.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696124",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tilt your head back and drop drug into the eye.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694401",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       After use, keep your eyes closed. Put pressure on the inside corner of the eye. Do this for 1 to 2 minutes. This keeps the drug in your eye.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695618",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Space each eye drug by 5 minutes.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"link\">",
"        urn:lims:b498:s2705387",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       <b>",
"        <span style=\"text-decoration: underline\">",
"         Eye ointment:",
"        </span>",
"       </b>",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696185",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Use as you have been told, even if you are feeling better.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694913",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       For the eye only.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694635",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not wear contact lenses at any time while using this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694779",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not touch the container tip to the eye, lid, or other skin.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695513",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Place drug inside the lower lid. Close the eye for 1 to 2 minutes. Roll eyeball around.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695617",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Space each eye drug by 10 minutes.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10031208\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696583",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Use a missed dose as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it is close to the time for your next dose, skip the missed dose and go back to your normal time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696475",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take 2 doses at the same time or extra doses.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10031213\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699336",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store at room temperature.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10031214\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 11693 Version 34.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1004-61.234.146.186-B1BE4F5CD0-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f27_23_28020=[""].join("\n");
var outline_f27_23_28020=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F8107111\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F8107112\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10031205\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10031204\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10031209\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10031210\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10031212\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10031207\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10031208\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10031213\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10031214\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?3/21/3412?source=related_link\">",
"      Gentamicin (ophthalmic): Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?36/36/37443?source=related_link\">",
"      Gentamicin (ophthalmic): Pediatric drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?0/47/761?source=related_link\">",
"      Gentamicin (systemic): Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?18/8/18564?source=related_link\">",
"      Gentamicin (systemic): Patient drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?7/63/8185?source=related_link\">",
"      Gentamicin (systemic): Pediatric drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?16/46/17123?source=related_link\">",
"      Gentamicin (topical): Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?37/59/38835?source=related_link\">",
"      Gentamicin (topical): Patient drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?30/20/31042?source=related_link\">",
"      Gentamicin (topical): Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f27_23_28021="Voiding history question";
var content_f27_23_28021=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F78721&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F78721&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 611px\">",
"   <div class=\"ttl\">",
"    Voiding history questionaire",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 591px; height: 586px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f27_23_28021=[""].join("\n");
var outline_f27_23_28021=null;
var title_f27_23_28022="Stage 1 prolapse";
var content_f27_23_28022=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F58962%7EOBGYN%2F69729&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F58962%7EOBGYN%2F69729&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Stage I posterior vaginal wall prolapse",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 447px; height: 308px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    When the levator ani no longer holds the vagina closed, the anterior wall pressure no longer balances the posterior wall pressure. Stress is placed on the connective tissue support structures, as the pressure on the rectum is not counterbalanced. A rectocele may subsequently develop (arrow).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Walters, MD, Karram, MM. Urogynecology and reconstructive pelvic surgery, 3rd ed, Mosby-Elsevier, 2007. Copyright &copy;2007 Elsevier.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 499px\">",
"   <div class=\"ttl\">",
"    Stage II prolapse",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 479px; height: 305px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Increased distal abdominal pressure on a damaged perineal body may result in severe rectocele and perineal descent (arrow).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Walters, MD, Karram, MM. Urogynecology and reconstructive pelvic surgery, 3rd ed, Mosby-Elsevier, 2007. Copyright &copy;2007 Elsevier.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f27_23_28022=[""].join("\n");
var outline_f27_23_28022=null;
var title_f27_23_28023="Glycemic control and intensive insulin therapy in critical illness";
var content_f27_23_28023=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Glycemic control and intensive insulin therapy in critical illness",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?27/23/28023/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?27/23/28023/contributors\">",
"     Renee D Stapleton, MD, PhD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?27/23/28023/contributors\">",
"     Daren K Heyland, MD, FRCPC, MSc",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?27/23/28023/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?27/23/28023/contributors\">",
"     Polly E Parsons, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?27/23/28023/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?27/23/28023/contributors\">",
"     Geraldine Finlay, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?27/23/28023/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jan 15, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hyperglycemia associated with critical illness (also called stress hyperglycemia or stress diabetes) is a consequence of many factors, including increased cortisol, catecholamines, glucagon, growth hormone, gluconeogenesis, and glycogenolysis [",
"    <a class=\"abstract\" href=\"UTD.htm?27/23/28023/abstract/1\">",
"     1",
"    </a>",
"    ]. Insulin resistance may also be a contributing factor, since it has been demonstrated in more than 80 percent of critically ill patients [",
"    <a class=\"abstract\" href=\"UTD.htm?27/23/28023/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Hyperglycemia was previously considered an adaptive response essential for survival and was not routinely controlled in intensive care units (ICU) [",
"    <a class=\"abstract\" href=\"UTD.htm?27/23/28023/abstract/3,4\">",
"     3,4",
"    </a>",
"    ]. However, more recent evidence indicating that uncontrolled hyperglycemia is associated with poor outcomes has prompted efforts to routinely correct and prevent hyperglycemia in critically ill patients.",
"   </p>",
"   <p>",
"    The association between hyperglycemia and worse clinical outcomes in critically ill patients is reviewed here. Outcomes related to glycemic control are also discussed. Nutritional support in critically ill patients is described separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/32/13831?source=see_link\">",
"     \"Nutrition support in critically ill patients: An overview\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     EFFECTS OF HYPERGLYCEMIA",
"    </span>",
"    &nbsp;&mdash;&nbsp;There is a wealth of observational evidence from different patient populations demonstrating that hyperglycemia is associated with poor clinical outcomes in critically ill patients. However, this evidence does not prove that hyperglycemia causes poor clinical outcomes, since hyperglycemia may merely be a marker of severe illness.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Trauma",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients who are hyperglycemic following trauma have an increased mortality rate, hospital length of stay, ICU length of stay, and incidence of nosocomial infection [",
"    <a class=\"abstract\" href=\"UTD.htm?27/23/28023/abstract/5-8\">",
"     5-8",
"    </a>",
"    ]. This was illustrated by a prospective cohort study of 1003 patients who were admitted to an ICU following trauma [",
"    <a class=\"abstract\" href=\"UTD.htm?27/23/28023/abstract/7\">",
"     7",
"    </a>",
"    ]. Hyperglycemia (blood glucose &ge;200",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    [12.2",
"    <span class=\"nowrap\">",
"     mmol/L])",
"    </span>",
"    was present in 255 patients (25 percent) at the time of ICU admission. Compared to normoglycemic patients, hyperglycemic patients had a significantly increased mortality rate (26 versus 12 percent) and incidence of nosocomial infection (52 versus 32 percent).",
"   </p>",
"   <p>",
"    Hyperglycemia is also associated with worse neurologic outcomes and increased intracranial pressure in patients with traumatic brain injury [",
"    <a class=\"abstract\" href=\"UTD.htm?27/23/28023/abstract/9,10\">",
"     9,10",
"    </a>",
"    ]. In a retrospective cohort study of 77 patients with severe traumatic brain injury, hyperglycemia (blood glucose &ge;170",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    [9.4",
"    <span class=\"nowrap\">",
"     mmol/L])",
"    </span>",
"    at the time of ICU admission was an independent predictor of a poor Glasgow coma score five days later [",
"    <a class=\"abstract\" href=\"UTD.htm?27/23/28023/abstract/10\">",
"     10",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The association between hyperglycemia and adverse outcomes in trauma patients exists regardless of whether the hyperglycemia is present only at ICU admission or persists throughout the ICU stay [",
"    <a class=\"abstract\" href=\"UTD.htm?27/23/28023/abstract/8,10\">",
"     8,10",
"    </a>",
"    ]. One prospective cohort study of 942 trauma patients admitted to an ICU found that patients whose blood glucose was elevated at ICU admission (blood glucose &ge;200",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    [11.1",
"    <span class=\"nowrap\">",
"     mmol/L]),",
"    </span>",
"    increased during the ICU stay, or was highly variable during the ICU stay had an increased mortality rate, duration of mechanical ventilation, and ICU and hospital length of stay, compared to patients with alternative patterns of glucose control [",
"    <a class=\"abstract\" href=\"UTD.htm?27/23/28023/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Medical/surgical",
"    </span>",
"    &nbsp;&mdash;&nbsp;Critically ill medical and surgical patients who are hyperglycemic have a higher mortality rate than patients who are normoglycemic [",
"    <a class=\"abstract\" href=\"UTD.htm?27/23/28023/abstract/11,12\">",
"     11,12",
"    </a>",
"    ]. This was illustrated by a retrospective cohort study of 1826 medical and surgical ICU patients [",
"    <a class=\"abstract\" href=\"UTD.htm?27/23/28023/abstract/11\">",
"     11",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Compared to patients who survived, those who died had significantly higher admission blood glucose levels (175 versus 151",
"      <span class=\"nowrap\">",
"       mg/dL",
"      </span>",
"      [9.7 versus 8.4",
"      <span class=\"nowrap\">",
"       mmol/L]),",
"      </span>",
"      mean blood glucose levels (172 versus 138",
"      <span class=\"nowrap\">",
"       mg/dL",
"      </span>",
"      [9.5 versus 7.7",
"      <span class=\"nowrap\">",
"       mmol/L]),",
"      </span>",
"      and maximum blood glucose levels (258 versus 177",
"      <span class=\"nowrap\">",
"       mg/dL",
"      </span>",
"      [14.3 versus 9.8",
"      <span class=\"nowrap\">",
"       mmol/L]).",
"      </span>",
"     </li>",
"     <li>",
"      There was a graded effect, with higher mortality among patients who had higher blood glucose levels. Mortality ranged from 10 percent in patients with a mean blood glucose between 80 and 99",
"      <span class=\"nowrap\">",
"       mg/dL",
"      </span>",
"      (4.4 and 5.5",
"      <span class=\"nowrap\">",
"       mmol/L)",
"      </span>",
"      to 43 percent in patients with a mean blood glucose greater than 300",
"      <span class=\"nowrap\">",
"       mg/dL",
"      </span>",
"      (16.6",
"      <span class=\"nowrap\">",
"       mmol/L).",
"      </span>",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Hyperglycemia is also associated with worse outcomes in several subgroups of critically ill medical patients, including patients with stroke or acute myocardial infarction. Hyperglycemia and glycemic control in these subgroups are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/29/33242?source=see_link\">",
"     \"Initial assessment and management of acute stroke\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?43/33/44567?source=see_link\">",
"     \"Glycemic control for acute myocardial infarction in patients with and without diabetes mellitus\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     GLYCEMIC CONTROL",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most clinicians accept that prevention of uncontrolled hyperglycemia is a desirable intervention. However, the optimal blood glucose range is controversial [",
"    <a class=\"abstract\" href=\"UTD.htm?27/23/28023/abstract/13\">",
"     13",
"    </a>",
"    ]. Numerous clinical trials have compared different ranges of blood glucose in various populations of critically ill patients, some of which are described in this section. Their impact on patient care is described in the next section. (See",
"    <a class=\"local\" href=\"#H15\">",
"     'General approach'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Surgical patients",
"    </span>",
"    &nbsp;&mdash;&nbsp;A single center trial (the Leuven surgical trial) randomly assigned 1548 surgical ICU patients to receive intensive insulin therapy (IIT) or conventional blood glucose management [",
"    <a class=\"abstract\" href=\"UTD.htm?27/23/28023/abstract/14\">",
"     14",
"    </a>",
"    ]. IIT was defined as an insulin infusion targeting a blood glucose of 80 to 110",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    (4.4 to 6.1",
"    <span class=\"nowrap\">",
"     mmol/L).",
"    </span>",
"    Conventional blood glucose management targeted a blood glucose of 180 to 200",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    (10 to 11.1",
"    <span class=\"nowrap\">",
"     mmol/L)",
"    </span>",
"    and used an insulin infusion only if the blood glucose was greater than 215",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    (11.9",
"    <span class=\"nowrap\">",
"     mmol/L).",
"    </span>",
"    Patients in both arms of the trial were given 200 to 300 grams of intravenous glucose during the first day of ICU admission. In the majority of patients, parenteral nutrition was added to enteral nutrition on the second day of ICU admission if necessary to achieve the caloric goal.",
"   </p>",
"   <p>",
"    Most patients were adult (mean age 63 years) males (71 percent) who had undergone cardiac surgery (63 percent) and were not severely ill (mean Acute Physiologic and Chronic Health Evaluation [APACHE II] score was 9). The following outcomes were detected:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The mean blood glucose was significantly lower in the IIT group (103 versus 153",
"      <span class=\"nowrap\">",
"       mg/dL",
"      </span>",
"      [5.7 versus 8.5",
"      <span class=\"nowrap\">",
"       mmol/L]).",
"      </span>",
"     </li>",
"     <li>",
"      ICU mortality was significantly lower in the IIT group (4.6 versus 8.0 percent). The magnitude of the benefit was greatest among patients who were in the ICU for five days or longer.",
"     </li>",
"     <li>",
"      Hospital mortality was significantly lower in the IIT group (7.2 versus 10.9 percent).",
"     </li>",
"     <li>",
"      IIT decreased critical illness polymyoneuropathy, acute renal failure, transfusion requirement, and blood stream infections.",
"     </li>",
"     <li>",
"      Hypoglycemia (blood glucose &lt;40",
"      <span class=\"nowrap\">",
"       mg/dL",
"      </span>",
"      [2.2",
"      <span class=\"nowrap\">",
"       mmol/L])",
"      </span>",
"      was more frequent in the IIT group (5.1 versus 0.8 percent).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    A concern about this trial was the high mortality rates in the control group; specifically, ICU mortality was 8 percent and hospital mortality was 11 percent. These mortality rates are higher than the 1.5 to 3.5 percent reported for most patients undergoing routine cardiac surgery [",
"    <a class=\"abstract\" href=\"UTD.htm?27/23/28023/abstract/15,16\">",
"     15,16",
"    </a>",
"    ]. This high mortality raises the possibility that there was a harmful intervention in the control group that was ameliorated by IIT. One possibility is that the large glucose load administered on the first and second ICU day was harmful to the control group, but not the IIT group, because the IIT group was rescued by its more aggressive insulin regimen.",
"   </p>",
"   <p>",
"    These findings were supported by a meta-analysis of five randomized trials (1972 patients) that compared IIT to less stringent glycemic control in surgical ICU patients [",
"    <a class=\"abstract\" href=\"UTD.htm?27/23/28023/abstract/17\">",
"     17",
"    </a>",
"    ]. IIT was defined as a target blood glucose level &le;150",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    (8.3",
"    <span class=\"nowrap\">",
"     mmol/L).",
"    </span>",
"    Patients who received IIT had significantly lower mortality than those who received less stringent glycemic control (7.4 versus 11.8 percent, relative risk 0.63, 95% CI 0.44-0.91). However, the results of the meta-analysis were largely driven by the Leuven surgical trial, an important limitation.",
"   </p>",
"   <p>",
"    In contrast, when the Normoglycemia in Intensive Care Evaluation Survival Using Glucose Algorithm Regulation (NICE-SUGAR) trial analyzed its surgical patients, there was increased mortality among those who received IIT compared to those who received conventional glucose control [",
"    <a class=\"abstract\" href=\"UTD.htm?27/23/28023/abstract/18\">",
"     18",
"    </a>",
"    ]. These findings are described in detail below (see",
"    <a class=\"local\" href=\"#H9\">",
"     'NICE-SUGAR trial'",
"    </a>",
"    below).",
"   </p>",
"   <p>",
"    In a pediatric ICU trial not included in the above meta-analysis, tight glycemic control was compared with standard care in 989 children after surgery that involved cardiopulmonary bypass [",
"    <a class=\"abstract\" href=\"UTD.htm?27/23/28023/abstract/19\">",
"     19",
"    </a>",
"    ]. Participants were randomly assigned to tight glycemic control using an insulin-dosing algorithm targeting a blood glucose of 80 to 110 mg per dL (4.4 to 6.1 mmol per L) or standard care. Tight glycemic control, as compared with standard care in the cardiac ICU, did not change the rate of health care-associated infections (primary end-point), mortality, the length of stay in the cardiac ICU, or several organ-specific end points. Severe hypoglycemia (blood glucose &lt;40 mg per deciliter [2.2 mmol per liter]) occurred in 3 percent of patients in the tight glycemic control group and 1 percent of the standard care group. The incidence of hypoglycemia in the tight control group was lower than in other similar trials, which the authors attributed in part to use of subcutaneous continuous glucose monitoring that alerted nursing staff to actual or impending hypoglycemia.",
"   </p>",
"   <p>",
"    In summary, the Leuven surgical trial found that IIT improves mortality in surgical patients, while a higher quality trial found that IIT did not improve mortality in its surgical subgroup. Meta-analyses are limited because they are largely driven by the Leuven surgical trial. In all trials, patients who received IIT have had a significantly increased risk of severe hypoglycemia.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Medical patients",
"    </span>",
"    &nbsp;&mdash;&nbsp;The same investigators who performed the Leuven surgical trial conducted a similar trial exclusively in critically ill medical patients. The single center trial (the Leuven medical trial) randomly assigned 1200 medical ICU patients to receive IIT (target blood glucose level of 80 to 110",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    [4.4 to 6.1",
"    <span class=\"nowrap\">",
"     mmol/L])",
"    </span>",
"    or conventional glucose control (target blood glucose of 180 to 200",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    [10 to 11.1",
"    <span class=\"nowrap\">",
"     mmol/L])",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?27/23/28023/abstract/20\">",
"     20",
"    </a>",
"    ]. The insulin infusion protocols and nutritional strategies were the same as the Leuven surgical trial (see",
"    <a class=\"local\" href=\"#H6\">",
"     'Surgical patients'",
"    </a>",
"    above):",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Mean blood glucose was lower in the IIT group than the conventional therapy group (105 versus 160",
"      <span class=\"nowrap\">",
"       mg/dL",
"      </span>",
"      [5.8 versus 8.9",
"      <span class=\"nowrap\">",
"       mmol/L])",
"      </span>",
"     </li>",
"     <li>",
"      IIT did not change overall hospital mortality (37.3 versus 40.0 percent in the control group)",
"     </li>",
"     <li>",
"      IIT significantly reduced ICU length of stay, hospital length of stay, duration of mechanical ventilation, and acute kidney failure",
"     </li>",
"     <li>",
"      Hypoglycemia was significantly more common in the IIT group (18.7 versus 3.1 percent)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Like the Leuven surgical trial, the nutritional approach in the Leuven medical trial (ie, glucose loading by adding early",
"    <a class=\"drug drug_general\" href=\"UTD.htm?41/40/42628?source=see_link\">",
"     total parenteral nutrition",
"    </a>",
"    to enteral nutrition) is not the standard of care worldwide [",
"    <a class=\"abstract\" href=\"UTD.htm?27/23/28023/abstract/21,22\">",
"     21,22",
"    </a>",
"    ]. As a result, it is uncertain whether the results of this trial are generalizable to patients who receive a more usual nutritional approach, such as enteral nutrition started early and increased over the first few ICU days.",
"   </p>",
"   <p>",
"    A more recent trial supports the notion that strict blood glucose control is not beneficial in medical patients. The Corticosteroids and Intensive Insulin Therapy for Septic Shock (COIITSS) trial randomly assigned 509 patients with septic shock who were receiving corticosteroids to either intensive insulin therapy using the same protocol as the Leuven medical trial or conventional blood glucose control [",
"    <a class=\"abstract\" href=\"UTD.htm?27/23/28023/abstract/23\">",
"     23",
"    </a>",
"    ]. For the latter group, the blood glucose target, insulin dose, and route of administration were left to the discretion of the clinician, although they were encouraged to target a blood glucose level &lt;150",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    (8.3",
"    <span class=\"nowrap\">",
"     mmol/L).",
"    </span>",
"    The trial found no difference in mortality, ICU length of stay, ventilator-free days, or vasopressor-free days.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Mixed patients",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several randomized trials have evaluated IIT in mixed populations of critically ill medical and surgical patients [",
"    <a class=\"abstract\" href=\"UTD.htm?27/23/28023/abstract/18,24-26\">",
"     18,24-26",
"    </a>",
"    ]. At least two of the trials were stopped early for safety.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     NICE-SUGAR trial",
"    </span>",
"    &nbsp;&mdash;&nbsp;The largest trial was the multicenter Normoglycemia in Intensive Care Evaluation Survival Using Glucose Algorithm Regulation (NICE-SUGAR) trial, which randomly assigned 6104 medical and surgical ICU patients to either IIT (target blood glucose level of 81 to 108",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    [4.5 to 6",
"    <span class=\"nowrap\">",
"     mmol/L])",
"    </span>",
"    or conventional glucose control (target blood glucose of &lt;180",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    [&lt;10",
"    <span class=\"nowrap\">",
"     mmol/L])",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?27/23/28023/abstract/18\">",
"     18",
"    </a>",
"    ]. Although the conventional glucose control group was defined only by a maximal blood glucose target, the insulin infusion was reduced and then discontinued if the blood glucose level dropped below 144",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    (8.0",
"    <span class=\"nowrap\">",
"     mmol/L).",
"    </span>",
"    Compared to the conventional glucose control group:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The IIT group had a significantly lower time-weighted blood glucose (115 versus 144",
"      <span class=\"nowrap\">",
"       mg/dL",
"      </span>",
"      [6.2 versus 7.9",
"      <span class=\"nowrap\">",
"       mmol/L])",
"      </span>",
"     </li>",
"     <li>",
"      The IIT group had a significantly higher 90 day mortality (27.5 versus 24.9 percent, odds ratio 1.14, 95% CI 1.02-1.28)",
"     </li>",
"     <li>",
"      The IIT group had a significantly higher incidence of severe hypoglycemia (6.8 versus 0.5 percent), defined as a blood glucose &lt;40",
"      <span class=\"nowrap\">",
"       mg/dL",
"      </span>",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In the subgroup of 2232 operative patients, those who received IIT had a significantly higher mortality than those who received conventional glycemic control (24.4 versus 19.8 percent, odds ratio 1.31, 95% CI 1.07-1.61).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     VISEP trial",
"    </span>",
"    &nbsp;&mdash;&nbsp;The Volume Substitution and Insulin Therapy in Severe Sepsis (VISEP) trial was a multicenter two-by-two factorial trial conducted in medical and surgical ICU patients with severe sepsis [",
"    <a class=\"abstract\" href=\"UTD.htm?27/23/28023/abstract/24\">",
"     24",
"    </a>",
"    ]. It compared IIT (target blood glucose level of 80 to 110",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    [4.4 to 6.1",
"    <span class=\"nowrap\">",
"     mmol/L])",
"    </span>",
"    to conventional glucose control (target blood glucose level of 180 to 200",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    [10 to 11.1",
"    <span class=\"nowrap\">",
"     mmol/L]),",
"    </span>",
"    as well as comparing two methods of volume resuscitation. The IIT arm of the trial was stopped after 488 patients were enrolled because IIT significantly increased the rate of hypoglycemia (12.1 versus 2.1 percent) and serious adverse events (10.9 versus 5.2 percent). The trial then continued with only patients in the conventional therapy group until 537 patients were enrolled. The following outcomes were detected when IIT was compared to conventional glucose control:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Mean morning blood glucose was significantly lower in the IIT group (112 versus 151",
"      <span class=\"nowrap\">",
"       mg/dL",
"      </span>",
"      [6.2 versus 8.4",
"      <span class=\"nowrap\">",
"       mmol/L])",
"      </span>",
"     </li>",
"     <li>",
"      Hypoglycemia (blood glucose &le;40",
"      <span class=\"nowrap\">",
"       mg/dL",
"      </span>",
"      [2.2",
"      <span class=\"nowrap\">",
"       mmol/L])",
"      </span>",
"      was significantly more common in the IIT group (17 versus 4.1 percent)",
"     </li>",
"     <li>",
"      There was no significant difference in 28 day mortality (24.7 versus 26.0 percent in the conventional glucose control group), morbidity, or organ failures",
"     </li>",
"     <li>",
"      There was a nonstatistically significant increase in 90 day mortality in the IIT group (39.7 versus 35.4 percent)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h3\">",
"     Glucontrol trial",
"    </span>",
"    &nbsp;&mdash;&nbsp;The Glucontrol trial was a multicenter trial that randomly assigned 1101 critically ill medical and surgical patients to IIT (target blood glucose of 80 to 110",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    [4.4 to 6.1",
"    <span class=\"nowrap\">",
"     mmol/L])",
"    </span>",
"    or conventional glucose control (target blood glucose of 140 to 180",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    [7.8 to 10",
"    <span class=\"nowrap\">",
"     mmol/L])",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?27/23/28023/abstract/25\">",
"     25",
"    </a>",
"    ]. The trial was terminated early because of a high rate of unintended protocol violations. IIT significantly increased the rate of hypoglycemia (8.7 versus 2.7 percent). There was no difference in ICU mortality, although the IIT group had a nonsignificant trend toward increased 28 day mortality and hospital mortality.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h3\">",
"     Meta-analysis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Meta-analyses have been performed in an effort to consolidate the data from numerous randomized trials [",
"    <a class=\"abstract\" href=\"UTD.htm?27/23/28023/abstract/17,27-29\">",
"     17,27-29",
"    </a>",
"    ]. One such meta-analysis of 15 randomized trials (10,140 patients) compared IIT (defined as a target blood glucose level &le;150",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    [8.3",
"    <span class=\"nowrap\">",
"     mmol/L])",
"    </span>",
"    to less stringent glycemic control in mixed medical and surgical ICU patients [",
"    <a class=\"abstract\" href=\"UTD.htm?27/23/28023/abstract/17\">",
"     17",
"    </a>",
"    ]. Patients who received IIT had a similar mortality to those who received less stringent glycemic control (26.7 versus 25.6 percent, relative risk 0.99, 95% CI 0.87-1.12).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h3\">",
"     Summary",
"    </span>",
"    &nbsp;&mdash;&nbsp;In mixed populations of critically ill medical and surgical patients, IIT (target blood glucose of 80 to 110",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    [4.4 to 6.1",
"    <span class=\"nowrap\">",
"     mmol/L])",
"    </span>",
"    increased the incidence of severe hypoglycemia and either increased mortality or had no effect on mortality, when compared to the more permissive blood glucose ranges of 140 to 180",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    (7.8 to 10",
"    <span class=\"nowrap\">",
"     mmol/L)",
"    </span>",
"    and 180 to 200",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    (10 to 11.1",
"    <span class=\"nowrap\">",
"     mmol/L).",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Hypoglycemia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hypoglycemia",
"    is the most common adverse effect of IIT. It occurs in up to 19 percent of patients when defined as a blood glucose &lt;40",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    (2.2",
"    <span class=\"nowrap\">",
"     mmol/L)",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?27/23/28023/abstract/20\">",
"     20",
"    </a>",
"    ], or up to 32 percent of patients when defined as a blood glucose &lt;60",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    (3.3",
"    <span class=\"nowrap\">",
"     mmol/L)",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?27/23/28023/abstract/30\">",
"     30",
"    </a>",
"    ]. Its frequent occurrence is problematic because hypoglycemia can lead to seizures, brain damage, depression, and cardiac arrhythmias [",
"    <a class=\"abstract\" href=\"UTD.htm?27/23/28023/abstract/25,31-33\">",
"     25,31-33",
"    </a>",
"    ]. Hypoglycemia is also a risk factor for death [",
"    <a class=\"abstract\" href=\"UTD.htm?27/23/28023/abstract/25,32,34\">",
"     25,32,34",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In a post hoc analysis of 6026 patients from the NICE-SUGAR trial described above, patients with moderate or severe hypoglycemia (blood glucose, 41 to 70 mg per deciliter [2.3 to 3.9 mmol per liter] and &le;40 mg per deciliter [2.2 mmol per liter], respectively) had a higher risk of death compared with those without hypoglycemia (adjusted hazard ratio 1.41 [95% CI, 1.21-1.62] and 2.10 [95% CI, 1.59-2.77], respectively) [",
"      <a class=\"abstract\" href=\"UTD.htm?27/23/28023/abstract/35\">",
"       35",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      As part of a retrospective cohort study of more than 5000 medical and surgical critically ill patients, a nested case-control study found that a blood glucose &lt;40",
"      <span class=\"nowrap\">",
"       mg/dL",
"      </span>",
"      (2.2",
"      <span class=\"nowrap\">",
"       mmol/L)",
"      </span>",
"      was an independent risk factor for death after adjustment for severity of illness, age, mechanical ventilation, renal failure, sepsis, and diabetes (adjusted odds ratio 2.28, 95% CI, 1.41-3.70) [",
"      <a class=\"abstract\" href=\"UTD.htm?27/23/28023/abstract/32\">",
"       32",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In the control group of the Glucontrol trial, mortality among patients who had an episode of hypoglycemia was 53.8 percent, compared to only 15.2 percent among patients who had not had an episode of hypoglycemia [",
"      <a class=\"abstract\" href=\"UTD.htm?27/23/28023/abstract/25\">",
"       25",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In contrast, the Leuven trials found that hypoglycemia did not cause early deaths or neurologic sequelae [",
"    <a class=\"abstract\" href=\"UTD.htm?27/23/28023/abstract/36\">",
"     36",
"    </a>",
"    ]. This has led some clinicians to believe that transient hypoglycemia may not be harmful [",
"    <a class=\"abstract\" href=\"UTD.htm?27/23/28023/abstract/37\">",
"     37",
"    </a>",
"    ]. We believe, however, that the preponderance of evidence indicates that iatrogenic hypoglycemia is a life-threatening condition.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h1\">",
"     GENERAL APPROACH",
"    </span>",
"    &nbsp;&mdash;&nbsp;We recommend a blood glucose target of 140 to 180",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    (7.7 to 10",
"    <span class=\"nowrap\">",
"     mmol/L)",
"    </span>",
"    in most critically ill patients, rather than a more stringent target (eg, 80 to 110",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    [4.4 to 6.1",
"    <span class=\"nowrap\">",
"     mmol/L])",
"    </span>",
"    or a more liberal target (eg, 180 to 200",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    [10 to 11.1",
"    <span class=\"nowrap\">",
"     mmol/L]).",
"    </span>",
"    This range avoids marked hyperglycemia, while minimizing the risk of both iatrogenic hypoglycemia and other harms associated with a lower blood glucose target. The following evidence supports our approach:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Hyperglycemia, defined as a blood glucose level greater than 180 to 200",
"      <span class=\"nowrap\">",
"       mg/dL",
"      </span>",
"      (10 to 11.1",
"      <span class=\"nowrap\">",
"       mmol/L),",
"      </span>",
"      is associated with poor clinical outcomes. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Effects of hyperglycemia'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Intensive insulin therapy (IIT, target blood glucose range of 80 to 110",
"      <span class=\"nowrap\">",
"       mg/dL",
"      </span>",
"      [4.4 to 6.1",
"      <span class=\"nowrap\">",
"       mmol/L])",
"      </span>",
"      significantly increases the incidence of severe hypoglycemia. Its effect on mortality is uncertain, since various randomized trials have reported increased mortality, no effect on mortality, or decreased mortality. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Glycemic control'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H14\">",
"       'Hypoglycemia'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Patients managed with our blood glucose target had a significantly lower mortality and incidence of hypoglycemia in the largest trial that directly compared our recommended blood glucose target to IIT. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'NICE-SUGAR trial'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    To achieve our target blood glucose range, we first attempt to avoid the use of intravenous fluids that contain glucose and administer insulin only when necessary [",
"    <a class=\"abstract\" href=\"UTD.htm?27/23/28023/abstract/21,22\">",
"     21,22",
"    </a>",
"    ]. There is no universally accepted insulin regimen. Careful monitoring of blood glucose should always accompany administration of insulin, as hypoglycemia is associated with poor outcomes [",
"    <a class=\"abstract\" href=\"UTD.htm?27/23/28023/abstract/38\">",
"     38",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    Hyperglycemia is associated with poor clinical outcomes in critically ill patients. (See",
"    <a class=\"local\" href=\"#H2\">",
"     'Effects of hyperglycemia'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    While most clinicians agree that such glycemic control is a desirable intervention, the optimal blood glucose range is controversial. (See",
"    <a class=\"local\" href=\"#H5\">",
"     'Glycemic control'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    For hyperglycemic critically ill patients:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      We recommend a blood glucose target of 140 to 180",
"      <span class=\"nowrap\">",
"       mg/dL",
"      </span>",
"      (7.7 to 10",
"      <span class=\"nowrap\">",
"       mmol/L),",
"      </span>",
"      rather than a more stringent target (eg, 80 to 110",
"      <span class=\"nowrap\">",
"       mg/dL",
"      </span>",
"      [4.4 to 6.1",
"      <span class=\"nowrap\">",
"       mmol/L])",
"      </span>",
"      (",
"      <a class=\"grade\" href=\"._grade_1?title=Grade 1A\">",
"       Grade 1A",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H15\">",
"       'General approach'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We also suggest a blood glucose target of 140 to 180",
"      <span class=\"nowrap\">",
"       mg/dL",
"      </span>",
"      (7.7 to 10",
"      <span class=\"nowrap\">",
"       mmol/L),",
"      </span>",
"      rather than a more liberal target (eg, 180 to 200",
"      <span class=\"nowrap\">",
"       mg/dL",
"      </span>",
"      [10 to 11.1",
"      <span class=\"nowrap\">",
"       mmol/L])",
"      </span>",
"      (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H15\">",
"       'General approach'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      To achieve our target blood glucose, we minimize our use of intravenous fluids that contain glucose and administer insulin only when necessary. A widely accepted insulin regimen has not been established. Careful monitoring of blood glucose should always accompany administration of insulin, as hypoglycemia is associated with poor outcomes. (See",
"      <a class=\"local\" href=\"#H15\">",
"       'General approach'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H14\">",
"       'Hypoglycemia'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28023/abstract/1\">",
"      McCowen KC, Malhotra A, Bistrian BR. Stress-induced hyperglycemia. Crit Care Clin 2001; 17:107.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28023/abstract/2\">",
"      Saberi F, Heyland D, Lam M, et al. Prevalence, incidence, and clinical resolution of insulin resistance in critically ill patients: an observational study. JPEN J Parenter Enteral Nutr 2008; 32:227.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28023/abstract/3\">",
"      Chinsky K. The evolving paradigm of hyperglycemia and critical illness. Chest 2004; 126:674.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28023/abstract/4\">",
"      Robinson LE, van Soeren MH. Insulin resistance and hyperglycemia in critical illness: role of insulin in glycemic control. AACN Clin Issues 2004; 15:45.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28023/abstract/5\">",
"      Yendamuri S, Fulda GJ, Tinkoff GH. Admission hyperglycemia as a prognostic indicator in trauma. J Trauma 2003; 55:33.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28023/abstract/6\">",
"      Laird AM, Miller PR, Kilgo PD, et al. Relationship of early hyperglycemia to mortality in trauma patients. J Trauma 2004; 56:1058.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28023/abstract/7\">",
"      Sung J, Bochicchio GV, Joshi M, et al. Admission hyperglycemia is predictive of outcome in critically ill trauma patients. J Trauma 2005; 59:80.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28023/abstract/8\">",
"      Bochicchio GV, Sung J, Joshi M, et al. Persistent hyperglycemia is predictive of outcome in critically ill trauma patients. J Trauma 2005; 58:921.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28023/abstract/9\">",
"      Rovlias A, Kotsou S. The influence of hyperglycemia on neurological outcome in patients with severe head injury. Neurosurgery 2000; 46:335.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28023/abstract/10\">",
"      Jeremitsky E, Omert LA, Dunham CM, et al. The impact of hyperglycemia on patients with severe brain injury. J Trauma 2005; 58:47.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28023/abstract/11\">",
"      Krinsley JS. Association between hyperglycemia and increased hospital mortality in a heterogeneous population of critically ill patients. Mayo Clin Proc 2003; 78:1471.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28023/abstract/12\">",
"      Falciglia M, Freyberg RW, Almenoff PL, et al. Hyperglycemia-related mortality in critically ill patients varies with admission diagnosis. Crit Care Med 2009; 37:3001.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28023/abstract/13\">",
"      Qaseem A, Humphrey LL, Chou R, et al. Use of intensive insulin therapy for the management of glycemic control in hospitalized patients: a clinical practice guideline from the American College of Physicians. Ann Intern Med 2011; 154:260.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28023/abstract/14\">",
"      van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in critically ill patients. N Engl J Med 2001; 345:1359.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28023/abstract/15\">",
"      Likosky DS, Nugent WC, Clough RA, et al. Comparison of three measurements of cardiac surgery mortality for the Northern New England Cardiovascular Disease Study Group. Ann Thorac Surg 2006; 81:1393.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28023/abstract/16\">",
"      Becker ER, McPherson MA, Rahimi A. Influence of source and type of admission on in-hospital mortality for coronary artery bypass surgery patients: national results from 1.7 million CABG patients, 1998 to 2002. J Card Surg 2007; 22:203.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28023/abstract/17\">",
"      Griesdale DE, de Souza RJ, van Dam RM, et al. Intensive insulin therapy and mortality among critically ill patients: a meta-analysis including NICE-SUGAR study data. CMAJ 2009; 180:821.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28023/abstract/18\">",
"      NICE-SUGAR Study Investigators, Finfer S, Chittock DR, et al. Intensive versus conventional glucose control in critically ill patients. N Engl J Med 2009; 360:1283.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28023/abstract/19\">",
"      Agus MS, Steil GM, Wypij D, et al. Tight glycemic control versus standard care after pediatric cardiac surgery. N Engl J Med 2012; 367:1208.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28023/abstract/20\">",
"      Van den Berghe G, Wilmer A, Hermans G, et al. Intensive insulin therapy in the medical ICU. N Engl J Med 2006; 354:449.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28023/abstract/21\">",
"      Heyland DK, Dhaliwal R, Drover JW, et al. Canadian clinical practice guidelines for nutrition support in mechanically ventilated, critically ill adult patients. JPEN J Parenter Enteral Nutr 2003; 27:355.",
"     </a>",
"    </li>",
"    <li>",
"     Published version of the clinical practice guidelines. In: Nutrition CPGs. www.criticalcarenutrition.com (Accessed on October 14, 2008).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28023/abstract/23\">",
"      COIITSS Study Investigators, Annane D, Cariou A, et al. Corticosteroid treatment and intensive insulin therapy for septic shock in adults: a randomized controlled trial. JAMA 2010; 303:341.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28023/abstract/24\">",
"      Brunkhorst FM, Engel C, Bloos F, et al. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med 2008; 358:125.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28023/abstract/25\">",
"      Preiser JC, Devos P, Ruiz-Santana S, et al. A prospective randomised multi-centre controlled trial on tight glucose control by intensive insulin therapy in adult intensive care units: the Glucontrol study. Intensive Care Med 2009; 35:1738.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28023/abstract/26\">",
"      Arabi YM, Dabbagh OC, Tamim HM, et al. Intensive versus conventional insulin therapy: a randomized controlled trial in medical and surgical critically ill patients. Crit Care Med 2008; 36:3190.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28023/abstract/27\">",
"      Wiener RS, Wiener DC, Larson RJ. Benefits and risks of tight glucose control in critically ill adults: a meta-analysis. JAMA 2008; 300:933.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28023/abstract/28\">",
"      Marik PE, Preiser JC. Toward understanding tight glycemic control in the ICU: a systematic review and metaanalysis. Chest 2010; 137:544.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28023/abstract/29\">",
"      Kansagara D, Fu R, Freeman M, et al. Intensive insulin therapy in hospitalized patients: a systematic review. Ann Intern Med 2011; 154:268.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28023/abstract/30\">",
"      Grey NJ, Perdrizet GA. Reduction of nosocomial infections in the surgical intensive-care unit by strict glycemic control. Endocr Pract 2004; 10 Suppl 2:46.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28023/abstract/31\">",
"      Vanhorebeek I, Langouche L, Van den Berghe G. Tight blood glucose control with insulin in the ICU: facts and controversies. Chest 2007; 132:268.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28023/abstract/32\">",
"      Krinsley JS, Grover A. Severe hypoglycemia in critically ill patients: risk factors and outcomes. Crit Care Med 2007; 35:2262.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28023/abstract/33\">",
"      Dowdy DW, Dinglas V, Mendez-Tellez PA, et al. Intensive care unit hypoglycemia predicts depression during early recovery from acute lung injury. Crit Care Med 2008; 36:2726.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28023/abstract/34\">",
"      Hermanides J, Bosman RJ, Vriesendorp TM, et al. Hypoglycemia is associated with intensive care unit mortality. Crit Care Med 2010; 38:1430.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28023/abstract/35\">",
"      The NICE-SUGAR Study Investigators. Hypoglycemia and risk of death in critically ill patients. N Engl J Med 2012; 367:1108.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28023/abstract/36\">",
"      Van den Berghe G, Wilmer A, Milants I, et al. Intensive insulin therapy in mixed medical/surgical intensive care units: benefit versus harm. Diabetes 2006; 55:3151.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28023/abstract/37\">",
"      Mackenzie, I, Ingle, S, Zaidi, S, Buczaski, S. Hypoglycemia? So what! Intensive Care Med 2006; 32:620.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28023/abstract/38\">",
"      Jacobi J, Bircher N, Krinsley J, et al. Guidelines for the use of an insulin infusion for the management of hyperglycemia in critically ill patients. Crit Care Med 2012; 40:3251.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 1600 Version 17.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1104-60.18.131.125-A0D016103C-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f27_23_28023=[""].join("\n");
var outline_f27_23_28023=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H16\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      EFFECTS OF HYPERGLYCEMIA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Trauma",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Medical/surgical",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      GLYCEMIC CONTROL",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Surgical patients",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Medical patients",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Mixed patients",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - NICE-SUGAR trial",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - VISEP trial",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      - Glucontrol trial",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      - Meta-analysis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      - Summary",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Hypoglycemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      GENERAL APPROACH",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?43/33/44567?source=related_link\">",
"      Glycemic control for acute myocardial infarction in patients with and without diabetes mellitus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/29/33242?source=related_link\">",
"      Initial assessment and management of acute stroke",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/32/13831?source=related_link\">",
"      Nutrition support in critically ill patients: An overview",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f27_23_28024="Right and extended right colectomy: Open technique";
var content_f27_23_28024=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Right and extended right colectomy: Open technique",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?27/23/28024/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?27/23/28024/contributors\">",
"     Andrea Bafford, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?27/23/28024/contributors\">",
"     Randolph Steinhagen, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?27/23/28024/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?27/23/28024/contributors\">",
"     Martin Weiser, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?27/23/28024/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?27/23/28024/contributors\">",
"     Rosemary B Duda, MD, MPH, FACS",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?27/23/28024/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Dec 1, 2011.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H186829949\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Right colectomy refers to the resection of a portion of the distal ileum, cecum, ascending colon, and proximal to mid-transverse colon. Extended right hemicolectomy refers to extension of the distal resection to include the left transverse colon up to the splenic flexure.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H452004\">",
"    <span class=\"h1\">",
"     INDICATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Malignant and benign diseases are indications for a right colectomy and include a right colon cancer (eg, cecum, ascending colon), appendiceal cancer, right-sided diverticulitis, inflammatory bowel disease,",
"    <span class=\"nowrap\">",
"     ischemia/infarction,",
"    </span>",
"    infection, trauma, and cecal volvulus. The indications for an extended right colectomy include a cancer located at the hepatic flexure to the mid-transverse colon.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H186829957\">",
"    <span class=\"h1\">",
"     PREOPERATIVE PREPARATION",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H186829972\">",
"    <span class=\"h2\">",
"     Mechanical bowel preparation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Preoperative mechanical bowel preparation (MBP) is unnecessary for patients undergoing elective open right-sided colon surgery, based upon the review of 14 randomized trials and 8 meta-analyses by the Canadian Society of Colon and Rectal Surgeons [",
"    <a class=\"abstract\" href=\"UTD.htm?27/23/28024/abstract/1\">",
"     1",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?16/23/16762?source=see_link&amp;anchor=H125365066#H125365066\">",
"     \"Surgical oncologic principles for the resection of colon cancer\", section on 'Bowel preparation'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H186829979\">",
"    <span class=\"h2\">",
"     Prophylactic antibiotics",
"    </span>",
"    &nbsp;&mdash;&nbsp;It is our practice to give a first generation cephalosporin (typically",
"    <a class=\"drug drug_general\" href=\"UTD.htm?4/2/4136?source=see_link\">",
"     cefazolin",
"    </a>",
"    ) as well as",
"    <a class=\"drug drug_general\" href=\"UTD.htm?19/38/20065?source=see_link\">",
"     metronidazole",
"    </a>",
"    intravenously within one hour of incision for right colectomy (",
"    <a class=\"graphic graphic_table graphicRef65369 \" href=\"UTD.htm?23/52/24397\">",
"     table 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_table graphicRef79097 \" href=\"UTD.htm?22/46/23275\">",
"     table 2",
"    </a>",
"    ). We do not use oral antibiotics or continue prophylaxis postoperatively. The efficacy of adding oral antibiotics to decrease the surgical wound infection rate has not been established in uncleansed bowel.",
"   </p>",
"   <p>",
"    The use and timing of antimicrobial prophylaxis for prevention of surgical site infection following gastrointestinal procedures is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/23/18806?source=see_link\">",
"     \"Control measures to prevent surgical site infection following gastrointestinal procedures\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/35/31290?source=see_link&amp;anchor=H10#H10\">",
"     \"Overview of control measures to prevent surgical site infection\", section on 'Timing of prophylaxis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27175149\">",
"    <span class=\"h2\">",
"     Venous thromboembolism prophylaxis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients undergoing a colectomy are at risk for developing a deep venous thrombosis. Prophylaxis is discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/52/41802?source=see_link\">",
"     \"Prevention of venous thromboembolic disease in surgical patients\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H186830001\">",
"    <span class=\"h1\">",
"     OPEN SURGICAL TECHNIQUE",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H451735\">",
"    <span class=\"h2\">",
"     Optional equipment",
"    </span>",
"    &nbsp;&mdash;&nbsp;It can be helpful to have a flexible colonoscope available in the operating room, as it may be needed to identify a cancer or other mucosal lesion if it cannot be palpated.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H452622\">",
"    <span class=\"h2\">",
"     Exploration for resectability",
"    </span>",
"    &nbsp;&mdash;&nbsp;Prior to initiating the resection, the abdomen is thoroughly examined for resectability of the right colon.",
"   </p>",
"   <p>",
"    For patients with cancer, this evaluation includes an assessment of local, regional, and distant disease.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The abdomen is explored for evidence of anomalies",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      metastatic disease, including peritoneal implants, hepatic metastases, and distant nodal metastases.",
"     </li>",
"     <li>",
"      The primary tumor is palpated to confirm its location. Local and regional resectability is determined by assessing tumor invasion into the stomach, vena cava, duodenum, pancreas,",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      superior mesenteric vessels (",
"      <a class=\"graphic graphic_figure graphicRef60998 \" href=\"UTD.htm?31/6/31846\">",
"       figure 1",
"      </a>",
"      ). The entire colon is palpated to identify synchronous colonic lesions.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H186830016\">",
"    <span class=\"h2\">",
"     Extent of resection",
"    </span>",
"    &nbsp;&mdash;&nbsp;The selection of the operative procedure (eg, right or extended right colectomy) is based upon the location of the lesion, malignant or benign indication, blood supply, and venous and lymphatic drainage of the colon. The blood supply, venous return, and lymphatic drainage of the colon are shown in the attached figures and are critical in planning a colectomy (",
"    <a class=\"graphic graphic_figure graphicRef73756 \" href=\"UTD.htm?40/32/41479\">",
"     figure 2",
"    </a>",
"    and",
"    <a class=\"graphic graphic_figure graphicRef81960 \" href=\"UTD.htm?3/3/3127\">",
"     figure 3",
"    </a>",
"    and",
"    <a class=\"graphic graphic_figure graphicRef58219 \" href=\"UTD.htm?38/33/39448\">",
"     figure 4",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H115081012\">",
"    <span class=\"h3\">",
"     Right colectomy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Malignant lesions located in the appendix, cecum, and ascending colon, and benign lesions (eg, cecal diverticulum, inflammatory bowel disease) limited to the right colon can be resected by a standard right colectomy. The resection extends from the distal ileum to the mid-transverse colon, and involves isolating and dividing the ileocolic, right colic, and either the right or hepatic branch of the middle colic artery and vein (",
"    <a class=\"graphic graphic_figure graphicRef70995 \" href=\"UTD.htm?24/61/25556\">",
"     figure 5",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H115081019\">",
"    <span class=\"h3\">",
"     Right extended colectomy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Malignant lesions located in the hepatic flexure or proximal to the mid-transverse colon, and benign inflammatory conditions extending to the mid-transverse colon are resected with an extended right colectomy (",
"    <a class=\"graphic graphic_figure graphicRef51067 \" href=\"UTD.htm?25/39/26228\">",
"     figure 6",
"    </a>",
"    ). An extended right colectomy includes the resection of the distal transverse colon and sometimes the splenic flexure, and involves ligating the ileocolic, right colic, and middle colic vessels. An anastomosis is avoided in areas of unreliable blood supply (eg, mid-ascending colon or splenic flexure). An option to the extended right colectomy for proximal to mid-transverse colon cancers is a transverse colectomy (",
"    <a class=\"graphic graphic_figure graphicRef60729 \" href=\"UTD.htm?43/8/44163\">",
"     figure 7",
"    </a>",
"    and",
"    <a class=\"graphic graphic_figure graphicRef69341 \" href=\"UTD.htm?19/24/19844\">",
"     figure 8",
"    </a>",
"    ). The caveat of this procedure is the poor blood supply to the distal and proximal ends of the resected bowel and a tenuous anastomosis; hence, the extended right colectomy is typically preferred in these settings.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H115081026\">",
"    <span class=\"h3\">",
"     Mesenteric resection",
"    </span>",
"    &nbsp;&mdash;&nbsp;The extent of the mesenteric resection also varies according to the indication for surgery. For example, when performing a colectomy for benign disease, mesenteric vessels are typically divided close to the mesenteric border of the colon since it is unnecessary to resect draining lymph nodes. However, for settings of severe mesenteric inflammation (eg, diverticulitis, inflammatory bowel disease) and thickening of the mesentery near the bowel wall, a more radical mesenteric dissection may be warranted [",
"    <a class=\"abstract\" href=\"UTD.htm?27/23/28024/abstract/2\">",
"     2",
"    </a>",
"    ]. When colectomies are performed for malignancy, the mesenteric vessels are ligated close to their root for optimal resection of lymphovascular tissue.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H115081033\">",
"    <span class=\"h3\">",
"     Omental resection",
"    </span>",
"    &nbsp;&mdash;&nbsp;The omentum is divided at the distal bowel resection margin and the proximal portion removed for ascending colon, hepatic flexure, and transverse colon cancers (",
"    <a class=\"graphic graphic_figure graphicRef53153 \" href=\"UTD.htm?17/33/17938\">",
"     figure 9",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H451980\">",
"    <span class=\"h2\">",
"     Mobilization of the right colon",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are two approaches to resecting the right colon, one begins laterally by mobilizing the colon and progresses medially, while the other begins medially by identifying the lymphovascular bundle and progresses laterally. The approach is at the discretion of the surgeon, although in most settings the lateral to medial approach is performed.",
"   </p>",
"   <p>",
"    In the lateral to medial approach, the mesentery is thoroughly mobilized prior to vascular division. This allows for accurate identification of the root of the mesentery, the retroperitoneal duodenum, and the right ureter prior to dissection in the mesenteric root and division of the vessels. The medial to lateral technique has been utilized primarily in laparoscopic surgery where vascular ligation prior to mobilization is necessary in order to maintain necessary traction and exposure of the mesenteric structures.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H186830023\">",
"    <span class=\"h3\">",
"     Lateral to medial approach",
"    </span>",
"    &nbsp;&mdash;&nbsp;The lateral to medial approach begins by mobilizing the right colon by first dividing the lateral attachment of the colon and developing the retromesenteric plane in a lateral to medial fashion. This approach is performed for both malignant and benign right colon diseases.",
"   </p>",
"   <p>",
"    The general principles for performing a right or extended right colectomy, beginning with the mobilization of the colon, include [",
"    <a class=\"abstract\" href=\"UTD.htm?27/23/28024/abstract/2\">",
"     2",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Retract the colon medially and divide the lateral peritoneal attachments of the cecum and ascending colon along the white line of Toldt (",
"      <a class=\"graphic graphic_figure graphicRef78271 \" href=\"UTD.htm?19/37/20063\">",
"       figure 10",
"      </a>",
"      ). The peritoneum and the colon are gently separated from the loose areolar tissue by finger dissection (",
"      <a class=\"graphic graphic_figure graphicRef70302 \" href=\"UTD.htm?35/24/36238\">",
"       figure 11",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      Avoid injury to the duodenum, right ureter, and gonadal vessels. These structures should remain posterior and lateral to the right colon, underneath an intact retroperitoneum fascia (",
"      <a class=\"graphic graphic_figure graphicRef54457 \" href=\"UTD.htm?1/18/1318\">",
"       figure 12",
"      </a>",
"      ). Dissection is carried out between the posterior aspect of the right colon mesentery and Gerota's fascia, taking care to avoid excessive traction on the duodenum. Some degree of fusion may exist between Toldt&rsquo;s retroperitoneal fascia and the mesentery, making dissection precarious, particularly around Gerota's fascia.",
"     </li>",
"     <li>",
"      Divide the right renocolic ligament using electrocautery.",
"     </li>",
"     <li>",
"      Dissect distally along the colon until the gastrocolic ligament is encountered. The gastrocolic ligament extends from the greater curvature of the stomach to the transverse colon and forms the anterior portion of the lesser sac (omental bursa). It is inferior and parallel to the stomach and is the left continuation of the transverse mesocolon (",
"      <a class=\"graphic graphic_figure graphicRef75897 \" href=\"UTD.htm?25/62/26594\">",
"       figure 13",
"      </a>",
"      ). Once the lesser sac is opened, the gastrocolic ligament is divided from left to right, completing mobilization of the hepatic flexure. The duodenum and head of the pancreas are now exposed (",
"      <a class=\"graphic graphic_figure graphicRef85980 \" href=\"UTD.htm?31/17/32017\">",
"       figure 14",
"      </a>",
"      ). Any remaining attachments between the right colon mesentery and anterolateral portion of the second and third part of the duodenum are divided.",
"     </li>",
"     <li>",
"      Release the terminal ileum by dividing the fold of Treves on its antimesenteric border.",
"     </li>",
"     <li>",
"      Ligate the lymphovascular pedicle and resect the bowel. (See",
"      <a class=\"local\" href=\"#H186830030\">",
"       'Medial to lateral approach'",
"      </a>",
"      below.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H186830030\">",
"    <span class=\"h3\">",
"     Medial to lateral approach",
"    </span>",
"    &nbsp;&mdash;&nbsp;The medial to lateral approach is ideal for resection of inflamed bowel and adjacent mesentery, and for performing the &ldquo;no-touch&rdquo; approach to colon cancer resection by ligating the lymphovascular pedicle prior to mobilizing the colon.",
"   </p>",
"   <p>",
"    The advantages of this approach include maximal time for sharp demarcation between ischemic and well-perfused bowel, lymphovascular pedicle ligated prior to risk of injury by torsion during colon mobilization, and more efficient identification of the resection plane in the setting of severe mesenteric inflammation (eg, diverticulitis, inflammatory bowel disease).",
"   </p>",
"   <p>",
"    The general principles for performing a right or extended right colectomy, beginning with ligation of the mesenteric lymphovascular pedicle, include [",
"    <a class=\"abstract\" href=\"UTD.htm?27/23/28024/abstract/2\">",
"     2",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Identify the lymphovascular pedicles by retracting the small bowel to the left side of the abdominal cavity and elevating the right colon to expose the root of the mesentery (",
"      <a class=\"graphic graphic_figure graphicRef58219 \" href=\"UTD.htm?38/33/39448\">",
"       figure 4",
"      </a>",
"      and",
"      <a class=\"graphic graphic_figure graphicRef81960 \" href=\"UTD.htm?3/3/3127\">",
"       figure 3",
"      </a>",
"      and",
"      <a class=\"graphic graphic_figure graphicRef73756 \" href=\"UTD.htm?40/32/41479\">",
"       figure 2",
"      </a>",
"      ).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      The ileocolic vessels are located at the caudal portion of the root of the mesentery and",
"      <span class=\"nowrap\">",
"       supply/drain",
"      </span>",
"      the terminal ileum and cecum.",
"     </li>",
"     <li>",
"      The right colic vessels are variable, but classically are located at the middle of the root of the mesentery and",
"      <span class=\"nowrap\">",
"       supply/drain",
"      </span>",
"      the distal ascending colon and hepatic flexure. A common variation is for the right colic artery to arise from the middle colic artery rather than the superior mesenteric artery.",
"     </li>",
"     <li>",
"      The middle colic vessels exit the root of the mesentery close to the third portion of the duodenum and",
"      <span class=\"nowrap\">",
"       supply/drain",
"      </span>",
"      the transverse colon.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Identify the superior mesenteric artery to prevent injury or inadvertent ligation.",
"     </li>",
"     <li>",
"      Incise the peritoneum overlying the vascular pedicle and ligate the vessels in close proximity to their origins. We typically doubly ligate the larger vessels with a nonabsorbable (ie, silk) or a slowly dissolving (ie, polyglycolic acid) suture. Single ligatures are used for small to medium-size vessels (",
"      <a class=\"graphic graphic_figure graphicRef73546 \" href=\"UTD.htm?6/20/6465\">",
"       figure 15",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      Resect the mesentery by sequentially clamping and tying or with the use of energy devices (eg, LigaSure&trade;, Enseal&trade;) (",
"      <a class=\"graphic graphic_figure graphicRef73546 \" href=\"UTD.htm?6/20/6465\">",
"       figure 15",
"      </a>",
"      and",
"      <a class=\"graphic graphic_figure graphicRef53575 \" href=\"UTD.htm?8/45/8913\">",
"       figure 16",
"      </a>",
"      ). In cases of right colectomy for Crohn's disease where the mesentery is thick and friable, we often find the clamp and tie technique superior.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H186830037\">",
"    <span class=\"h2\">",
"     Restoring bowel continuity",
"    </span>",
"    &nbsp;&mdash;&nbsp;Options for restoring bowel continuity include a side-to-side or an end-to-side ileocolic anastomosis, which is performed with a stapling device or hand-sewn. Experience, surgeon&rsquo;s preference, and availability of equipment dictate the type of anastomosis a surgeon performs in a given situation. Stapling the anastomosis requires less time to perform and offers the potential for reduced fecal contamination.",
"   </p>",
"   <p>",
"    There appears to be no significant advantage of a stapled anastomosis verus a hand-sewn one for outcomes that include mortality, overall dehiscence, clinical and radiographic leaks, hemorrhage, and wound infection. A meta-analysis of nine randomized trials that included 1233 adults undergoing elective colorectal surgery found insufficient evidence to demonstrate superiority of stapled over hand-sewn anastomosis [",
"    <a class=\"abstract\" href=\"UTD.htm?27/23/28024/abstract/3\">",
"     3",
"    </a>",
"    ]. Stricture rate was, however, significantly higher for stapled versus hand-sewn anastomosis (40 of 500 patients [8 percent] versus 10 of 496 patients [2 percent]).",
"   </p>",
"   <p>",
"    These findings cannot be generalized to patients with inflammatory bowel disease as there were only 94 patients (9 percent) with Crohn&rsquo;s disease. Limitations of these trials include the lack of description of the type of hand-sewn anastomosis (one layer versus two layers) and lack of comparison of sewing materials, which may contribute to the higher leak rates with hand-sewn anastomoses. The difference in clinical leak rates was small. There were no data on the outcomes of patients with leaks. Given these limitations and the equivalence of the two approaches for all other outcomes evaluated, we feel that the anastomotic technique should depend on the surgeon&rsquo;s preference, experience, and availability of equipment. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?4/5/4186?source=see_link&amp;anchor=H800363#H800363\">",
"     \"Management of anastomotic complications of colorectal surgery\", section on 'Dehiscence and leaks'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In patients with Crohn&rsquo;s disease, the risk of recurrence of disease is not influenced by the approach used for bowel anastomosis. A randomized trial of 139 patients with Crohn&rsquo;s disease found no difference in symptomatic or endoscopic recurrence rates at 12 months for patients undergoing a stapled side-to-side ileocolic anastomosis compared with a hand-sewn end-to-end ileocolic anastomosis (22.7 versus 21.9 percent and 37.9 versus 42.5 percent, respectively) [",
"    <a class=\"abstract\" href=\"UTD.htm?27/23/28024/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H186830044\">",
"    <span class=\"h3\">",
"     Stapled side-to-side functional end-to-end anastomosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;When the bowel is very thick, hand-sewn techniques are preferred. The anastomotic suture depth can be adjusted according to bowel thickness, unlike staple heights, which are pre-set.",
"   </p>",
"   <p>",
"    The technical steps for a stapled side-to-side functional end-to-end anastomosis include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The ileum and colon are transected using a linear cutting stapler in an area cleared of mesentery for 2 cm (",
"      <a class=\"graphic graphic_figure graphicRef63206 \" href=\"UTD.htm?25/52/26447\">",
"       figure 17",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      The ileum and colon are lined up side-by-side such that their mesenteries are not twisted and the antimesenteric and mesenteric borders of the two bowel loops approximate each other.",
"     </li>",
"     <li>",
"      The antimesenteric staple line corners are removed using either heavy scissors or electrocautery.",
"     </li>",
"     <li>",
"      The arms of a linear cutting stapler are inserted into the bowel lumens (",
"      <a class=\"graphic graphic_figure graphicRef71016 \" href=\"UTD.htm?0/13/223\">",
"       figure 18",
"      </a>",
"      and",
"      <a class=\"graphic graphic_figure graphicRef63851 \" href=\"UTD.htm?40/19/41264\">",
"       figure 19",
"      </a>",
"      ). The staple line is cleared of the mesenteries, the ileum and colon are placed at the inside corner of the instrument, and the stapler is fired.",
"     </li>",
"     <li>",
"      The remaining enterotomy is closed using a TA&trade; stapler (",
"      <a class=\"graphic graphic_picture graphicRef58090 \" href=\"UTD.htm?42/25/43422\">",
"       picture 1",
"      </a>",
"      ), including the serosa circumferentially. Care is taken to off-set the two staple lines from each other.",
"     </li>",
"     <li>",
"      A single nonabsorbable seromuscular suture should be placed at the apex of the anastomosis to prevent &ldquo;unzipping&rdquo;.",
"     </li>",
"     <li>",
"      Any excessive bleeding from the staple lines is controlled with electrocautery or with figure-of-eight absorbable sutures (",
"      <a class=\"graphic graphic_figure graphicRef55591 \" href=\"UTD.htm?20/28/20942\">",
"       figure 20",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      The mesenteric defect is closed by suturing together the peritoneum overlying the two cut mesenteries with a running absorbable suture. It is the authors&rsquo; preference to prevent internal hernias. Some surgeons do not close the mesenteric defect as the risk of internal herniation is low.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    An alternative, based on surgeon preference, to transecting the ileum and colon as the initial step is to create transverse enterotomies in preparation for placement of the linear cutting stapler (",
"    <a class=\"graphic graphic_figure graphicRef51045 \" href=\"UTD.htm?4/52/4943\">",
"     figure 21",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?27/23/28024/abstract/5\">",
"     5",
"    </a>",
"    ]. The specimen is divided after the ileum and colon are stapled together to form the anastomosis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H186830051\">",
"    <span class=\"h3\">",
"     Stapled end-to-side anastomosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;An ileocolic anastomosis can also be performed with the use of a circular stapler. These technical steps are followed when performing a stapled end-to-side anastomosis:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      The distal ileum is prepared for the anastomosis by clearing the mesentery and sharply dividing the bowel against a distal clamp (",
"      <a class=\"graphic graphic_figure graphicRef59880 \" href=\"UTD.htm?42/63/44030\">",
"       figure 22",
"      </a>",
"      ). Electrocautery can also be used to divide the bowel.",
"     </li>",
"     <li>",
"      The anvil of a circular stapler is placed into the bowel lumen and secured with a manually- or stapler-placed purse-string suture (",
"      <a class=\"graphic graphic_figure graphicRef52179 \" href=\"UTD.htm?36/4/36942\">",
"       figure 23",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      A longitudinal colotomy is made on the specimen side of the colon at least 10 cm proximal to the site chosen for transection and the circular stapler inserted (",
"      <a class=\"graphic graphic_figure graphicRef71735 \" href=\"UTD.htm?16/9/16543\">",
"       figure 24",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      The spike of the stapler is brought through the antimesenteric side of the colon 1 cm distal to the transection site, preferably through a taenia coli (",
"      <a class=\"graphic graphic_figure graphicRef50719 \" href=\"UTD.htm?17/56/18319\">",
"       figure 25",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      The anvil and spike are connected and the circular stapler closed and fired, creating an anastomosis between the end of the ileum and the side of colon (",
"      <a class=\"graphic graphic_figure graphicRef62534 \" href=\"UTD.htm?24/47/25342\">",
"       figure 26",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      A TA&trade; stapler is used to transect the colon from the specimen (",
"      <a class=\"graphic graphic_figure graphicRef78357 \" href=\"UTD.htm?15/39/15984\">",
"       figure 27",
"      </a>",
"      ). Any bleeding points can be oversewn with a silk suture.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H186830058\">",
"    <span class=\"h3\">",
"     Hand-sewn end-to-end anastomosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Single-layer and double-layer techniques using absorbable and nonabsorbable suture can be used to perform a hand-sewn end-to-end anastomosis. A meta-analysis of seven randomized trials including 842 patients identified no significant difference between single-layer and double-layer anastomosis closure for anastomotic dehiscence, perioperative complications, or mortality [",
"    <a class=\"abstract\" href=\"UTD.htm?27/23/28024/abstract/6\">",
"     6",
"    </a>",
"    ]. We perform a two-layer anastomosis using an inner running absorbable suture and outer, interrupted nonabsorbable sutures.",
"   </p>",
"   <p>",
"    The technical steps when performing a hand-sewn end-to-side anastomosis include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The ileum and transverse colon are divided using a scalpel, scissors, or Bovie electrocautery (",
"      <a class=\"graphic graphic_figure graphicRef59880 \" href=\"UTD.htm?42/63/44030\">",
"       figure 22",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      A Cheatle slit is made in the antimesenteric border of the ileum to accommodate any size discrepancy between the ileum and colon (",
"      <a class=\"graphic graphic_figure graphicRef53083 \" href=\"UTD.htm?39/45/40669\">",
"       figure 28",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      The ileum and colon are aligned end-to-end, ensuring that their mesenteries are not twisted, and stay sutures placed in the antimesenteric and mesenteric borders of these bowel loops in preparation for suturing (",
"      <a class=\"graphic graphic_figure graphicRef64854 \" href=\"UTD.htm?2/22/2415\">",
"       figure 29",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      The outer, posterior layer is approximated by placing interrupted Lembert seromuscular nonabsorbable sutures approximately 3 to 4 mm apart.",
"     </li>",
"     <li>",
"      The inner, posterior layer is performed using a full-thickness, running, absorbable suture starting from the middle of the anastomosis and proceeding outwards in either direction (",
"      <a class=\"graphic graphic_figure graphicRef64854 \" href=\"UTD.htm?2/22/2415\">",
"       figure 29",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      Connell-type sutures are utilized to transition to and complete the superficial inner layer (",
"      <a class=\"graphic graphic_figure graphicRef76648 \" href=\"UTD.htm?1/40/1678\">",
"       figure 30",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      The anterior outer layer is approximated using interrupted Lembert seromuscular nonabsorbable sutures (",
"      <a class=\"graphic graphic_figure graphicRef67600 \" href=\"UTD.htm?38/60/39885\">",
"       figure 31",
"      </a>",
"      ).",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11450188\">",
"    <span class=\"h2\">",
"     Steps prior to abdominal closure",
"    </span>",
"    &nbsp;&mdash;&nbsp;After completion of the ileocolic anastomosis and closure of the mesenteric defect, the abdominal cavity is irrigated with sterile saline and suctioned dry. Hemostasis is confirmed and omentum is positioned over the anastomosis (",
"    <a class=\"graphic graphic_figure graphicRef55835 \" href=\"UTD.htm?36/63/37885\">",
"     figure 32",
"    </a>",
"    ) and under the incision. The fascia and skin are closed in standard fashion. It is not necessary to place drainage catheters following a right colectomy. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/24/10633?source=see_link\">",
"     \"Principles of abdominal wall closure\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H186830065\">",
"    <span class=\"h1\">",
"     INTRA-OPERATIVE CHALLENGES",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are several critical structures that must not be damaged during the colectomy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H186830074\">",
"    <span class=\"h2\">",
"     Right ureter and gonadal vessels",
"    </span>",
"    &nbsp;&mdash;&nbsp;When incising the lateral peritoneal attachments of the cecum and ascending colon, the operating surgeon must be keenly aware of the location of the right ureter and right gonadal vessels. Injury to these structures is avoided by dissecting anteromedial to them within the areolar plane along the white line of Toldt (",
"    <a class=\"graphic graphic_figure graphicRef54457 \" href=\"UTD.htm?1/18/1318\">",
"     figure 12",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H186830081\">",
"    <span class=\"h2\">",
"     Duodenum",
"    </span>",
"    &nbsp;&mdash;&nbsp;Injury to the duodenum can occur during hepatic flexure mobilization. This usually results from excessive caudal and medial retraction of the colon during attempts to bring the superior aspect of the hepatic flexure into view, or from overly aggressive blunt dissection of the retroperitoneal structures including the duodenum off the posterior aspect of the transverse colon mesentery (",
"    <a class=\"graphic graphic_figure graphicRef57463 \" href=\"UTD.htm?42/61/43985\">",
"     figure 33",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H186830088\">",
"    <span class=\"h2\">",
"     Middle colic vessel ligation",
"    </span>",
"    &nbsp;&mdash;&nbsp;When ligating the middle colic vessels, the surgeon must avoid excessive upward traction, as this may cause avulsion of a large collateral branch between the middle colic vein and inferior pancreaticoduodenal vein (",
"    <a class=\"graphic graphic_figure graphicRef81960 \" href=\"UTD.htm?3/3/3127\">",
"     figure 3",
"    </a>",
"    ). The most effective method of obtaining hemostasis if bleeding occurs in this area is by carefully placed figure-of-eight sutures incorporating the point of injury. Attempting to clamp and tie the injured vessel can cause further avulsion and hemorrhage.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H186830095\">",
"    <span class=\"h2\">",
"     Misidentification of the superior mesenteric artery",
"    </span>",
"    &nbsp;&mdash;&nbsp;The superior mesenteric artery (SMA) must not be mistaken for the right colic artery (",
"    <a class=\"graphic graphic_figure graphicRef73756 \" href=\"UTD.htm?40/32/41479\">",
"     figure 2",
"    </a>",
"    ). The surgeon should lift the right and transverse colon in a cephalad direction and visualize and palpate the ileocolic vessels arising from the root of the mesentery, traversing to the terminal ileum and cecum. The superior mesenteric vessels are located medial to the ileocolic trunk. Ligation of the SMA will result in bowel infarction.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H186830102\">",
"    <span class=\"h2\">",
"     Tension free anastomosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Failure to divide a sufficient amount of the gastrocolic ligament distally can lead to suboptimal mobility of the transverse colon and, consequently, undue tension on the ileocolic anastomosis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H186830109\">",
"    <span class=\"h1\">",
"     \"FAST TRACK\" POSTOPERATIVE MANAGEMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Postoperative management of colectomy patients has evolved, with contemporary emphasis on early postoperative feeding, early ambulation, and reduction of perioperative fluid volume [",
"    <a class=\"abstract\" href=\"UTD.htm?27/23/28024/abstract/7-14\">",
"     7-14",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H96405644\">",
"    <span class=\"h2\">",
"     Fast track protocol",
"    </span>",
"    &nbsp;&mdash;&nbsp;Following a &ldquo;fast track&rdquo; (multimodal) postcolectomy protocol including clear liquid oral intake on postoperative day two, regular diet on postoperative day three, and discharge home as tolerated, 173 of 200 consecutive patients undergoing an open colectomy tolerated the early feeding plan and experienced no anastomotic leaks or intra-abdominal abscesses [",
"    <a class=\"abstract\" href=\"UTD.htm?27/23/28024/abstract/11\">",
"     11",
"    </a>",
"    ]. The &ldquo;fast track&rdquo; protocol was tolerated by fewer patients undergoing a total colectomy versus a less extensive colectomy",
"    <span class=\"nowrap\">",
"     (23/189",
"    </span>",
"    patients [12 percent] versus",
"    <span class=\"nowrap\">",
"     5/11",
"    </span>",
"    patients [45 percent]) and less often by men",
"    <span class=\"nowrap\">",
"     (18/86",
"    </span>",
"    men [21 percent] versus",
"    <span class=\"nowrap\">",
"     5/73",
"    </span>",
"    women [7 percent]). A randomized trial of 64 patients undergoing an open colectomy found no difference in complication and readmission rates, pain scores, quality of life, or overall satisfaction with hospital stay for patients treated by the &ldquo;fast track&rdquo; protocol compared with the traditional approach [",
"    <a class=\"abstract\" href=\"UTD.htm?27/23/28024/abstract/13\">",
"     13",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In addition, this &ldquo;fast track&rdquo; approach in the elderly patients (aged 70 years and older) also resulted in a short hospital stay and low postoperative morbidity. A prospective study of 87 elderly patients undergoing an open colectomy (53 percent had a right colectomy) found that early postoperative feeding was tolerated by 90 percent of patients, with a mean hospital length of stay of 3.9 days [",
"    <a class=\"abstract\" href=\"UTD.htm?27/23/28024/abstract/12\">",
"     12",
"    </a>",
"    ]. Urinary retention was the most common complication (15 percent), and there were no deaths, anastomotic leaks, intra-abdominal abscesses, or pneumonia.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H96405651\">",
"    <span class=\"h2\">",
"     Analgesia",
"    </span>",
"    &nbsp;&mdash;&nbsp;The authors use thoracic epidural (TE) analgesia for postoperative pain control. However, a randomized trial including 56 patients undergoing a colectomy found that patients treated with a TE had no significant difference in pain control, length of hospital stay, quality of life, or postoperative complications compared with those treated with a patient-controlled analgesia (PCA) [",
"    <a class=\"abstract\" href=\"UTD.htm?27/23/28024/abstract/15\">",
"     15",
"    </a>",
"    ]. Management of postoperative pain is discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/57/27546?source=see_link\">",
"     \"Management of postoperative pain\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H96405658\">",
"    <span class=\"h2\">",
"     Restrictive perioperative fluid administration",
"    </span>",
"    &nbsp;&mdash;&nbsp;The authors restrict the volume of perioperative fluid administered. Restrictive fluid management is defined as less than 10 percent of standard fluid therapy previously used to maintain conventional hemodynamic measurements (eg, blood pressure, heart rate). A meta-analysis of four randomized trials including 393 patients undergoing colorectal surgery found that patients treated with restrictive fluid administration had a significant reduction in postoperative complications compared with standard fluid administration (odds ratio [OR] 0.41, 95% CI 0.22-0.77) [",
"    <a class=\"abstract\" href=\"UTD.htm?27/23/28024/abstract/16\">",
"     16",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The same meta-analysis also found that patients undergoing goal-directed therapy determined by esophageal Doppler (eg, aortic flow time, stroke volume, cardiac output, cardiac index) had significantly lower morbidity compared with conventional guidance (OR 0.43, 0.26-0.71; 3 trials, 288 patients) [",
"    <a class=\"abstract\" href=\"UTD.htm?27/23/28024/abstract/16\">",
"     16",
"    </a>",
"    ]. There was no difference for postoperative mortality for either analysis. Limitations of this analysis include lack of standardization of definitions for volume administration, variable duration of restrictive fluid administration, variable use of a mechanical bowel preparation, and the lack of uniformity of the studies. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/46/42729?source=see_link\">",
"     \"Intraoperative fluid management\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H96405637\">",
"    <span class=\"h2\">",
"     Discharge instructions",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients are discharged with instructions to avoid strenuous activity and heavy lifting for four to six weeks following surgery, but are encouraged to participate in light activity such as walking, and to return if unexpected symptoms (eg, significant abdominal pain,",
"    <span class=\"nowrap\">",
"     nausea/vomiting,",
"    </span>",
"    obstipation, fevers and chills, and signs of wound infection including redness or drainage) should occur. Otherwise, patients return for an outpatient visit 10 to 14 days after hospital discharge for wound examination and skin staple removal.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H186830132\">",
"    <span class=\"h1\">",
"     COMPLICATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Complications of right colectomy include anastomotic leak, intra-abdominal abscess, fistula, hemorrhage, bowel obstruction, and wound infection, as well as complications of general anesthesia. A retrospective review of the American College of Surgeon's National Surgical Quality Improvement Program (NSQIP) database that included 1392 patients undergoing an open partial colectomy with ileocolostomy found a 24 percent postoperative complication rate [",
"    <a class=\"abstract\" href=\"UTD.htm?27/23/28024/abstract/17\">",
"     17",
"    </a>",
"    ]. The most frequent complications were infectious (13 percent), wound (8 percent), and anastomotic leak (6 percent). Risk factors for anastomotic dehiscence included patient health factors (eg, malnutrition, tobacco and alcohol use, cardiovascular disease, and higher American Society of Anesthesia classification score (",
"    <a class=\"graphic graphic_table graphicRef78084 \" href=\"UTD.htm?9/5/9307\">",
"     table 3",
"    </a>",
"    )), and operative factors (eg, longer operative times, preoperative bowel obstruction, intraoperative septic conditions, perioperative blood transfusion) [",
"    <a class=\"abstract\" href=\"UTD.htm?27/23/28024/abstract/18\">",
"     18",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Management of intra-operative complications following colorectal surgery is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/57/1946?source=see_link\">",
"     \"Management of intra-abdominal, pelvic, and genitourinary complications of colorectal surgery\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H186830139\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      We recommend not using a mechanical bowel preparation for elective, open right and extended right hemicolectomies (",
"      <a class=\"grade\" href=\"._grade_1?title=Grade 1A\">",
"       Grade 1A",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H186829957\">",
"       'Preoperative preparation'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?16/23/16762?source=see_link&amp;anchor=H125365129#H125365129\">",
"       \"Surgical oncologic principles for the resection of colon cancer\", section on 'Mechanical bowel preparation'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Malignant lesions located in the appendix, cecum, and ascending colon and benign lesions (eg, cecal diverticulum, inflammatory bowel disease) limited to the right colon can be resected by a standard",
"      <strong>",
"       right colectomy",
"      </strong>",
"      . The resection extends from the distal ileum to the mid-transverse colon, and involves isolating and dividing the ileocolic, right colic, and either the right or hepatic branch of the middle colic artery and vein. (See",
"      <a class=\"local\" href=\"#H186830016\">",
"       'Extent of resection'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Malignant lesions located in the hepatic flexure or proximal to the mid-transverse colon, and benign inflammatory conditions extending to the mid-transverse colon are resected with an",
"      <strong>",
"       extended right colectomy",
"      </strong>",
"      (",
"      <a class=\"graphic graphic_figure graphicRef51067 \" href=\"UTD.htm?25/39/26228\">",
"       figure 6",
"      </a>",
"      ). An extended right colectomy includes the resection of the distal transverse colon and sometimes the splenic flexure, and involves ligating the ileocolic, right colic, and middle colic vessels. (See",
"      <a class=\"local\" href=\"#H186830016\">",
"       'Extent of resection'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The continuity of the bowel is restored by an ileocolic anastomosis, which is performed by a stapled or hand-sewn technique, depending on the preference of the surgeon. There is insufficient evidence to demonstrate superiority of stapled over hand-sewn anastomosis. The authors suggest a hand-sewn anastomosis in settings of thickened bowel and inflammation (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H186830037\">",
"       'Restoring bowel continuity'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We recommend a &ldquo;fast track&rdquo; protocol for postoperative management (",
"      <a class=\"grade\" href=\"._grade_2?title=Grade 1B\">",
"       Grade 1B",
"      </a>",
"      ). This includes oral feedings on postoperative day one, solid foods on postoperative day two, early ambulation, and discharge as tolerated. (See",
"      <a class=\"local\" href=\"#H186830109\">",
"       '\"Fast track\" Postoperative management'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We recommend restrictive fluid management in the perioperative period (",
"      <a class=\"grade\" href=\"._grade_2?title=Grade 1B\">",
"       Grade 1B",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H96405658\">",
"       'Restrictive perioperative fluid administration'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28024/abstract/1\">",
"      Eskicioglu C, Forbes SS, Fenech DS, et al. Preoperative bowel preparation for patients undergoing elective colorectal surgery: a clinical practice guideline endorsed by the Canadian Society of Colon and Rectal Surgeons. Can J Surg 2010; 53:385.",
"     </a>",
"    </li>",
"    <li>",
"     Sonoda T, Milsom JW.  Section 5: Gastrointestinal tract and abdomen. Chapter 34: Segmental colon resection.ACS Surgery: Principles and Practice file://www.acssurgery.com/acs/chapters/ch0534.htm (Accessed on November 07, 2011).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28024/abstract/3\">",
"      Neutzling CB, Lustosa SA, Proenca IM, et al. Stapled versus handsewn methods for colorectal anastomosis surgery. Cochrane Database Syst Rev 2012; 2:CD003144.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28024/abstract/4\">",
"      McLeod RS, Wolff BG, Ross S, et al. Recurrence of Crohn's disease after ileocolic resection is not affected by anastomotic type: results of a multicenter, randomized, controlled trial. Dis Colon Rectum 2009; 52:919.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28024/abstract/5\">",
"      Meagher AP, Wolff BG. Right hemicolectomy with a linear cutting stapler. Dis Colon Rectum 1994; 37:1043.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28024/abstract/6\">",
"      Sajid MS, Siddiqui MR, Baig MK. Single layer versus double layer suture anastomosis of the gastrointestinal tract. Cochrane Database Syst Rev 2012; 1:CD005477.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28024/abstract/7\">",
"      Delaney CP, Fazio VW, Senagore AJ, et al. 'Fast track' postoperative management protocol for patients with high co-morbidity undergoing complex abdominal and pelvic colorectal surgery. Br J Surg 2001; 88:1533.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28024/abstract/8\">",
"      Basse L, Hjort Jakobsen D, Billesb&oslash;lle P, et al. A clinical pathway to accelerate recovery after colonic resection. Ann Surg 2000; 232:51.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28024/abstract/9\">",
"      Basse L, Thorb&oslash;l JE, L&oslash;ssl K, Kehlet H. Colonic surgery with accelerated rehabilitation or conventional care. Dis Colon Rectum 2004; 47:271.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28024/abstract/10\">",
"      Behrns KE, Kircher AP, Galanko JA, et al. Prospective randomized trial of early initiation and hospital discharge on a liquid diet following elective intestinal surgery. J Gastrointest Surg 2000; 4:217.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28024/abstract/11\">",
"      Di Fronzo LA, Cymerman J, O'Connell TX. Factors affecting early postoperative feeding following elective open colon resection. Arch Surg 1999; 134:941.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28024/abstract/12\">",
"      DiFronzo LA, Yamin N, Patel K, O'Connell TX. Benefits of early feeding and early hospital discharge in elderly patients undergoing open colon resection. J Am Coll Surg 2003; 197:747.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28024/abstract/13\">",
"      Delaney CP, Zutshi M, Senagore AJ, et al. Prospective, randomized, controlled trial between a pathway of controlled rehabilitation with early ambulation and diet and traditional postoperative care after laparotomy and intestinal resection. Dis Colon Rectum 2003; 46:851.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28024/abstract/14\">",
"      Khoo CK, Vickery CJ, Forsyth N, et al. A prospective randomized controlled trial of multimodal perioperative management protocol in patients undergoing elective colorectal resection for cancer. Ann Surg 2007; 245:867.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28024/abstract/15\">",
"      Zutshi M, Delaney CP, Senagore AJ, et al. Randomized controlled trial comparing the controlled rehabilitation with early ambulation and diet pathway versus the controlled rehabilitation with early ambulation and diet with preemptive epidural anesthesia/analgesia after laparotomy and intestinal resection. Am J Surg 2005; 189:268.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28024/abstract/16\">",
"      Rahbari NN, Zimmermann JB, Schmidt T, et al. Meta-analysis of standard, restrictive and supplemental fluid administration in colorectal surgery. Br J Surg 2009; 96:331.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28024/abstract/17\">",
"      Kennedy GD, Heise C, Rajamanickam V, et al. Laparoscopy decreases postoperative complication rates after abdominal colectomy: results from the national surgical quality improvement program. Ann Surg 2009; 249:596.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28024/abstract/18\">",
"      Kingham TP, Pachter HL. Colonic anastomotic leak: risk factors, diagnosis, and treatment. J Am Coll Surg 2009; 208:269.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 15011 Version 3.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0503-200.167.4.114-2B3BC00349-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f27_23_28024=[""].join("\n");
var outline_f27_23_28024=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H186830139\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H186829949\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H452004\">",
"      INDICATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H186829957\">",
"      PREOPERATIVE PREPARATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H186829972\">",
"      Mechanical bowel preparation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H186829979\">",
"      Prophylactic antibiotics",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H27175149\">",
"      Venous thromboembolism prophylaxis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H186830001\">",
"      OPEN SURGICAL TECHNIQUE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H451735\">",
"      Optional equipment",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H452622\">",
"      Exploration for resectability",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H186830016\">",
"      Extent of resection",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H115081012\">",
"      - Right colectomy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H115081019\">",
"      - Right extended colectomy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H115081026\">",
"      - Mesenteric resection",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H115081033\">",
"      - Omental resection",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H451980\">",
"      Mobilization of the right colon",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H186830023\">",
"      - Lateral to medial approach",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H186830030\">",
"      - Medial to lateral approach",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H186830037\">",
"      Restoring bowel continuity",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H186830044\">",
"      - Stapled side-to-side functional end-to-end anastomosis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H186830051\">",
"      - Stapled end-to-side anastomosis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H186830058\">",
"      - Hand-sewn end-to-end anastomosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11450188\">",
"      Steps prior to abdominal closure",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H186830065\">",
"      INTRA-OPERATIVE CHALLENGES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H186830074\">",
"      Right ureter and gonadal vessels",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H186830081\">",
"      Duodenum",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H186830088\">",
"      Middle colic vessel ligation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H186830095\">",
"      Misidentification of the superior mesenteric artery",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H186830102\">",
"      Tension free anastomosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H186830109\">",
"      \"FAST TRACK\" POSTOPERATIVE MANAGEMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H96405644\">",
"      Fast track protocol",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H96405651\">",
"      Analgesia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H96405658\">",
"      Restrictive perioperative fluid administration",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H96405637\">",
"      Discharge instructions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H186830132\">",
"      COMPLICATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H186830139\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"SURG/15011\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"SURG/15011|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?31/6/31846\" title=\"figure 1\">",
"      Anatomic relationship of colon to surrounding structures",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?40/32/41479\" title=\"figure 2\">",
"      Blood supply to the colon and rectum",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?3/3/3127\" title=\"figure 3\">",
"      Venous drainage of the colon and rectum",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?38/33/39448\" title=\"figure 4\">",
"      Lymphatic drainage of the colon and rectum",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?24/61/25556\" title=\"figure 5\">",
"      Right colectomy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?25/39/26228\" title=\"figure 6\">",
"      Extended right colectomy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?43/8/44163\" title=\"figure 7\">",
"      Colectomy for proximal transverse colon cancer",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?19/24/19844\" title=\"figure 8\">",
"      Colectomy for mid transverse colon cancer",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?17/33/17938\" title=\"figure 9\">",
"      Dissection of greater omentum",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?19/37/20063\" title=\"figure 10\">",
"      Mobilization of the ascending colon",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?35/24/36238\" title=\"figure 11\">",
"      Blunt mobilization of the right colon",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?1/18/1318\" title=\"figure 12\">",
"      Relationship between ascending colon and posterior structures",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?25/62/26594\" title=\"figure 13\">",
"      Gastrocolic ligament and the lesser sac",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?31/17/32017\" title=\"figure 14\">",
"      Mobilization of the hepatic flexure for colon cancer",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?6/20/6465\" title=\"figure 15\">",
"      Ligation of mesenteric vessels for right hemicolectomy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?8/45/8913\" title=\"figure 16\">",
"      Resection of right colon mesentery",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?25/52/26447\" title=\"figure 17\">",
"      Ileocolic anastomosis - Transection of ileum and colon",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?0/13/223\" title=\"figure 18\">",
"      Ileocolic anastomosis and linear cutting stapler",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?40/19/41264\" title=\"figure 19\">",
"      Ileocolic anastomosis - Dividing the bowel",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?20/28/20942\" title=\"figure 20\">",
"      Ileocolic anastomosis - Stapled anastomosis reinforced",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?4/52/4943\" title=\"figure 21\">",
"      Ileocolic anastomosis - Transverse enterostomies",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?42/63/44030\" title=\"figure 22\">",
"      Right colectomy - transecting the ileum and colon",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?36/4/36942\" title=\"figure 23\">",
"      Insertion of anvil of circular stapler into ileum",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?16/9/16543\" title=\"figure 24\">",
"      Insertion of circular stapler into colon",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?17/56/18319\" title=\"figure 25\">",
"      Ileocolic anastomosis created with a circular stapler",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?24/47/25342\" title=\"figure 26\">",
"      Ileocolic anastomosis - anvil and spike of circular stapler",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?15/39/15984\" title=\"figure 27\">",
"      Ileocolic stapled anastomosis - end to side",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?39/45/40669\" title=\"figure 28\">",
"      Cheatle slit in ileum",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?2/22/2415\" title=\"figure 29\">",
"      Hand-sewn ileocolic anastomosis - two layer closure",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?1/40/1678\" title=\"figure 30\">",
"      Hand-sewn ileocolic anastomosis - two layer closur anterior wall",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?38/60/39885\" title=\"figure 31\">",
"      Hand-sewn ileocolic anastomosis - Lembert sutures",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?36/63/37885\" title=\"figure 32\">",
"      Ileocolic anastomosis protected by omental flap",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?42/61/43985\" title=\"figure 33\">",
"      Mobilization of the hepatic flexure",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"SURG/15011|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?42/25/43422\" title=\"picture 1\">",
"      TA stapling device",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"SURG/15011|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/52/24397\" title=\"table 1\">",
"      Antimicrobial prophylaxis for gastrointestinal surgery",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?22/46/23275\" title=\"table 2\">",
"      Timing of surgical prophylaxis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?9/5/9307\" title=\"table 3\">",
"      ASA physical status scale",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/23/18806?source=related_link\">",
"      Control measures to prevent surgical site infection following gastrointestinal procedures",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/46/42729?source=related_link\">",
"      Intraoperative fluid management",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?4/5/4186?source=related_link\">",
"      Management of anastomotic complications of colorectal surgery",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/57/1946?source=related_link\">",
"      Management of intra-abdominal, pelvic, and genitourinary complications of colorectal surgery",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/57/27546?source=related_link\">",
"      Management of postoperative pain",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/35/31290?source=related_link\">",
"      Overview of control measures to prevent surgical site infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/52/41802?source=related_link\">",
"      Prevention of venous thromboembolic disease in surgical patients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/24/10633?source=related_link\">",
"      Principles of abdominal wall closure",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?16/23/16762?source=related_link\">",
"      Surgical oncologic principles for the resection of colon cancer",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f27_23_28025="Clinical manifestations and diagnosis of echinococcosis";
var content_f27_23_28025=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Clinical manifestations and diagnosis of echinococcosis",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?27/23/28025/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?27/23/28025/contributors\">",
"     Pedro L Moro, MD, MPH",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?27/23/28025/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?27/23/28025/contributors\">",
"     Peter F Weller, MD, FACP",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?27/23/28025/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?27/23/28025/contributors\">",
"     Elinor L Baron, MD, DTMH",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?27/23/28025/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Mar 5, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Echinococcal disease is caused by infection with the metacestode stage of the tapeworm Echinococcus, which belongs to the family Taeniidae. Four species of Echinococcus produce infection in humans; E. granulosus and E. multilocularis are the most common, causing cystic echinococcosis (CE) and alveolar echinococcosis (AE), respectively. The two other species, E. vogeli and E. oligarthrus, cause polycystic echinococcosis, but have only rarely been associated with human infection.",
"   </p>",
"   <p>",
"    The clinical manifestations and diagnosis of cystic and alveolar echinococcal infection will be reviewed here. The epidemiology, treatment, and prevention of echinococcosis are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/59/20407?source=see_link\">",
"     \"Epidemiology and control of echinococcosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/58/27561?source=see_link\">",
"     \"Treatment of echinococcosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     CLINICAL MANIFESTATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The Echinococcus species have different geographic distributions and involve different hosts. E. granulosus and E. multilocularis also differ in their clinical presentation. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/59/20407?source=see_link\">",
"     \"Epidemiology and control of echinococcosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Echinococcus granulosus",
"    </span>",
"    &nbsp;&mdash;&nbsp;The initial phase of primary infection is always asymptomatic. Many infections are acquired in childhood but do not cause clinical manifestations until adulthood. Latent periods of more than 50 years before symptoms arise have been reported. While approximately 50 percent of detected cases occur in asymptomatic patients, many more cases remain undiagnosed or are found incidentally at autopsy.",
"   </p>",
"   <p>",
"    The clinical presentation of E. granulosus infection depends upon the site of the cysts and their size. Small",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    calcified cysts may remain asymptomatic indefinitely. However, symptoms due to mass effect within organs, obstruction of blood or lymphatic flow, or complications such as rupture or secondary bacterial infections can result.",
"   </p>",
"   <p>",
"    Cysts typically increase in diameter at a rate of one to five centimeters per year. However, cyst growth rates and time courses are highly variable [",
"    <a class=\"abstract\" href=\"UTD.htm?27/23/28025/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. Hydatid cysts may be found in almost any site of the body, either from primary inoculation or via secondary spread. The liver is affected in approximately two-thirds of patients, the lungs in approximately 25 percent, and other organs including the brain, muscle, kidneys, bone, heart, and pancreas in a small proportion of patients. Single organ involvement occurs in 85 to 90 percent of patients with E. granulosus infection, and only one cyst is observed in more than 70 percent of cases (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef58845 \" href=\"UTD.htm?13/23/13685\">",
"     image 1",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h3\">",
"     Liver involvement",
"    </span>",
"    &nbsp;&mdash;&nbsp;E. granulosus infection of the liver frequently produces no symptoms. The right lobe is affected in 60 to 85 percent of cases. Significant symptoms are unusual before the cyst has reached at least 10 cm in diameter. If the cysts become large, hepatomegaly with or without associated right upper quadrant pain, nausea and vomiting can result (",
"    <a class=\"graphic graphic_picture graphicRef74847 \" href=\"UTD.htm?9/26/9632\">",
"     picture 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    E. granulosus cysts can rupture into the biliary tree and produce biliary colic, obstructive jaundice, cholangitis, or pancreatitis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/6/42087?source=see_link\">",
"     \"Endoscopic diagnosis and management of biliary parasitosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Pressure or mass effects on the bile ducts, portal and hepatic veins, or on the inferior vena cava can result in cholestasis, portal hypertension, venous obstruction, or the Budd-Chiari syndrome. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/53/31575?source=see_link\">",
"     \"Etiology of the Budd-Chiari syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Liver cysts can also rupture into the peritoneum, causing peritonitis, or transdiaphragmatically into the pleural space or bronchial tree, causing pulmonary hydatidosis or a bronchial fistula. Secondary bacterial infection of the cysts can result in liver abscesses. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/53/29526?source=see_link\">",
"     \"Pyogenic liver abscess\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h3\">",
"     Lung involvement",
"    </span>",
"    &nbsp;&mdash;&nbsp;The most common symptoms of pulmonary cystic echinococcosis (CE) described in the literature include cough (53 to 62 percent), chest pain (49 to 91 percent), dyspnea (10 to 70 percent), and hemoptysis (12 to 21 percent). Less-frequent symptoms include malaise, nausea and vomiting, and thoracic deformations [",
"    <a class=\"abstract\" href=\"UTD.htm?27/23/28025/abstract/3,4\">",
"     3,4",
"    </a>",
"    ]. The majority of children and adolescents with lung lesions are asymptomatic despite having lesions of impressive size, assumedly because of a weaker immune response and the relatively higher elasticity of the lung parenchyma relative to older patients [",
"    <a class=\"abstract\" href=\"UTD.htm?27/23/28025/abstract/3,5\">",
"     3,5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Cysts can break or develop secondary bacterial infection. The presence of these complications changes the clinical presentation, either by causing new symptoms or by increasing the severity of existing symptoms. The principal complication is cyst rupture, with spilling of cyst material containing fragments of larval tissue and protoscolices into the bronchial tree or the pleural cavity. Bronchial tree involvement can lead to cough, chest pain, hemoptysis, or emesis; pleural cavity involvement can cause pneumothorax, pleural effusion, or empyema. Secondary bacterial infection of the cyst can manifest as a pulmonary abscess with poorly defined margins [",
"    <a class=\"abstract\" href=\"UTD.htm?27/23/28025/abstract/6-8\">",
"     6-8",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Approximately 60 percent of pulmonary hydatid disease affects the right lung, and 50 to 60 percent of cases involve the lower lobes [",
"    <a class=\"abstract\" href=\"UTD.htm?27/23/28025/abstract/9\">",
"     9",
"    </a>",
"    ]. Multiple cysts are common. Approximately 20 percent of patients with lung cysts also have liver cysts [",
"    <a class=\"abstract\" href=\"UTD.htm?27/23/28025/abstract/10\">",
"     10",
"    </a>",
"    ]. The ratio of lung to liver involvement is higher in children than in adults [",
"    <a class=\"abstract\" href=\"UTD.htm?27/23/28025/abstract/10\">",
"     10",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h3\">",
"     Other organs",
"    </span>",
"    &nbsp;&mdash;&nbsp;Involvement of organs outside of the liver or lung is unusual but can lead to significant morbidity and mortality:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Infection of the heart can result in mechanical rupture with widespread dissemination or pericardial tamponade [",
"      <a class=\"abstract\" href=\"UTD.htm?27/23/28025/abstract/11,12\">",
"       11,12",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Central nervous system involvement can lead to seizures or signs of raised intracranial pressure; infection of the spinal cord can result in spinal cord compression [",
"      <a class=\"abstract\" href=\"UTD.htm?27/23/28025/abstract/13\">",
"       13",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Cysts in the kidney can cause hematuria or flank pain [",
"      <a class=\"abstract\" href=\"UTD.htm?27/23/28025/abstract/14\">",
"       14",
"      </a>",
"      ]. Immune complex-mediated disease, glomerulonephritis leading to the nephrotic syndrome, and secondary amyloidosis have also been described [",
"      <a class=\"abstract\" href=\"UTD.htm?27/23/28025/abstract/15,16\">",
"       15,16",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Bone cysts are usually asymptomatic until a pathologic fracture develops; the spine, pelvis, and long bones are most frequently affected [",
"      <a class=\"abstract\" href=\"UTD.htm?27/23/28025/abstract/17\">",
"       17",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Ocular cysts also occur [",
"      <a class=\"abstract\" href=\"UTD.htm?27/23/28025/abstract/18,19\">",
"       18,19",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     Cyst rupture",
"    </span>",
"    &nbsp;&mdash;&nbsp;Fever and acute hypersensitivity reactions, including anaphylaxis, may be the principal manifestations of cyst rupture. Hypersensitivity reactions are related to the release of antigenic material and secondary immunologic reactions. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/29/35290?source=see_link\">",
"     \"Anaphylaxis: Rapid recognition and treatment\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     Outcome",
"    </span>",
"    &nbsp;&mdash;&nbsp;The outcome of infection varies with the stage of the disease. One study reported on the long-term outcome of 33 patients with asymptomatic liver hydatid cysts [",
"    <a class=\"abstract\" href=\"UTD.htm?27/23/28025/abstract/1\">",
"     1",
"    </a>",
"    ]. The natural history of infection was variable. Approximately 15 percent of patients had undergone surgery 10 to 12 years after the initial diagnosis. Among patients who did not undergo surgery, 75 percent remained asymptomatic; 57 percent did not have a change in the size of the cyst by imaging.",
"   </p>",
"   <p>",
"    Calcification usually requires 5 to 10 years to develop and occurs most commonly with hepatic cysts, but rarely with pulmonary or bone cysts. Total calcification of the cyst wall suggests that the cyst may be nonviable.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Echinococcus multilocularis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Infection due to E. multilocularis infections is usually symptomatic, although the clinical manifestations are frequently nonspecific. The most common presenting complaints include malaise, weight loss, and right upper quadrant discomfort due to hepatomegaly. Cholestatic jaundice, cholangitis, portal hypertension, and the Budd-Chiari syndrome can also occur. The clinical presentation may mimic that of hepatocellular carcinoma.",
"   </p>",
"   <p>",
"    Extrahepatic primary disease is very rare (one percent of cases). Multiorgan disease was described in 13 percent of cases in one series, in which metacestodes involved the lungs, spleen, or brain in addition to the liver [",
"    <a class=\"abstract\" href=\"UTD.htm?27/23/28025/abstract/20\">",
"     20",
"    </a>",
"    ]. Immunodeficiency, such as HIV or transplantation, may accelerate the manifestations of alveolar echinococcosis [",
"    <a class=\"abstract\" href=\"UTD.htm?27/23/28025/abstract/21\">",
"     21",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    If left untreated, more than 90 percent of patients will die within 10 years of the onset of clinical symptoms, and virtually 100 percent will die by 15 years [",
"    <a class=\"abstract\" href=\"UTD.htm?27/23/28025/abstract/22\">",
"     22",
"    </a>",
"    ]. Since treatment with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/6/24678?source=see_link\">",
"     albendazole",
"    </a>",
"    has been introduced, the prognosis has improved considerably. Of 117 patients from France who underwent long-term follow-up, the actuarial survival rate was 88 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?27/23/28025/abstract/23\">",
"     23",
"    </a>",
"    ]. Life expectancy has improved, and patients undergoing radical treatment have a better outcome now than 40 years ago. In Switzerland in 1970, the life expectancy for an average 54-year-old patient with echinococcosis was estimated to be reduced by 18 and 21 years for men and women, respectively; by 2005, life expectancy was reduced by approximately 3.5 and 2.6 years for men and women, respectively [",
"    <a class=\"abstract\" href=\"UTD.htm?27/23/28025/abstract/23\">",
"     23",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Both cystic and alveolar echinococcus may be diagnosed with a combination of imaging and serology [",
"    <a class=\"abstract\" href=\"UTD.htm?27/23/28025/abstract/24\">",
"     24",
"    </a>",
"    ]. Serologic assays for E. multilocularis infection are more sensitive and specific than for E. granulosus infection. The following discussion primarily deals with the more common E. granulosus infection, except as indicated. Specific discussion related to the diagnosis of alveolar echinococcosis follows below.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17741682\">",
"    <span class=\"h2\">",
"     E. granulosus",
"    </span>",
"    &nbsp;&mdash;&nbsp;Nonspecific leukopenia or thrombocytopenia, mild eosinophilia, and nonspecific liver function abnormalities may be observed but are not diagnostic. Eosinophilia is observed in fewer than 15 percent of cases and generally occurs only if there is leakage of antigenic material.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h3\">",
"     Imaging",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hydatid cysts may be visualized and evaluated with ultrasonography, computed tomography (CT), or magnetic resonance imaging (MRI). Ultrasonography is employed most widely because it is easy to perform and relatively inexpensive. Portable ultrasound machines are frequently used for screening patients in communities in which E. granulosus infection is endemic, sometimes with confirmatory serologic testing to maximize the diagnostic yield [",
"    <a class=\"abstract\" href=\"UTD.htm?27/23/28025/abstract/25\">",
"     25",
"    </a>",
"    ]. However, CT or MRI may be useful for circumstances in which greater anatomic detail is needed to establish the location and number of cysts, the presence or absence of daughter cysts, and presence of ruptured or calcified cysts, which are important for guiding management (",
"    <a class=\"graphic graphic_table graphicRef71806 \" href=\"UTD.htm?38/57/39836\">",
"     table 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Plain radiography may demonstrate calcification within a cyst, but cannot detect uncalcified cysts, so is not adequate for definitive diagnostic evaluation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h4\">",
"     Ultrasonography",
"    </span>",
"    &nbsp;&mdash;&nbsp;The sensitivity of ultrasonography for evaluation of echinococcus is 90 to 95 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?27/23/28025/abstract/26,27\">",
"     26,27",
"    </a>",
"    ]. The most common appearance on ultrasound is an anechoic, smooth, round cyst, which can be difficult to distinguish from a benign cyst. In the presence of liver cyst membranes, mixed echoes can be confused with an abscess or neoplasm. In the presence of daughter cysts, characteristic internal septation can be seen.",
"   </p>",
"   <p>",
"    Shifting the patient's position during ultrasonography may demonstrate &lsquo;hydatid sand&rsquo; which consists predominantly of hooklets and scolexes from the protoscolices. Hydatid disease is probable in the setting of hydatid sand, inner cyst wall infoldings, and separation of the hydatid membrane from the wall of the cyst observed on ultrasound [",
"    <a class=\"abstract\" href=\"UTD.htm?27/23/28025/abstract/28\">",
"     28",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Ultrasound allows classification of the cyst(s) as active, transitional, or inactive based on biologic activity; such categorizations may influence the choice of treatment. Characteristics suggestive of an inactive lesion include a collapsing, flattened elliptical cyst (corresponds to low pressure within the cyst), detachment of the germinal layer from the cyst wall (\"water lily sign\"), coarse echoes within the cyst, and cyst wall calcification [",
"    <a class=\"abstract\" href=\"UTD.htm?27/23/28025/abstract/29,30\">",
"     29,30",
"    </a>",
"    ]. Cysts with a calcified rim may have an \"eggshell\" appearance.",
"   </p>",
"   <p>",
"    Several other classification systems are based upon ultrasound appearance:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The World Health Organization (WHO) classification characterizes cysts by type and size (",
"      <a class=\"graphic graphic_table graphicRef71806 \" href=\"UTD.htm?38/57/39836\">",
"       table 1",
"      </a>",
"      ) [",
"      <a class=\"abstract\" href=\"UTD.htm?27/23/28025/abstract/31,32\">",
"       31,32",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The Gharbi classification divides cysts into five types [",
"      <a class=\"abstract\" href=\"UTD.htm?27/23/28025/abstract/33\">",
"       33",
"      </a>",
"      ]. Type I cysts consist of pure fluid; type II have a fluid collection with a split wall; type III cysts contain daughter cysts (with or without degenerated solid material); type IV have a heterogeneous echo pattern; and type V have a calcified wall [",
"      <a class=\"abstract\" href=\"UTD.htm?27/23/28025/abstract/33\">",
"       33",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    WHO categories CE1 and CE2 as active cysts. Type CE1 is unilocular and type CE2 is multilocular with daughter cysts (",
"    <a class=\"graphic graphic_figure graphicRef87460 \" href=\"UTD.htm?40/39/41589\">",
"     figure 1",
"    </a>",
"    ). Class CE3 consists of cysts that are thought to be degenerating (transitional group). There are two types of CE3: CE3a, featuring the &lsquo;water-lily&rsquo; sign for floating membranes, and CE3b, which is predominantly solid with daughter cysts. Establishing whether daughter cysts are present is important for guiding treatment. In addition, nuclear magnetic resonance has demonstrated that CE3a and CE3b have different metabolic characteristics [",
"    <a class=\"abstract\" href=\"UTD.htm?27/23/28025/abstract/34\">",
"     34",
"    </a>",
"    ]. Classes CE4 and CE5 are considered inactive. By ultrasonography they are echogenic with increasing degrees of calcification and are nearly always nonviable.",
"   </p>",
"   <p>",
"    It is important to establish whether daughter cysts (cysts that have involuted from the wall and reside within the larger cyst) are present and to distinguish them from brood capsules, which are attached to the wall of the larger cyst. This distinction is important for guiding treatment.",
"   </p>",
"   <p>",
"    Lung cysts may be single or multiple, usually do not calcify, rarely lead to daughter cyst formation, and may contain air if the cyst has ruptured.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h4\">",
"     Computed tomography",
"    </span>",
"    &nbsp;&mdash;&nbsp;Many reports suggest that computed tomography (CT) has higher overall sensitivity than ultrasonography (95 to 100 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?27/23/28025/abstract/26,27,35\">",
"     26,27,35",
"    </a>",
"    ]. CT is the best mode for determining the number, size, and anatomic location of the cysts, and is better than ultrasound for detection of extrahepatic cysts. CT may also be used for monitoring lesions during therapy and to detect recurrences (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef58845 \" href=\"UTD.htm?13/23/13685\">",
"     image 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?27/23/28025/abstract/36\">",
"     36",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    CT may be superior to ultrasonography in assessing for complications such as infection and intrabiliary rupture [",
"    <a class=\"abstract\" href=\"UTD.htm?27/23/28025/abstract/37\">",
"     37",
"    </a>",
"    ]. In one study, ultrasound performed better than CT in the investigation of the cyst wall, hydatid sand, daughter cysts, and splitting of the cyst wall, while CT was superior for detecting gas and minute calcifications within the cysts, in attenuation measurement, and in anatomic mapping [",
"    <a class=\"abstract\" href=\"UTD.htm?27/23/28025/abstract/30,38\">",
"     30,38",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h4\">",
"     Magnetic resonance imaging",
"    </span>",
"    &nbsp;&mdash;&nbsp;Magnetic resonance imaging (MRI) has no major advantage over CT for evaluation of abdominal or pulmonary hydatid cysts, except in defining changes in the intra- and extrahepatic venous system [",
"    <a class=\"abstract\" href=\"UTD.htm?27/23/28025/abstract/39\">",
"     39",
"    </a>",
"    ]. MRI may delineate the cyst capsule better than CT and may be better at diagnosing complications, particularly for cysts with infection or biliary communication. However, MRI is usually not required and in most instances, is not cost effective [",
"    <a class=\"abstract\" href=\"UTD.htm?27/23/28025/abstract/40-42\">",
"     40-42",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Both CT and MRI are useful in diagnosing echinococcal infection in other sites such as in the brain [",
"    <a class=\"abstract\" href=\"UTD.htm?27/23/28025/abstract/43\">",
"     43",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h4\">",
"     Other",
"    </span>",
"    &nbsp;&mdash;&nbsp;Other imaging techniques such as cholangiography may be indicated to diagnose biliary involvement, particularly in patients with cholestatic jaundice. Endoscopic retrograde cholangiopancreatography (ERCP) or magnetic resonance cholangiopancreatography (MRCP) is frequently performed in patients with liver cysts prior to intervention to ascertain potential involvement of the biliary system and to guide the treatment approach. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/6/42087?source=see_link\">",
"     \"Endoscopic diagnosis and management of biliary parasitosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h3\">",
"     Serologic and antigen assays",
"    </span>",
"    &nbsp;&mdash;&nbsp;Serology is useful for primary diagnosis and for follow-up after treatment [",
"    <a class=\"abstract\" href=\"UTD.htm?27/23/28025/abstract/20,44,45\">",
"     20,44,45",
"    </a>",
"    ]. Antibody detection is more sensitive than antigen detection for diagnosis of E. granulosus [",
"    <a class=\"abstract\" href=\"UTD.htm?27/23/28025/abstract/20\">",
"     20",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17745935\">",
"    <span class=\"h4\">",
"     Laboratory serologic tools",
"    </span>",
"    &nbsp;&mdash;&nbsp;Diagnostic serologic techniques include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Complement fixation",
"     </li>",
"     <li>",
"      Indirect hemagglutination (IHA)",
"     </li>",
"     <li>",
"      Indirect immunofluorescence",
"     </li>",
"     <li>",
"      Latex agglutination",
"     </li>",
"     <li>",
"      Double diffusion immunoelectrophoresis",
"     </li>",
"     <li>",
"      Counter-current immunoelectrophoresis (CIEP)",
"     </li>",
"     <li>",
"      Radioimmunoassay (RIA)",
"     </li>",
"     <li>",
"      Enzyme-linked immunosorbent assay (ELISA)",
"     </li>",
"     <li>",
"      Enzyme-linked immunoelectrotransfer blots (EITB)",
"     </li>",
"     <li>",
"      Enzyme-linked immunoelectrodiffusion assay (ELIEDA)",
"     </li>",
"     <li>",
"      Time-resolved fluoroimmunoassay (TR-FLA)",
"     </li>",
"     <li>",
"      Immunoblot",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The sensitivity and specificity of a number of the serologic tests have been compared (",
"    <a class=\"graphic graphic_table graphicRef66506 \" href=\"UTD.htm?17/28/17867\">",
"     table 2",
"    </a>",
"    ). ELISA appears to be the most sensitive and specific of the available assays [",
"    <a class=\"abstract\" href=\"UTD.htm?27/23/28025/abstract/46-51\">",
"     46-51",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      One study of 79 patients with surgically confirmed pulmonary hydatidosis demonstrated that IgG ELISA was the most sensitive (84 percent), followed by IgM ELISA (62 percent), passive hemagglutination (61 percent), latex agglutination (58 percent), immunoelectrophoresis (51 percent), and specific IgE ELISA (44 percent). The specificity of all tests was 98 to 100 percent. Specific IgG ELISA had the highest negative predictive value (93 percent) [",
"      <a class=\"abstract\" href=\"UTD.htm?27/23/28025/abstract/46\">",
"       46",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      One study compared eight serologic tests among 131 patients with E. granulosus infection [",
"      <a class=\"abstract\" href=\"UTD.htm?27/23/28025/abstract/49\">",
"       49",
"      </a>",
"      ]. IgG ELISA was the most sensitive (94 percent) and specific (99 percent) for the majority of cyst locations.",
"     </li>",
"     <li>",
"      One report compared six different serologic tests for the diagnosis of cystic hydatid disease among 243 patients with surgically confirmed infection [",
"      <a class=\"abstract\" href=\"UTD.htm?27/23/28025/abstract/50\">",
"       50",
"      </a>",
"      ]. The two ELISA tests gave identical results, with a sensitivity of 89 percent for liver cysts and 78 percent for lung cysts. In the 39 patients with false-negative results, the use of immunoblotting only increased the yield by 8 percent; ELIEDA did not identify any additional cases.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The methods most frequently employed for initial screening tests (using crude antigens such as hydatid fluid or protoscolex extracts) are ELISA and IHA. Confirmatory tests using specific antigens can then be performed, such as immunoelectrophoresis and immunoblotting [",
"    <a class=\"abstract\" href=\"UTD.htm?27/23/28025/abstract/48\">",
"     48",
"    </a>",
"    ]. Additional tests using recombinant or purified species-specific antigens may also be useful diagnosis [",
"    <a class=\"abstract\" href=\"UTD.htm?27/23/28025/abstract/52\">",
"     52",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Simple, heat-stable, inexpensive tests, such as hydatid antigen dot immunoassays, are often used for field testing and population screening [",
"    <a class=\"abstract\" href=\"UTD.htm?27/23/28025/abstract/53\">",
"     53",
"    </a>",
"    ]. The dot-ELISA has a reported sensitivity of 88 to 96 percent and a specificity of 90 to 98 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?27/23/28025/abstract/54-56\">",
"     54-56",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Two major E. granulosus antigens utilized in serologic testing include antigen 5 and antigen B:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Antigen 5 is a major parasite antigen found on the inner aspect of the germinal layer, brood capsule, and protoscolices. Only a few studies have assessed the value of tests based on recombinant antigen 5, which has relatively low specificity, although it is used quite extensively for diagnosis in clinical practice [",
"      <a class=\"abstract\" href=\"UTD.htm?27/23/28025/abstract/48\">",
"       48",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Antigen B is a highly immunogenic polymeric lipoprotein. Studies have showed that antigen B shows a high degree of genetic variability [",
"      <a class=\"abstract\" href=\"UTD.htm?27/23/28025/abstract/57\">",
"       57",
"      </a>",
"      ]. It offers greater specificity than detection of antigen 5; however, neither antigen is specific for E. granulosus per se despite a very high specificity for echinococcal infection [",
"      <a class=\"abstract\" href=\"UTD.htm?27/23/28025/abstract/58,59\">",
"       58,59",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The sensitivity of these antigens in ELISA assays is 60 to 90 percent and the specificity is usually approximately 90 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?27/23/28025/abstract/60\">",
"     60",
"    </a>",
"    ]. The sensitivity in immunoblot and gel diffusion assays is approximately 90 percent with a specificity of 97 to 100 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?27/23/28025/abstract/59,61\">",
"     59,61",
"    </a>",
"    ]. One study demonstrated that the immunoblot with the antigen-B rich fraction was positive in 92 percent of patients with E. granulosus, but was also positive in 79 percent of patients with E. multilocularis [",
"    <a class=\"abstract\" href=\"UTD.htm?27/23/28025/abstract/62\">",
"     62",
"    </a>",
"    ]. No cross-reactivity was observed with sera from patients with other parasitic diseases, malignancies, or healthy controls.",
"   </p>",
"   <p>",
"    A variety of issues influence the rates of false positive and false negative serologic results. First, there is a lack of standardization among different laboratories; for example, one study showed that ELISA using antigen B had a sensitivity of 63 percent, whereas immunoblotting using the same antigen had a sensitivity of 80 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?27/23/28025/abstract/63\">",
"     63",
"    </a>",
"    ]. Second, methods of antigen isolation and purification can influence the results. Third, serological assays with high sensitivity and specificity for diagnosis of cystic echinococcosis in clinical settings can be less useful in epidemiological studies; these assays may detect only half of liver cysts in field surveys and as few as 20 percent of lung cysts [",
"    <a class=\"abstract\" href=\"UTD.htm?27/23/28025/abstract/64,65\">",
"     64,65",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The utility of serology can be improved by using a combination of tests or sequential testing [",
"    <a class=\"abstract\" href=\"UTD.htm?27/23/28025/abstract/66\">",
"     66",
"    </a>",
"    ]. Tests employing a number of recombinant antigens are being evaluated to improve the sensitivity and specificity of the commercially available serologic tests. A highly sensitive assay, usually an ELISA or indirect hemagglutination test, is commonly used as an initial screen, followed by a highly specific immunoblot or gel diffusion assay for confirmation. Testing for specific antibodies, such as specific IgG1 or IgG4 rather than total IgG, may improve specificity [",
"    <a class=\"abstract\" href=\"UTD.htm?27/23/28025/abstract/63,67-69\">",
"     63,67-69",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17745950\">",
"    <span class=\"h5\">",
"     Clinical factors",
"    </span>",
"    &nbsp;&mdash;&nbsp;A negative serologic test generally does not rule out echinococcosis. There is no consistent correlation between serologic results and the number or size of cysts [",
"    <a class=\"abstract\" href=\"UTD.htm?27/23/28025/abstract/46\">",
"     46",
"    </a>",
"    ]. In general liver cysts elicit an antibody response more frequently than lung cysts. Overall, approximately 85 to 95 percent of liver cysts and 65 percent of lung cysts are associated with positive serology, although this varies with the specific serologic test used and cyst activity [",
"    <a class=\"abstract\" href=\"UTD.htm?27/23/28025/abstract/47\">",
"     47",
"    </a>",
"    ]. Brain, eye, and splenic cysts often do not produce detectable antibodies, whereas bone cysts frequently are associated with positive serology. Serology is less likely to be positive with cysts at any site if the cysts are intact, calcified, or nonviable.",
"   </p>",
"   <p>",
"    The likelihood of false-negative results is variable depending on the lesion site of the lesion and the integrity and viability of the cyst. Antigen-antibody complexes that \"mop\" up all antibodies may lead to false-negative reactions. Children and pregnant women more frequently have negative serology than other patient populations [",
"    <a class=\"abstract\" href=\"UTD.htm?27/23/28025/abstract/9\">",
"     9",
"    </a>",
"    ]. False-positive reactions are more likely in the presence of other helminth infections (such as Taenia saginata, Taenia solium, and particularly neurocysticercosis), cancer, and immune disorders.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h4\">",
"     Antigen assays",
"    </span>",
"    &nbsp;&mdash;&nbsp;A variety of purified or recombinant diagnostic antigens have been evaluated. Demonstration of antigens in cystic fluid or serum can also be used for diagnosis of primary infection or relapse [",
"    <a class=\"abstract\" href=\"UTD.htm?27/23/28025/abstract/66,70,71\">",
"     66,70,71",
"    </a>",
"    ]. However, up to 50 percent of patients with echinococcal cysts do not have circulating antigens. Latex agglutination or a dot-ELISA to detect echinococcal antigens from cyst fluid have excellent sensitivity and specificity [",
"    <a class=\"abstract\" href=\"UTD.htm?27/23/28025/abstract/72-74\">",
"     72-74",
"    </a>",
"    ]. Antigen assays and tests for circulating immune complexes are not widely available, but may become useful secondary tests in the future [",
"    <a class=\"abstract\" href=\"UTD.htm?27/23/28025/abstract/75\">",
"     75",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h2\">",
"     E. multilocularis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Nonspecific leukopenia or thrombocytopenia, mild eosinophilia, and nonspecific liver function abnormalities may be detected, but are not diagnostic. Hypergammaglobulinemia and elevated serum IgE levels are present in more than 50 percent of cases.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28\">",
"    <span class=\"h3\">",
"     Imaging",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnosis of E. multilocularis is generally made by imaging techniques in conjunction with serology. On ultrasound or CT, the lesions usually have an irregular contour with no well-defined wall, central necrosis, and irregular intralesional and wall calcifications. They may be difficult to distinguish from a tumor, but the patient's overall condition is usually better than would be expected for a malignancy.",
"   </p>",
"   <p>",
"    Obstruction of the inferior vena cava or of the portal venous system may be evident, which may be more easily appreciated on MRI. Lung, brain, and bone lesions may also be detected.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29\">",
"    <span class=\"h3\">",
"     Serology",
"    </span>",
"    &nbsp;&mdash;&nbsp;Serologic tests are more reliable for diagnosis of E. multilocularis infection than for E. granulosus infection; sensitivity and specificity rates are 95 to 100 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?27/23/28025/abstract/76\">",
"     76",
"    </a>",
"    ]. A specific E. multilocularis antigen such as the affinity purified Em2 antigen from AE metacestodes is often used; the Em2-ELISA can discriminate between E. granulosus and E. multilocularis in 95 percent of cases. Serology usually remains positive indefinitely; following complete surgical resection, serology may normalize within a few years [",
"    <a class=\"abstract\" href=\"UTD.htm?27/23/28025/abstract/77\">",
"     77",
"    </a>",
"    ]. The Em2-ELISA frequently becomes negative within four years of surgery and becomes positive again in the setting of a recurrence [",
"    <a class=\"abstract\" href=\"UTD.htm?27/23/28025/abstract/76,78,79\">",
"     76,78,79",
"    </a>",
"    ]. An Em2plus-ELISA assay uses additional species-specific antigens; it has sensitivity and specificity of 97 and 99 percent, respectively, and is also useful for monitoring recurrence following surgical resection [",
"    <a class=\"abstract\" href=\"UTD.htm?27/23/28025/abstract/80-82\">",
"     80-82",
"    </a>",
"    ]. These tests may not be readily available and may be found only in specialized centers.",
"   </p>",
"   <p>",
"    ELISA and immunoblot studies using Em 18, an 18-kD protoscolex antigen, are sensitive and highly species-specific [",
"    <a class=\"abstract\" href=\"UTD.htm?27/23/28025/abstract/62,83-87\">",
"     62,83-87",
"    </a>",
"    ]. The antigen is also useful for differentiating between active and inactive infection and is useful for follow-up of patients on treatment [",
"    <a class=\"abstract\" href=\"UTD.htm?27/23/28025/abstract/82,83,88,89\">",
"     82,83,88,89",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Clinical recurrence is frequently associated with rising serologic titers. IgG1 and IgG4 antibodies are the most sensitive isotypes for monitoring success of therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?27/23/28025/abstract/83\">",
"     83",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17746768\">",
"    <span class=\"h2\">",
"     Cyst aspiration or biopsy",
"    </span>",
"    &nbsp;&mdash;&nbsp;In the absence of a positive serologic test, percutaneous aspiration or biopsy may be required to confirm the diagnosis by demonstrating the presence of protoscolices, hooklets, or hydatid membranes. Percutaneous aspiration of liver cyst contents is associated with very low rates of complications, but this method of diagnosis is generally reserved for situations when other diagnostic methods are inconclusive because of the potential for anaphylaxis and secondary spread of the infection [",
"    <a class=\"abstract\" href=\"UTD.htm?27/23/28025/abstract/90-93\">",
"     90-93",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Active cysts have clear watery fluid containing scolices and elevated pressure; inactive cysts have cloudy fluid without detectable scolices and do not have elevated pressure [",
"    <a class=\"abstract\" href=\"UTD.htm?27/23/28025/abstract/29\">",
"     29",
"    </a>",
"    ]. In the setting of lung cysts, protoscolices or degenerated hooklets may be demonstrable in sputum or bronchial washings. A variety of staining methods to detect parasitic material can be used. Stains for visualization of hydatid elements include Ryan trichrome blue stain, modified Baxby stain. Ziehl-Neelsen stain is also useful; under green excitation light (546 nm) the hydatid elements have a fluorescent bright red appearance [",
"    <a class=\"abstract\" href=\"UTD.htm?27/23/28025/abstract/94\">",
"     94",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    If aspiration is required, it should be performed under ultrasound or CT guidance; complications can be minimized by concurrent administration of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/6/24678?source=see_link\">",
"     albendazole",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?25/16/25860?source=see_link\">",
"     praziquantel",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?27/23/28025/abstract/95\">",
"     95",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/58/27561?source=see_link\">",
"     \"Treatment of echinococcosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17746795\">",
"    <span class=\"h2\">",
"     Polymerase chain reaction",
"    </span>",
"    &nbsp;&mdash;&nbsp;Polymerase chain reaction (PCR) techniques are limited to research settings, but may play a diagnostic role in the future [",
"    <a class=\"abstract\" href=\"UTD.htm?27/23/28025/abstract/96\">",
"     96",
"    </a>",
"    ]. DNA probes using Southern hybridization tests are also being developed [",
"    <a class=\"abstract\" href=\"UTD.htm?27/23/28025/abstract/80\">",
"     80",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H31\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      E. granulosus infection is initially asymptomatic and may remain so for many years. Subsequent clinical features and complications depend upon the site and size of the cyst(s). The liver and lungs are affected in approximately 67 and 25 percent of cases, respectively. Most patients have single organ involvement, and a single cyst is present in more than 70 percent of cases. The long-term outcome is variable and many patients remain asymptomatic. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Echinococcus granulosus'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      E. multilocularis infection is more likely to be symptomatic than E. granulosus infection. The most common clinical manifestations include right upper quadrant discomfort, malaise, and weight loss, and the picture may mimic that associated with hepatocellular carcinoma. In the absence of treatment, more than 90 percent of patients with alveolar echinococcosis die within 10 years of the onset of clinical symptoms. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Echinococcus multilocularis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The diagnosis of echinococcosis is typically established by ultrasound imaging (",
"      <a class=\"graphic graphic_table graphicRef71806 \" href=\"UTD.htm?38/57/39836\">",
"       table 1",
"      </a>",
"      ) in combination with serologic testing (usually enzyme-linked immunosorbent assay [ELISA]). Hydatid disease is probable in the setting of ultrasound demonstrating infoldings of the inner cyst wall, separation of the hydatid membrane from the wall of the cyst, or hydatid sand. E. multilocularis lesions may have an irregular contour and may be difficult to differentiate from tumor. (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Ultrasonography'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Diagnostic judgment must take into consideration the limitations of serologic testing. The likelihood of a positive serology depends on cyst location and viability. Patients with liver cysts are more likely to be seropositive than patients with lung cysts. Serologic assays are less likely to be positive in the setting of calcified or nonviable cysts. In addition, the sensitivity and specificity of serology is greater for E. multilocularis than for E. granulosus. (See",
"      <a class=\"local\" href=\"#H17\">",
"       'Serologic and antigen assays'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Percutaneous aspiration or biopsy should be reserved for situations when other diagnostic methods are inconclusive because of the potential for anaphylaxis and secondary spread of the infection. If aspiration is required, it should be performed under ultrasound or CT guidance. Complications can be minimized by concurrent administration of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?24/6/24678?source=see_link\">",
"       albendazole",
"      </a>",
"      and",
"      <a class=\"drug drug_general\" href=\"UTD.htm?25/16/25860?source=see_link\">",
"       praziquantel",
"      </a>",
"      . (See",
"      <a class=\"local\" href=\"#H17746768\">",
"       'Cyst aspiration or biopsy'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H110418067\">",
"    <span class=\"h1\">",
"     ACKNOWLEDGMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;The editorial staff at UpToDate, Inc. would like to acknowledge Dr. Karin Leder and Dr. Peter Weller, who contributed to an earlier version of this topic review.",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28025/abstract/1\">",
"      Frider B, Larrieu E, Odriozola M. Long-term outcome of asymptomatic liver hydatidosis. J Hepatol 1999; 30:228.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28025/abstract/2\">",
"      Moro PL, Gilman RH, Verastegui M, et al. Human hydatidosis in the central Andes of Peru: evolution of the disease over 3 years. Clin Infect Dis 1999; 29:807.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28025/abstract/3\">",
"      Santivanez S, Garcia HH. Pulmonary cystic echinococcosis. Curr Opin Pulm Med 2010; 16:257.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28025/abstract/4\">",
"      Arinc S, Kosif A, Ertugrul M, et al. Evaluation of pulmonary hydatid cyst cases. Int J Surg 2009; 7:192.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28025/abstract/5\">",
"      Arroud M, Afifi MA, El Ghazi K, et al. Lung hydatic cysts in children: comparison study between giant and non-giant cysts. Pediatr Surg Int 2009; 25:37.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28025/abstract/6\">",
"      Dopchiz MC, Elissondo MC, Andresiuk MV, et al. Pediatric hydatidosis in the south-east of the Buenos Aires province, Argentina. Rev Argent Microbiol 2009; 41:105.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28025/abstract/7\">",
"      Turgut AT, Altinok T, Top&ccedil;u S, Ko��ar U. Local complications of hydatid disease involving thoracic cavity: imaging findings. Eur J Radiol 2009; 70:49.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28025/abstract/8\">",
"      Dziri C, Haouet K, Fingerhut A, Zaouche A. Management of cystic echinococcosis complications and dissemination: where is the evidence? World J Surg 2009; 33:1266.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28025/abstract/9\">",
"      Bhatia G. Echinococcus. Semin Respir Infect 1997; 12:171.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28025/abstract/10\">",
"      Baden LR, Elliott DD. Case records of the Massachusetts General Hospital. Weekly Clinicopathological exercises. Case 4-2003. A 42-year-old woman with cough, fever, and abnormalities on thoracoabdominal computed tomography. N Engl J Med 2003; 348:447.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28025/abstract/11\">",
"      Ben-Hamda K, Maatouk F, Ben-Farhat M, et al. Eighteen-year experience with echinococcosus of the heart: clinical and echocardiographic features in 14 patients. Int J Cardiol 2003; 91:145.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28025/abstract/12\">",
"      D&iacute;az-Men&eacute;ndez M, P&eacute;rez-Molina JA, Norman FF, et al. Management and outcome of cardiac and endovascular cystic echinococcosis. PLoS Negl Trop Dis 2012; 6:e1437.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28025/abstract/13\">",
"      Nourbakhsh A, Vannemreddy P, Minagar A, et al. Hydatid disease of the central nervous system: a review of literature with an emphasis on Latin American countries. Neurol Res 2010; 32:245.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28025/abstract/14\">",
"      G&ouml;��&uuml;�� C, Safak M, Baltaci S, T&uuml;rk&ouml;lmez K. Isolated renal hydatidosis: experience with 20 cases. J Urol 2003; 169:186.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28025/abstract/15\">",
"      Ali-Khan Z, Rausch RL. Demonstration of amyloid and immune complex deposits in renal and hepatic parenchyma of Alaskan alveolar hydatid disease patients. Ann Trop Med Parasitol 1987; 81:381.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28025/abstract/16\">",
"      Gelman R, Brook G, Green J, et al. Minimal change glomerulonephritis associated with hydatid disease. Clin Nephrol 2000; 53:152.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28025/abstract/17\">",
"      Zlitni M, Ezzaouia K, Lebib H, et al. Hydatid cyst of bone: diagnosis and treatment. World J Surg 2001; 25:75.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28025/abstract/18\">",
"      Chaabouni M, Ben Zina Z, Ben Ayez H, et al. [Hydatid orbital cyst: a unique intra-orbital locality. A case report]. J Fr Ophtalmol 1999; 22:329.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28025/abstract/19\">",
"      Sinav S, Demirci A, Sinav B, et al. A primary intraocular hydatid cyst. Acta Ophthalmol (Copenh) 1991; 69:802.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28025/abstract/20\">",
"      McManus DP, Zhang W, Li J, Bartley PB. Echinococcosis. Lancet 2003; 362:1295.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28025/abstract/21\">",
"      Kern P, Bardonnet K, Renner E, et al. European echinococcosis registry: human alveolar echinococcosis, Europe, 1982-2000. Emerg Infect Dis 2003; 9:343.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28025/abstract/22\">",
"      Ammann RW, Eckert J. Cestodes. Echinococcus. Gastroenterol Clin North Am 1996; 25:655.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28025/abstract/23\">",
"      Torgerson PR, Schweiger A, Deplazes P, et al. Alveolar echinococcosis: from a deadly disease to a well-controlled infection. Relative survival and economic analysis in Switzerland over the last 35 years. J Hepatol 2008; 49:72.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28025/abstract/24\">",
"      Morar R, Feldman C. Pulmonary echinococcosis. Eur Respir J 2003; 21:1069.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28025/abstract/25\">",
"      Barbieri M, Severi MA, P&iacute;rez MI, et al. Use of specific antibody and circulating antigen serum levels in the hydatid immunodiagnosis of asymptomatic population. Int J Parasitol 1994; 24:937.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28025/abstract/26\">",
"      Dhar P, Chaudhary A, Desai R, et al. Current trends in the diagnosis and management of cystic hydatid disease of the liver. J Commun Dis 1996; 28:221.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28025/abstract/27\">",
"      Safioleas M, Misiakos E, Manti C, et al. Diagnostic evaluation and surgical management of hydatid disease of the liver. World J Surg 1994; 18:859.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28025/abstract/28\">",
"      Pant CS, Gupta RK. Diagnostic value of ultrasonography in hydatid disease in abdomen and chest. Acta Radiol 1987; 28:743.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28025/abstract/29\">",
"      Salama H, Farid Abdel-Wahab M, Strickland GT. Diagnosis and treatment of hepatic hydatid cysts with the aid of echo-guided percutaneous cyst puncture. Clin Infect Dis 1995; 21:1372.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28025/abstract/30\">",
"      Suwan Z. Sonographic findings in hydatid disease of the liver: comparison with other imaging methods. Ann Trop Med Parasitol 1995; 89:261.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28025/abstract/31\">",
"      WHO Informal Working Group. International classification of ultrasound images in cystic echinococcosis for application in clinical and field epidemiological settings. Acta Trop 2003; 85:253.",
"     </a>",
"    </li>",
"    <li>",
"     file://www.medicalweb.it/aumi/echinonet/ (Accessed on December 04, 2012).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28025/abstract/33\">",
"      Gharbi HA, Hassine W, Brauner MW, Dupuch K. Ultrasound examination of the hydatic liver. Radiology 1981; 139:459.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28025/abstract/34\">",
"      Hosch W, Stojkovic M, J&auml;nisch T, et al. MR imaging for diagnosing cysto-biliary fistulas in cystic echinococcosis. Eur J Radiol 2008; 66:262.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28025/abstract/35\">",
"      Xynos E, Pechlivanides G, Tzortzinis A, et al. Hydatid disease of the liver. Diagnosis and surgical treatment. HPB Surg 1991; 4:59.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28025/abstract/36\">",
"      el-Tahir MI, Omojola MF, Malatani T, et al. Hydatid disease of the liver: evaluation of ultrasound and computed tomography. Br J Radiol 1992; 65:390.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28025/abstract/37\">",
"      Kervancioglu R, Bayram M, Elbeyli L. CT findings in pulmonary hydatid disease. Acta Radiol 1999; 40:510.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28025/abstract/38\">",
"      al Karawi MA, el-Shiekh Mohamed AR, Yasawy MI. Advances in diagnosis and management of hydatid disease. Hepatogastroenterology 1990; 37:327.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28025/abstract/39\">",
"      Marani SA, Canossi GC, Nicoli FA, et al. Hydatid disease: MR imaging study. Radiology 1990; 175:701.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28025/abstract/40\">",
"      von Sinner WN, Rifai A, te Strake L, Sieck J. Magnetic resonance imaging of thoracic hydatid disease. Correlation with clinical findings, radiography, ultrasonography, CT and pathology. Acta Radiol 1990; 31:59.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28025/abstract/41\">",
"      Morris DL, Buckley J, Gregson R, Worthington BS. Magnetic resonance imaging in hydatid disease. Clin Radiol 1987; 38:141.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28025/abstract/42\">",
"      Taourel P, Marty-Ane B, Charasset S, et al. Hydatid cyst of the liver: comparison of CT and MRI. J Comput Assist Tomogr 1993; 17:80.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28025/abstract/43\">",
"      T&uuml;z&uuml;n M, Altin&ouml;rs N, Arda IS, Hekimo��lu B. Cerebral hydatid disease CT and MR findings. Clin Imaging 2002; 26:353.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28025/abstract/44\">",
"      Rigan&ograve; R, Profumo E, Ioppolo S, et al. Immunological markers indicating the effectiveness of pharmacological treatment in human hydatid disease. Clin Exp Immunol 1995; 102:281.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28025/abstract/45\">",
"      Rigan&ograve; R, Ioppolo S, Ortona E, et al. Long-term serological evaluation of patients with cystic echinococcosis treated with benzimidazole carbamates. Clin Exp Immunol 2002; 129:485.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28025/abstract/46\">",
"      Zarzosa MP, Ordu&ntilde;a Domingo A, Guti&eacute;rrez P, et al. Evaluation of six serological tests in diagnosis and postoperative control of pulmonary hydatid disease patients. Diagn Microbiol Infect Dis 1999; 35:255.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28025/abstract/47\">",
"      Biava MF, Dao A, Fortier B. Laboratory diagnosis of cystic hydatic disease. World J Surg 2001; 25:10.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28025/abstract/48\">",
"      Ortona E, Rigan&ograve; R, Buttari B, et al. An update on immunodiagnosis of cystic echinococcosis. Acta Trop 2003; 85:165.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28025/abstract/49\">",
"      Force L, Torres JM, Carrillo A, Busc&agrave; J. Evaluation of eight serological tests in the diagnosis of human echinococcosis and follow-up. Clin Infect Dis 1992; 15:473.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28025/abstract/50\">",
"      Babba H, Messedi A, Masmoudi S, et al. Diagnosis of human hydatidosis: comparison between imagery and six serologic techniques. Am J Trop Med Hyg 1994; 50:64.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28025/abstract/51\">",
"      Sbihi Y, Rmiqui A, Rodriguez-Cabezas MN, et al. Comparative sensitivity of six serological tests and diagnostic value of ELISA using purified antigen in hydatidosis. J Clin Lab Anal 2001; 15:14.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28025/abstract/52\">",
"      Siles-Lucas MM, Gottstein BB. Molecular tools for the diagnosis of cystic and alveolar echinococcosis. Trop Med Int Health 2001; 6:463.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28025/abstract/53\">",
"      Parija SC. A review of some simple immunoassays in the serodiagnosis of cystic hydatid disease. Acta Trop 1998; 70:17.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28025/abstract/54\">",
"      Rogan MT, Craig PS, Zeyhle E, et al. Evaluation of a rapid dot-ELISA as a field test for the diagnosis of cystic hydatid disease. Trans R Soc Trop Med Hyg 1991; 85:773.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28025/abstract/55\">",
"      Romia SA, Youssef ME, Handoussa AE, et al. Dot-ELISA as a diagnostic test in hydatid disease. J Egypt Soc Parasitol 1992; 22:603.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28025/abstract/56\">",
"      Pappas MG, Schantz PM, Cannon LT Sr, Wahlquist SP. Dot-ELISA for the rapid serodiagnosis of human hydatid disease. Diagn Immunol 1986; 4:271.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28025/abstract/57\">",
"      Mamuti W, Sako Y, Nakao M, et al. Recent advances in characterization of Echinococcus antigen B. Parasitol Int 2006; 55 Suppl:S57.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28025/abstract/58\">",
"      Maddison SE, Slemenda SB, Schantz PM, et al. A specific diagnostic antigen of Echinococcus granulosus with an apparent molecular weight of 8 kDA. Am J Trop Med Hyg 1989; 40:377.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28025/abstract/59\">",
"      Poretti D, Felleisen E, Grimm F, et al. Differential immunodiagnosis between cystic hydatid disease and other cross-reactive pathologies. Am J Trop Med Hyg 1999; 60:193.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28025/abstract/60\">",
"      Kaddah MH, Maher KM, Hassanein HI, et al. Evaluation of different immunodiagnostic techniques for diagnosis of hydatidosis in Egypt. J Egypt Soc Parasitol 1992; 22:653.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28025/abstract/61\">",
"      Siracusano A, Ioppolo S, Notargiacomo S, et al. Detection of antibodies against Echinococcus granulosus major antigens and their subunits by immunoblotting. Trans R Soc Trop Med Hyg 1991; 85:239.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28025/abstract/62\">",
"      Ito A, Ma L, Schantz PM, et al. Differential serodiagnosis for cystic and alveolar echinococcosis using fractions of Echinococcus granulosus cyst fluid (antigen B) and E. multilocularis protoscolex (EM18). Am J Trop Med Hyg 1999; 60:188.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28025/abstract/63\">",
"      Ioppolo S, Notargiacomo S, Profumo E, et al. Immunological responses to antigen B from Echinococcus granulosus cyst fluid in hydatid patients. Parasite Immunol 1996; 18:571.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28025/abstract/64\">",
"      Moro PL, Bonifacio N, Gilman RH, et al. Field diagnosis of Echinococcus granulosus infection among intermediate and definitive hosts in an endemic focus of human cystic echinococcosis. Trans R Soc Trop Med Hyg 1999; 93:611.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28025/abstract/65\">",
"      Gavidia CM, Gonzalez AE, Zhang W, et al. Diagnosis of cystic echinococcosis, central Peruvian Highlands. Emerg Infect Dis 2008; 14:260.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28025/abstract/66\">",
"      Parija SC. Recent trends in the serodiagnosis of hydatid disease. Southeast Asian J Trop Med Public Health 1991; 22 Suppl:371.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28025/abstract/67\">",
"      Ramzy RM, Helmy H, El Zayyat EA, et al. An enzyme-linked immunosorbent assay for detection of IgG1 antibodies specific to human cystic echinococcosis in Egypt. Trop Med Int Health 1999; 4:616.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28025/abstract/68\">",
"      Virginio VG, Hern&aacute;ndez A, Rott MB, et al. A set of recombinant antigens from Echinococcus granulosus with potential for use in the immunodiagnosis of human cystic hydatid disease. Clin Exp Immunol 2003; 132:309.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28025/abstract/69\">",
"      Lawn SD, Bligh J, Craig PS, Chiodini PL. Human cystic echinococcosis: evaluation of post-treatment serologic follow-up by IgG subclass antibody detection. Am J Trop Med Hyg 2004; 70:329.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28025/abstract/70\">",
"      Craig PS, Bailey W, Nelson GS. A specific test for the identification of cyst fluid samples from suspected human hydatid infections. Trans R Soc Trop Med Hyg 1986; 80:256.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28025/abstract/71\">",
"      Ravinder PT, Parija SC. Countercurrent immunoelectrophoresis test for detection of hydatid antigen in the fluid from hydatid cysts: a preliminary report. Acta Trop 1997; 66:169.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28025/abstract/72\">",
"      Devi Chandrakesan S, Parija SC. Latex agglutination test (LAT) for antigen detection in the cystic fluid for the diagnosis of cystic echinococcosis. Diagn Microbiol Infect Dis 2003; 45:123.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28025/abstract/73\">",
"      Wang Y, Bradshaw H, Rogan MT, Craig PS. Rapid dot-ELISA for the detection of specific antigens in the cyst fluid from human cases of cystic echinococcosis. Ann Trop Med Parasitol 2002; 96:691.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28025/abstract/74\">",
"      Devi CS, Parija SC. A new serum hydatid antigen detection test for diagnosis of cystic echinococcosis. Am J Trop Med Hyg 2003; 69:525.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28025/abstract/75\">",
"      Gottstein B. An immunoassay for the detection of circulating antigens in human echinococcosis. Am J Trop Med Hyg 1984; 33:1185.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28025/abstract/76\">",
"      Lanier AP, Trujillo DE, Schantz PM, et al. Comparison of serologic tests for the diagnosis and follow-up of alveolar hydatid disease. Am J Trop Med Hyg 1987; 37:609.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28025/abstract/77\">",
"      Schantz PM, Wilson JF, Wahlquist SP, et al. Serologic tests for diagnosis and post-treatment evaluation of patients with alveolar hydatid disease (Echinococcus multilocularis). Am J Trop Med Hyg 1983; 32:1381.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28025/abstract/78\">",
"      Gottstein B, Tschudi K, Eckert J, Ammann R. Em2-ELISA for the follow-up of alveolar echinococcosis after complete surgical resection of liver lesions. Trans R Soc Trop Med Hyg 1989; 83:389.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28025/abstract/79\">",
"      Deplazes P, Gottstein B. A monoclonal antibody against Echinococcus multilocularis Em2 antigen. Parasitology 1991; 103 Pt 1:41.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28025/abstract/80\">",
"      Gottstein B. Molecular and immunological diagnosis of echinococcosis. Clin Microbiol Rev 1992; 5:248.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28025/abstract/81\">",
"      Gottstein B, Jacquier P, Bresson-Hadni S, Eckert J. Improved primary immunodiagnosis of alveolar echinococcosis in humans by an enzyme-linked immunosorbent assay using the Em2plus antigen. J Clin Microbiol 1993; 31:373.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28025/abstract/82\">",
"      Ma L, Ito A, Liu YH, et al. Alveolar echinococcosis: Em2plus-ELISA and Em18-western blots for follow-up after treatment with albendazole. Trans R Soc Trop Med Hyg 1997; 91:476.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28025/abstract/83\">",
"      Ito A, Schantz PM, Wilson JF. Em18, a new serodiagnostic marker for differentiation of active and inactive cases of alveolar hydatid disease. Am J Trop Med Hyg 1995; 52:41.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28025/abstract/84\">",
"      Akira I. Serodiagnosis of alveolar echinococcosis: detection of antibody against EM18 in patients and rodents. Southeast Asian J Trop Med Public Health 1997; 28 Suppl 1:117.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28025/abstract/85\">",
"      Ito A, Nakao M, Kutsumi H, et al. Serodiagnosis of alveolar hydatid disease by western blotting. Trans R Soc Trop Med Hyg 1993; 87:170.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28025/abstract/86\">",
"      Ito A, Xiao N, Liance M, et al. Evaluation of an enzyme-linked immunosorbent assay (ELISA) with affinity-purified Em18 and an ELISA with recombinant Em18 for differential diagnosis of alveolar echinococcosis: results of a blind test. J Clin Microbiol 2002; 40:4161.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28025/abstract/87\">",
"      Jiang L, Wen H, Ito A. Immunodiagnostic differentiation of alveolar and cystic echinococcosis using ELISA test with 18-kDa antigen extracted from Echinococcus protoscoleces. Trans R Soc Trop Med Hyg 2001; 95:285.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28025/abstract/88\">",
"      Sako Y, Nakao M, Nakaya K, et al. Alveolar echinococcosis: characterization of diagnostic antigen Em18 and serological evaluation of recombinant Em18. J Clin Microbiol 2002; 40:2760.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28025/abstract/89\">",
"      Fujimoto Y, Ito A, Ishikawa Y, et al. Usefulness of recombinant Em18-ELISA to evaluate efficacy of treatment in patients with alveolar echinococcosis. J Gastroenterol 2005; 40:426.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28025/abstract/90\">",
"      Gargouri M, Ben Amor N, Ben Chehida F, et al. Percutaneous treatment of hydatid cysts (Echinococcus granulosus). Cardiovasc Intervent Radiol 1990; 13:169.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28025/abstract/91\">",
"      Khuroo MS, Dar MY, Yattoo GN, et al. Percutaneous drainage versus albendazole therapy in hepatic hydatidosis: a prospective, randomized study. Gastroenterology 1993; 104:1452.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28025/abstract/92\">",
"      Filice C, Di Perri G, Strosselli M, et al. Parasitologic findings in percutaneous drainage of human hydatid liver cysts. J Infect Dis 1990; 161:1290.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28025/abstract/93\">",
"      Giorgio A, Tarantino L, Francica G, et al. Unilocular hydatid liver cysts: treatment with US-guided, double percutaneous aspiration and alcohol injection. Radiology 1992; 184:705.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28025/abstract/94\">",
"      Clavel A, Varea M, Doiz O, et al. Visualization of hydatid elements: comparison of several techniques. J Clin Microbiol 1999; 37:1561.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28025/abstract/95\">",
"      Brunetti E, Kern P, Vuitton DA, Writing Panel for the WHO-IWGE. Expert consensus for the diagnosis and treatment of cystic and alveolar echinococcosis in humans. Acta Trop 2010; 114:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28025/abstract/96\">",
"      Kern P, Frosch P, Helbig M, et al. Diagnosis of Echinococcus multilocularis infection by reverse-transcription polymerase chain reaction. Gastroenterology 1995; 109:596.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 5669 Version 6.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1005-190.92.87.115-5203FA14AB-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f27_23_28025=[""].join("\n");
var outline_f27_23_28025=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H31\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      CLINICAL MANIFESTATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Echinococcus granulosus",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      - Liver involvement",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      - Lung involvement",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      - Other organs",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - Cyst rupture",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - Outcome",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Echinococcus multilocularis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17741682\">",
"      E. granulosus",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      - Imaging",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Ultrasonography",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Computed tomography",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Magnetic resonance imaging",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Other",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      - Serologic and antigen assays",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H17745935\">",
"      Laboratory serologic tools",
"     </a>",
"    </li>",
"    <li class=\"dashItem2\">",
"     <a class=\"outlineLink\" href=\"#H17745950\">",
"      - Clinical factors",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      Antigen assays",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      E. multilocularis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H28\">",
"      - Imaging",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H29\">",
"      - Serology",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17746768\">",
"      Cyst aspiration or biopsy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17746795\">",
"      Polymerase chain reaction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H31\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H110418067\">",
"      ACKNOWLEDGMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ID/5669\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ID/5669|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?13/23/13685\" title=\"diagnostic image 1\">",
"      Echinococcal liver cyst CT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ID/5669|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?40/39/41589\" title=\"figure 1\">",
"      Structure of the echinococcal cyst",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ID/5669|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?9/26/9632\" title=\"picture 1\">",
"      Echinococcal liver cyst gross",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ID/5669|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?38/57/39836\" title=\"table 1\">",
"      Cystic echinococcus classification and treatment",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?17/28/17867\" title=\"table 2\">",
"      Echinococcosis serologic tests",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/29/35290?source=related_link\">",
"      Anaphylaxis: Rapid recognition and treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/6/42087?source=related_link\">",
"      Endoscopic diagnosis and management of biliary parasitosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/59/20407?source=related_link\">",
"      Epidemiology and control of echinococcosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/53/31575?source=related_link\">",
"      Etiology of the Budd-Chiari syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/53/29526?source=related_link\">",
"      Pyogenic liver abscess",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/58/27561?source=related_link\">",
"      Treatment of echinococcosis",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f27_23_28026="Congenital diaphragmatic hernia in the neonate";
var content_f27_23_28026=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Congenital diaphragmatic hernia in the neonate",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?27/23/28026/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?27/23/28026/contributors\">",
"     Holly L Hedrick, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?27/23/28026/contributors\">",
"     N Scott Adzick, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?27/23/28026/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?27/23/28026/contributors\">",
"     Leonard E Weisman, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?27/23/28026/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?27/23/28026/contributors\">",
"     Melanie S Kim, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?27/23/28026/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jan 22, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Congenital diaphragmatic hernia (CDH) is a developmental defect of the diaphragm that allows abdominal viscera to herniate into the chest. The volume of herniated contents may be small or large enough to contain most of the gut, spleen, or liver. Because herniation occurs during a critical period of lung development when bronchial and pulmonary artery branching occurs, lung compression by the herniated bowel results in pulmonary hypoplasia. With increasing severity of lung compression, there is a corresponding decrease in the bronchial branching resulting in a reduction of generations of bronchi and lung tissue. Pulmonary hypoplasia is most severe on the ipsilateral side but may also occur on the contralateral side if the mediastinum shifts and compresses the contralateral lung. In addition, arterial branching is reduced and there is muscular hyperplasia of the pulmonary arterial tree [",
"    <a class=\"abstract\" href=\"UTD.htm?27/23/28026/abstract/1\">",
"     1",
"    </a>",
"    ]. Biochemical analysis also indicates there is a secondary surfactant deficiency [",
"    <a class=\"abstract\" href=\"UTD.htm?27/23/28026/abstract/2-4\">",
"     2-4",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/11/42169?source=see_link\">",
"     \"Congenital diaphragmatic hernia: Prenatal diagnosis and management\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    CDH is estimated to occur in 1 out of 2200 births. Affected neonates usually present in the first few hours of life with respiratory distress that may be mild or so severe as to be incompatible with life. With the advent of antenatal diagnosis and improvement of neonatal care, survival has improved but there still remains significant risk of death and complications in infants with CDH.",
"   </p>",
"   <p>",
"    The clinical manifestations, diagnosis and management of the neonate with CDH will be reviewed here. The pathogenesis, anatomy, prenatal diagnosis, and management of CDH are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/11/42169?source=see_link\">",
"     \"Congenital diaphragmatic hernia: Prenatal diagnosis and management\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     CLINICAL MANIFESTATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Infants with congenital diaphragmatic hernia (CDH) most often develop respiratory distress in the first few hours or days of life. The spectrum of presentation can vary from acute, severe respiratory distress at birth, which is common, to minimal or no symptoms, which is observed in a much smaller group of patients.",
"   </p>",
"   <p>",
"    Physical examination will reveal a barrel-shaped chest, a scaphoid appearing abdomen because of loss of the abdominal contents into the chest, and absence of breath sounds on the ipsilateral side. In most patients with CDH (because the lesion is on the left side), the heartbeat is displaced to the right because of a shift in the mediastinum.",
"   </p>",
"   <p>",
"    Associated anomalies are seen in approximately 50 percent of CDH cases and include chromosomal abnormalities, congenital heart disease, and neural tube defects. In stillborn infants, associated anomalies are more common. These anomalies are often diagnosed prenatally and are discussed in greater detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/11/42169?source=see_link&amp;anchor=H7#H7\">",
"     \"Congenital diaphragmatic hernia: Prenatal diagnosis and management\", section on 'Associated anomalies'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Infants with CDH are at increased risk for developing persistent pulmonary hypertension (PPHN) because of in utero vascular anatomic changes. Postdelivery, hypoxemia, acidosis, and hypotension increase the risk of PPHN by inducing a reactive vasoconstrictive element to the preexisting fixed arterial muscular hyperplasia component.",
"   </p>",
"   <p>",
"    The degree of respiratory distress is dependent on the severity of lung hypoplasia and PPHN. In some cases, the lung hypoplasia is so severe as to be incompatible with life. Prenatally, lung hypoplasia can be estimated using ultrasound by determining if the herniated contents include the liver and by measuring the lung area to head circumference ratio. After delivery, there is no single test to determine the degree of hypoplasia. The severity of the respiratory distress and the response of the infant to treatment are the best measure of lung hypoplasia. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/11/42169?source=see_link&amp;anchor=H11#H11\">",
"     \"Congenital diaphragmatic hernia: Prenatal diagnosis and management\", section on 'Prognostic factors'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In most cases of CDH, herniation occurs on the left. Right-sided diaphragmatic hernias occur in 11 percent of cases and bilateral herniation in 2 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?27/23/28026/abstract/5\">",
"     5",
"    </a>",
"    ]. Disease severity appears to be similar in patients with right-sided lesions.",
"   </p>",
"   <p>",
"    In one case series of 194 cases of CDH diagnosed prenatally, 22 were right-sided [",
"    <a class=\"abstract\" href=\"UTD.htm?27/23/28026/abstract/5\">",
"     5",
"    </a>",
"    ]. In all cases, the fetal liver was herniated into the right chest. The overall survival rate was 70 percent, and rate of extracorporeal membrane oxygenation (ECMO) was 50 percent, which coincided with the rates for left CDH at that institution.",
"   </p>",
"   <p>",
"    Adrenal insufficiency is reported to be a common finding in infants with CDH. In one retrospective study of 58 patients with CDH admitted to a single tertiary center from 2002 to 2008, adrenal insufficiency (defined as a cortisol level &le;15",
"    <span class=\"nowrap\">",
"     &micro;g/dL",
"    </span>",
"    [415",
"    <span class=\"nowrap\">",
"     nmol/L])",
"    </span>",
"    was demonstrated in two-thirds of the group who were assessed for adrenal function (n = 34 patients) [",
"    <a class=\"abstract\" href=\"UTD.htm?27/23/28026/abstract/6\">",
"     6",
"    </a>",
"    ]. Infants with adrenal insufficiency were more likely to have herniation of the liver, and had more severe illness requiring epinephrine for vasopressor support, high-frequency ventilation, and inhaled nitric oxide for a longer duration of time.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;With the increase in the use of antenatal ultrasound, many cases of congenital diaphragmatic hernia (CDH) are diagnosed prenatally. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/11/42169?source=see_link&amp;anchor=H5#H5\">",
"     \"Congenital diaphragmatic hernia: Prenatal diagnosis and management\", section on 'Prenatal diagnosis'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Among infants in whom CDH is not diagnosed in utero, the diagnosis should be suspected in any full term infants with respiratory distress especially in the absence of breath sounds. The diagnosis is made by chest radiography showing herniation of abdominal contents (usually air or fluid containing bowel) into the hemithorax (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef52913 \" href=\"UTD.htm?14/37/14928\">",
"     image 1",
"    </a>",
"    ). There is little or no visible aerated lung on the side of the herniation. Other findings include the contralateral displacement of the heart and other mediastinal structures, compression of the contralateral lung, and reduced size of the abdomen with decreased or absent air-containing intra-abdominal bowel. Placement of a feeding tube into the stomach may facilitate the diagnosis if the chest radiograph demonstrates the feeding tube within the thoracic cavity or deviation from its expected anatomic course [",
"    <a class=\"abstract\" href=\"UTD.htm?27/23/28026/abstract/7\">",
"     7",
"    </a>",
"    ]. If the CDH is right sided, the liver may be the only herniated organ and will appear as a large thoracic soft tissue mass with absence of an intra-abdominal liver shadow on chest radiograph.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     DIFFERENTIAL DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Thoracic lesions that should also be considered when the diagnosis of congenital diaphragmatic hernia (CDH) is made prenatally by ultrasound include diaphragmatic eventration, congenital cystic adenomatoid malformation, bronchopulmonary sequestration, bronchogenic cysts, bronchial atresia, enteric cysts, and teratomas. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/11/42169?source=see_link&amp;anchor=H10#H10\">",
"     \"Congenital diaphragmatic hernia: Prenatal diagnosis and management\", section on 'Differential diagnosis'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In the full term neonate with severe respiratory distress, the differential diagnosis includes other causes of pulmonary hypoplasia either primary or secondary (eg, oligohydramnios from chronic amniotic fluid leak or renal",
"    <span class=\"nowrap\">",
"     hypoplasia/dysplasia),",
"    </span>",
"    and persistent pulmonary hypertension. CDH is differentiated from these conditions by the characteristic chest radiograph finding of herniated abdominal contents into the thorax. (See",
"    <a class=\"local\" href=\"#H3\">",
"     'Diagnosis'",
"    </a>",
"    above and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/37/27225?source=see_link\">",
"     \"Persistent pulmonary hypertension of the newborn\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     MANAGEMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;The treatment of congenital diaphragmatic hernia (CDH) in the neonate has changed since the first reports of surgical repair in the 1940s [",
"    <a class=\"abstract\" href=\"UTD.htm?27/23/28026/abstract/8,9\">",
"     8,9",
"    </a>",
"    ]. CDH had been treated as a surgical emergency with an emphasis on early surgical intervention to optimize survival. Survival, however, did not improve, but instead leveled off at 50 percent in series published from tertiary care centers. In the mid 1980s, it was recognized that the major determinants of mortality were pulmonary hypoplasia and pulmonary hypertension. As a result, the emphasis shifted from early surgical intervention to preoperative care directed towards optimal management of pulmonary hypoplasia and pulmonary hypertension, followed by surgical repair [",
"    <a class=\"abstract\" href=\"UTD.htm?27/23/28026/abstract/10-12\">",
"     10-12",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In one retrospective review of a single center, the survival rate improved in patients whose surgery was delayed to allow resolution of early pulmonary insufficiency and acute pulmonary hypertension compared to historical controls who underwent immediate surgical repair (79 versus 56 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?27/23/28026/abstract/13\">",
"     13",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Preoperative care is directed towards stabilizing the infant's oxygenation, blood pressure, and acid-base status. Although there are no randomized clinical trials, aggressive medical management with decompression of the lung tissue (or at least minimize any increase in compression), cardiovascular support with fluids and inotropic agents, and ventilatory support including high frequency ventilation and extracorporeal membrane oxygenation (ECMO) that minimize lung injury followed by surgical correction appear to be associated with improved survival rates [",
"    <a class=\"abstract\" href=\"UTD.htm?27/23/28026/abstract/11,13-15\">",
"     11,13-15",
"    </a>",
"    ]. In a review of the literature, strategies that aimed at minimizing lung injury, increased tolerance of postductal acidosis and hypoxemia (ie, permissive hypercapnia), and center-specific guidelines for initiation of ECMO appear to be associated with improved mortality [",
"    <a class=\"abstract\" href=\"UTD.htm?27/23/28026/abstract/16\">",
"     16",
"    </a>",
"    ]. However, this review demonstrates the need for prospective randomized management trials, which are difficult to perform because of the low incidence of CDH, wide spectrum of clinical disease, and the complexity of management.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Prenatal management",
"    </span>",
"    &nbsp;&mdash;&nbsp;(See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/11/42169?source=see_link&amp;anchor=H16#H16\">",
"     \"Congenital diaphragmatic hernia: Prenatal diagnosis and management\", section on 'Obstetrical management'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Initial treatment",
"    </span>",
"    &nbsp;&mdash;&nbsp;In the delivery room, infants with CDH should be immediately intubated; blow-by oxygen",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    bag-masking lead to",
"    <span class=\"nowrap\">",
"     gastric/abdominal",
"    </span>",
"    distension and compression of the lung and are therefore avoided. The infant should be ventilated with low peak pressure (goal, &lt;25 cm H",
"    <sub>",
"     2",
"    </sub>",
"    O) to minimize lung injury. Any delay in obtaining an airway can intensify the resultant acidosis and hypoxia, which can increase the risk of pulmonary hypertension. The downward spiral of hypoxia, hypercarbia, and acidosis is difficult to reverse in this population. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/37/27225?source=see_link\">",
"     \"Persistent pulmonary hypertension of the newborn\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    A nasogastric tube connected to continuous suction is placed in the stomach for decompression of the abdominal contents. This can help expand available lung tissue.",
"   </p>",
"   <p>",
"    The infant should have an umbilical artery line placed for frequent monitoring of blood gases and blood pressure, and if possible an umbilical vein (UV) catheter for administration of fluids and medications. In patients with the liver in the chest, the UV catheter is often difficult to position, and, therefore, once the patient is stabilized, other venous access should be obtained.",
"   </p>",
"   <p>",
"    Blood pressure support should be given to maintain arterial mean blood pressure levels &ge;50 mm Hg to minimize any right to left shunting. Support includes the use of isotonic fluids and inotropic agents such as dopamine",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?24/48/25348?source=see_link\">",
"     dobutamine",
"    </a>",
"    .",
"   </p>",
"   <p>",
"    The administration of surfactant therapy has been suggested in treating infants with CDH [",
"    <a class=\"abstract\" href=\"UTD.htm?27/23/28026/abstract/17\">",
"     17",
"    </a>",
"    ]. However, a report from the Congenital Diaphragmatic Hernia Registry (CDHR) did not find that surfactant improved outcomes [",
"    <a class=\"abstract\" href=\"UTD.htm?27/23/28026/abstract/18\">",
"     18",
"    </a>",
"    ]. Although this was not a prospective controlled trial and infants who received surfactant may have had more severe diseases, it does not appear that surfactant is beneficial in the treatment of CDH. We consider the use of surfactant in neonates &le;34 weeks gestation with chest radiographic findings of alveolar atelectasis suggestive of respiratory distress syndrome. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/12/19656?source=see_link&amp;anchor=H20#H20\">",
"     \"Pathophysiology and clinical manifestations of respiratory distress syndrome in the newborn\", section on 'Diagnosis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Ventilation",
"    </span>",
"    &nbsp;&mdash;&nbsp;The mode of ventilation is aimed at administering only enough pressure to maintain preductal oxygen saturations above 80 percent or preductal partial pressure of oxygen (PaO",
"    <sub>",
"     2",
"    </sub>",
"    ) above 60 mm Hg. Barotrauma to the hypoplastic lungs may be largely responsible for the instability of the infant and contributes to 25 percent of CDH deaths [",
"    <a class=\"abstract\" href=\"UTD.htm?27/23/28026/abstract/19-21\">",
"     19-21",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Initiation of conventional ventilator management includes pressure-limited ventilation at rates of 30 to 100 breaths per minute at peak inspiratory pressures of 20 to 25 cm H",
"    <sub>",
"     2",
"    </sub>",
"    O [",
"    <a class=\"abstract\" href=\"UTD.htm?27/23/28026/abstract/10,14\">",
"     10,14",
"    </a>",
"    ]. Peak inspiratory pressures that exceed 28 cm H",
"    <sub>",
"     2",
"    </sub>",
"    O are used transiently as a bridge to extracorporeal membrane oxygenation (ECMO). Positive end-expiratory pressure (PEEP) should be maintained at physiologic levels (3 to 5 cm H",
"    <sub>",
"     2",
"    </sub>",
"    O) whenever possible. Hyperventilation, hypocarbia, and alkalosis may decrease ductal shunting and control pulmonary hypertension in CDH [",
"    <a class=\"abstract\" href=\"UTD.htm?27/23/28026/abstract/22,23\">",
"     22,23",
"    </a>",
"    ], but at the expense of increased barotrauma. Permissive hypercapnia has been used in neonates with CDH with reports of increased survival compared to hyperventilation and alkalization [",
"    <a class=\"abstract\" href=\"UTD.htm?27/23/28026/abstract/10-12,14,24\">",
"     10-12,14,24",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H10\">",
"     'Extracorporeal membrane oxygenation'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    High frequency ventilation (HFV) is generally reserved for neonates that continue to have hypoxia and hypercarbia refractory to conventional ventilation. Although the indications for HFV are not clearly defined, there are retrospective reports of effective pCO",
"    <sub>",
"     2",
"    </sub>",
"    reduction and increased survival in neonates with CDH [",
"    <a class=\"abstract\" href=\"UTD.htm?27/23/28026/abstract/25-27\">",
"     25-27",
"    </a>",
"    ]. In the largest case series of 82 patients treated with a regimen of early high-frequency oscillatory ventilation, nitric oxide for pulmonary hypertension, and delayed surgery after respiratory and hemodynamic stabilization at a single institution from 2000 to 2005, the survival rate at one month was 66 percent in this group of patients, in whom there was no ECMO therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?27/23/28026/abstract/25\">",
"     25",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In contrast, in another study of 111 infants, HFV was used routinely and initiated when infants were admitted to the neonatal intensive care unit as part of the treatment protocol [",
"    <a class=\"abstract\" href=\"UTD.htm?27/23/28026/abstract/28\">",
"     28",
"    </a>",
"    ]. The survival rate was 69 percent. Nitric oxide was administered to 36 infants and 4 patients were placed upon ECMO. The overall survival rate is comparable to other reports that begin with conventional ventilation.",
"   </p>",
"   <p>",
"    In infants with CDH, there are no randomized trials comparing HFV to other modes of ventilation in infant. Further data are needed to determine whether HFV has a role in managing neonates with CDH, and if so, what are the indications for HFV.",
"   </p>",
"   <p>",
"    Frequent blood gases are important parameters to follow in the adjustment of ventilator settings. Oxygen should only be weaned after a period of stabilization and very slowly to prevent pulmonary hypertension and its resultant shunting.",
"   </p>",
"   <p>",
"    Paralysis and sedation reduce air swallowing and may enhance compliance and reduce sympathetic vasoconstriction, potentially leading to lower ventilator settings. Others argue that the loss of the infant's spontaneous contribution to minute ventilation and increased third-space edema negate the benefits of paralysis [",
"    <a class=\"abstract\" href=\"UTD.htm?27/23/28026/abstract/10\">",
"     10",
"    </a>",
"    ]. In our practice, we avoid the use of paralytic agents, and use",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?34/0/34821?source=see_link\">",
"     pancuronium",
"    </a>",
"    only when necessary (eg, failure of patient-ventilator synchrony).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Echocardiography",
"    </span>",
"    &nbsp;&mdash;&nbsp;Echocardiography is performed early to assess associated cardiac anomalies and establish the presence and severity of pulmonary hypertension and shunting (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef75412 graphicRef57522 \" href=\"UTD.htm?41/15/42226\">",
"     image 2A-B",
"    </a>",
"    ). The presence of associated severe cardiac anomalies may impact on how aggressive subsequent treatment should be as the survival rate of patients with CDH and major cardiac anomalies (such as hypoplastic left heart syndrome) is guarded. In one study, the reported survival rate of patients with concomitant CDH and congenital heart disease was 24 percent and was dependent on the severity of lung hypoplasia [",
"    <a class=\"abstract\" href=\"UTD.htm?27/23/28026/abstract/29\">",
"     29",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/11/42169?source=see_link&amp;anchor=H7#H7\">",
"     \"Congenital diaphragmatic hernia: Prenatal diagnosis and management\", section on 'Associated anomalies'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The echocardiographic signs of pulmonary hypertension include poor contractility of the right ventricle, enlarged right heart chambers, pulmonic and tricuspid valve regurgitation, and presence of ductal shunting. Left ventricular hypoplasia may also be identified. Pulmonary hypertension with right-to-left shunting, left ventricular dysfunction, or systemic hypotension are indications for prompt administration of inotropic agents as well as selective pulmonary vasodilators (eg, nitric oxide). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/37/27225?source=see_link&amp;anchor=H15#H15\">",
"     \"Persistent pulmonary hypertension of the newborn\", section on 'Management'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Extracorporeal membrane oxygenation",
"    </span>",
"    &nbsp;&mdash;&nbsp;The first CDH survivor treated with extracorporeal membrane oxygenation (ECMO) was reported in 1977 [",
"    <a class=\"abstract\" href=\"UTD.htm?27/23/28026/abstract/30\">",
"     30",
"    </a>",
"    ]. Subsequently, several single institution series have reported an improved survival rate with the use of ECMO in infants with CDH [",
"    <a class=\"abstract\" href=\"UTD.htm?27/23/28026/abstract/31-34\">",
"     31-34",
"    </a>",
"    ]. However the results of ECMO are heavily dependent on selection criteria, which can vary by institution. Initially, attempts were made to identify those neonates with a greater than 80 percent risk of death, and offered ECMO only to this group. However, there are no absolute predictors of lethal pulmonary hypoplasia in CDH; therefore, it was not possible to determine which neonates would otherwise not survive.",
"   </p>",
"   <p>",
"    Although there are no randomized controlled studies that have demonstrated the efficacy of ECMO in infants with CDH, ECMO, if available, is considered for almost all infants that cannot be managed with conventional therapy. Data from the Extracorporeal Life Support Organization (ELSO) Registry from 1989 through July 2004, demonstrated that CDH was the second most common diagnosis for neonatal patients on ECMO (total of 4,491 cases) [",
"    <a class=\"abstract\" href=\"UTD.htm?27/23/28026/abstract/35\">",
"     35",
"    </a>",
"    ]. The proportion of cases of CDH has also increased since the start of the registry with about one-third of reported neonatal patients in 2003 and 2004 diagnosed with CDH [",
"    <a class=\"abstract\" href=\"UTD.htm?27/23/28026/abstract/36\">",
"     36",
"    </a>",
"    ]. The survival rate of patients with CDH in the ELSO registry is 53 percent.",
"   </p>",
"   <p>",
"    The mean duration on ECMO tends to be longer for CDH than for other neonatal indications. Data from the ELSO registry reported a longer mean duration of ECMO for infants with CDH compared to those with meconium",
"    <span class=\"nowrap\">",
"     aspiration/persistent",
"    </span>",
"    pulmonary hypertension (PPHN) and idiopathic PPHN (222, 128 and 140 hours, respectively).",
"   </p>",
"   <p>",
"    With the development of double lumen venovenous (VV) cannulas, VV ECMO may now be administered safely to neonates [",
"    <a class=\"abstract\" href=\"UTD.htm?27/23/28026/abstract/37\">",
"     37",
"    </a>",
"    ]. One small series of 14 patients concluded that VV ECMO was as efficacious as VA ECMO in patients with CDH [",
"    <a class=\"abstract\" href=\"UTD.htm?27/23/28026/abstract/38\">",
"     38",
"    </a>",
"    ]. However, in our experience with severe CDH, right ventricular dysfunction has limited the successful use of VV ECMO.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h3\">",
"     Criteria",
"    </span>",
"    &nbsp;&mdash;&nbsp;In the early experience of patients with CDH, ECMO was used when instability developed after an early repair. With the advent of delayed repair in the mid 1980s, stabilization of the severely hypoxic infant became possible [",
"    <a class=\"abstract\" href=\"UTD.htm?27/23/28026/abstract/39-42\">",
"     39-42",
"    </a>",
"    ]. ECMO is now performed before, during, or after repair of CDH. In particular, the use of ECMO preoperatively is advocated as a means to support the patient until the reactive component of pulmonary hypertension resolves, which may take weeks.",
"   </p>",
"   <p>",
"    The prime Indication for ECMO is failure of conventional therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?27/23/28026/abstract/11,19,43\">",
"     11,19,43",
"    </a>",
"    ]. We use the following criteria:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Inability to maintain preductal saturations &gt;85 percent or postductal PaO",
"      <sub>",
"       2",
"      </sub>",
"      &gt;30",
"     </li>",
"     <li>",
"      Peak inspiratory pressure &gt;28 cm H",
"      <sub>",
"       2",
"      </sub>",
"      O or mean airway pressure &gt;15 cm H",
"      <sub>",
"       2",
"      </sub>",
"      O",
"     </li>",
"     <li>",
"      Hypotension that is resistant to fluid and inotropic support",
"     </li>",
"     <li>",
"      Inadequate oxygen delivery with persistent metabolic acidosis",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Traditional inclusion criteria also include all of the following [",
"    <a class=\"abstract\" href=\"UTD.htm?27/23/28026/abstract/44\">",
"     44",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Birth weight &gt;2 kg",
"     </li>",
"     <li>",
"      Gestational age &gt;34 weeks",
"     </li>",
"     <li>",
"      Absence of intracranial hemorrhage &gt;grade I",
"     </li>",
"     <li>",
"      Absence of other congenital or chromosomal anomalies",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    There have been reports of patients with cardiac disease, low-grade intracranial hemorrhage, and prematurity who have been placed on ECMO and survived [",
"    <a class=\"abstract\" href=\"UTD.htm?27/23/28026/abstract/29,31,45,46\">",
"     29,31,45,46",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Exclusionary criteria for ECMO vary between institutions. Most ECMO centers exclude patients with lethal chromosomal abnormalities or severe intracranial hemorrhage. There is an ongoing risk of intracranial bleed because all patients on ECMO must be continuously anti-coagulated with",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?7/39/7801?source=see_link\">",
"     heparin",
"    </a>",
"    . Extension of intracranial hemorrhage requires withdrawal of ECMO support.",
"   </p>",
"   <p>",
"    In our practice, head ultrasounds are performed before initiation of ECMO, daily for the first five days and then every other day while on ECMO support. In addition, head ultrasounds are performed emergently for onset of seizures, change in neurologic status, or following any significant clinical event (eg, surgical repair of CDH, and episodes of hypotension or hypertension).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h3\">",
"     Efficacy",
"    </span>",
"    &nbsp;&mdash;&nbsp;It is difficult to accurately assess the benefit of ECMO given the absence of clinical trials. In a study of 47 full term infants with CDH, serial echocardiography showed decreased survival with prolonged elevated pulmonary artery pressures [",
"    <a class=\"abstract\" href=\"UTD.htm?27/23/28026/abstract/47\">",
"     47",
"    </a>",
"    ]. As a result, once ECMO support is initiated, it may be required for persistent pulmonary hypertension. When ECMO flow is weaned, pulmonary artery pressures can be assessed by echocardiography during a clamp trial off ECMO.",
"   </p>",
"   <p>",
"    Survival observational data on 3100 patients from the CDH Study Group demonstrated a 49 percent survival rate for patients managed with ECMO (n = 1067) compared to the overall survival rate of 67 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?27/23/28026/abstract/48\">",
"     48",
"    </a>",
"    ]. Of the patients who underwent ECMO and attempted surgical repair, the survival rate increased to 61 percent, which most likely excluded the most severely ill patients who were too ill for surgical intervention. The highest survival rate (75 percent) occurred in those patients who did not require ECMO, who presumably had less severe illness.",
"   </p>",
"   <p>",
"    Once the infant is weaned from ECMO, there remains a risk of recurrent hypoxia secondary to pulmonary hypertension and right-to-left shunting [",
"    <a class=\"abstract\" href=\"UTD.htm?27/23/28026/abstract/49\">",
"     49",
"    </a>",
"    ]. In a report of patients treated with a second course of ECMO, 16 of 34 (47 percent) CDH patients survived [",
"    <a class=\"abstract\" href=\"UTD.htm?27/23/28026/abstract/50\">",
"     50",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Surgery",
"    </span>",
"    &nbsp;&mdash;&nbsp;Surgical repair consists of reduction of the abdominal viscera and primary closure of the diaphragmatic defect (",
"    <a class=\"graphic graphic_picture graphicRef58524 \" href=\"UTD.htm?21/11/21684\">",
"     picture 1",
"    </a>",
"    ). The diaphragmatic defect may be repaired with sutures alone, but increased tension, which compromises total thoracic compliance, often requires that a gore-tex patch be used in repair of the defect [",
"    <a class=\"abstract\" href=\"UTD.htm?27/23/28026/abstract/51\">",
"     51",
"    </a>",
"    ]. There are patch-related complications including an increased risk of infection and chest wall deformities by tethering of the ribs [",
"    <a class=\"abstract\" href=\"UTD.htm?27/23/28026/abstract/52\">",
"     52",
"    </a>",
"    ], however, in our center, there is a low recurrence of CDH rate similar to that observed with primary repair [",
"    <a class=\"abstract\" href=\"UTD.htm?27/23/28026/abstract/51\">",
"     51",
"    </a>",
"    ]. If the abdominal wall is difficult to close following reduction of the hernia, the use of a temporary abdominal wall silo or patch may be helpful [",
"    <a class=\"abstract\" href=\"UTD.htm?27/23/28026/abstract/53\">",
"     53",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H20\">",
"     'Patch-related'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    A less commonly used technique is the split abdominal wall muscle flap used to repair large diaphragmatic hernias when primary closure is not feasible [",
"    <a class=\"abstract\" href=\"UTD.htm?27/23/28026/abstract/54\">",
"     54",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h3\">",
"     Timing",
"    </span>",
"    &nbsp;&mdash;&nbsp;Advancement in surgical techniques in the 1940s led to the ability to surgically repair CDH and improved survival of children with CDH [",
"    <a class=\"abstract\" href=\"UTD.htm?27/23/28026/abstract/8,9\">",
"     8,9",
"    </a>",
"    ]. Over the next three decades, emphasis was placed on rapid surgical intervention in order to optimize results. Survival, however, did not improve, but instead leveled off at 50 percent. In the mid-1980s, pulmonary hypoplasia and pulmonary hypertension became recognized as the major determinants of survival. Patients with no or mild pulmonary hypoplasia and reversible pulmonary hypertension potentially could be salvaged [",
"    <a class=\"abstract\" href=\"UTD.htm?27/23/28026/abstract/55\">",
"     55",
"    </a>",
"    ], whereas, those with severe pulmonary hypoplasia and irreversible pulmonary hypertension could not. With a better understanding of the pathophysiology, the emphasis in the care of the CDH patient shifted from early surgical intervention to preoperative and postoperative care directed towards improved management of pulmonary hypoplasia and pulmonary hypertension [",
"    <a class=\"abstract\" href=\"UTD.htm?27/23/28026/abstract/16\">",
"     16",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/37/27225?source=see_link&amp;anchor=H15#H15\">",
"     \"Persistent pulmonary hypertension of the newborn\", section on 'Management'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Survival rates in newborns with CDH managed with pre-operative stabilization and selective use of ECMO followed by delayed surgical correction are reported to be 79 to 92 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?27/23/28026/abstract/11,13-16\">",
"     11,13-16",
"    </a>",
"    ]. In one retrospective review of a single center, the survival rate improved in patients whose surgery was delayed (allowing resolution of early pulmonary insufficiency and acute pulmonary hypertension) compared to those who underwent immediate surgical repair (79 versus 56 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?27/23/28026/abstract/13\">",
"     13",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The timing of the surgery is dependent on the severity of the respiratory distress:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In patients with only mild symptoms on minimal support, there may be no pulmonary hypertension or vascular lability; therefore, repair can be undertaken after 48 to 72 hours.",
"     </li>",
"     <li>",
"      In patients with no or mild pulmonary hypoplasia and reversible pulmonary hypertension, the timing of repair is delayed until maximum benefit is achieved from short-term, time-related resolution of pulmonary hypertension and improvements in pulmonary compliance [",
"      <a class=\"abstract\" href=\"UTD.htm?27/23/28026/abstract/56\">",
"       56",
"      </a>",
"      ]. The time course is variable. The most common group of patients will demonstrate initial lability, but then stabilize, allowing repair after 5 to 10 days.",
"     </li>",
"     <li>",
"      In a small group of patients with severe pulmonary hypoplasia",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      pulmonary hypertension, there will be no response to therapy of any kind including ECMO. In this group, support is often withdrawn.",
"     </li>",
"     <li>",
"      In patients who require ECMO therapy, there is some controversy about timing of the operative repair.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      One approach is to repair the defect while the infant is on ECMO [",
"      <a class=\"abstract\" href=\"UTD.htm?27/23/28026/abstract/57\">",
"       57",
"      </a>",
"      ]. However, early studies reported a high rate of hemorrhagic complications and high mortality once bleeding developed [",
"      <a class=\"abstract\" href=\"UTD.htm?27/23/28026/abstract/58,59\">",
"       58,59",
"      </a>",
"      ]. This problem has been partially resolved by administering perioperative",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?14/32/14854?source=see_link\">",
"       aminocaproic acid",
"      </a>",
"      (Amicar&reg;) [",
"      <a class=\"abstract\" href=\"UTD.htm?27/23/28026/abstract/57,60\">",
"       57,60",
"      </a>",
"      ], putting fibrin glue on the suture line [",
"      <a class=\"abstract\" href=\"UTD.htm?27/23/28026/abstract/61\">",
"       61",
"      </a>",
"      ], and avoiding extensive dissection of the diaphragmatic leaves.",
"     </li>",
"     <li>",
"      The repair may also be postponed until the point when the patient is ready to wean off ECMO or after resolution of pulmonary hypertension [",
"      <a class=\"abstract\" href=\"UTD.htm?27/23/28026/abstract/62\">",
"       62",
"      </a>",
"      ]. In this instance, if the circuit clots secondary to the use of",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?14/32/14854?source=see_link\">",
"       aminocaproic acid",
"      </a>",
"      or there is excessive bleeding, the baby may be decannulated without significant clinical compromise.",
"     </li>",
"     <li>",
"      Finally, some advocate a return to conventional ventilation and decannulation before repair of CDH [",
"      <a class=\"abstract\" href=\"UTD.htm?27/23/28026/abstract/44\">",
"       44",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h1\">",
"     COMPLICATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The most serious complication post-repair of congenital diaphragmatic hernia (CDH) is recurrent pulmonary hypertension [",
"    <a class=\"abstract\" href=\"UTD.htm?27/23/28026/abstract/47,63\">",
"     47,63",
"    </a>",
"    ]. Nonpulmonary complications early in the postoperative course include hemorrhage, chylothorax, and patch infection. Late complications include chronic respiratory disease, recurrent",
"    <span class=\"nowrap\">",
"     hernia/patch",
"    </span>",
"    problems,",
"    <span class=\"nowrap\">",
"     spinal/chest",
"    </span>",
"    wall abnormalities, gastrointestinal difficulties, and neurological sequelae.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Pulmonary complications",
"    </span>",
"    &nbsp;&mdash;&nbsp;Postoperative, some patients may develop pulmonary hypertension and require extracorporeal membrane oxygenation (ECMO) [",
"    <a class=\"abstract\" href=\"UTD.htm?27/23/28026/abstract/47,63\">",
"     47,63",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Although these patients have pulmonary hypoplasia, it appears that patients who survived without the need for ECMO preoperatively have no or minimal clinical pulmonary consequences, but infants who required ECMO therapy appear to be at risk for chronic lung disease and respiratory infections.",
"   </p>",
"   <p>",
"    In the pre-ECMO era, most patients who survived past the neonatal period reported no clinical consequences, although several studies have demonstrated some residual anatomic and physiological abnormalities [",
"    <a class=\"abstract\" href=\"UTD.htm?27/23/28026/abstract/64-67\">",
"     64-67",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      One study noted that although the lungs remained hypoplastic and hypoperfused as demonstrated by pulmonary function tests and lung scans, survivors remained asymptomatic with no effect on their daily function and no increased risk of respiratory infection [",
"      <a class=\"abstract\" href=\"UTD.htm?27/23/28026/abstract/64\">",
"       64",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Another study reported normal forced expiratory volume, forced vital capacity, and other pulmonary function tests in survivors of CDH repair at ages 6 to 18 years [",
"      <a class=\"abstract\" href=\"UTD.htm?27/23/28026/abstract/65\">",
"       65",
"      </a>",
"      ]. However, there was decreased perfusion to the ipsilateral side. Two additional studies reported similar findings with equal ventilation between lungs, but perfusion reduced on the ipsilateral side. These results suggest that adequate lung volumes develop, but that increased vascular resistance and reduced perfusion occur in the ipsilateral lung [",
"      <a class=\"abstract\" href=\"UTD.htm?27/23/28026/abstract/66,67\">",
"       66,67",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In one small study of 12 CDH adult survivors (mean age 24.3 years &plusmn; 4.1 years), patients had mild airway obstruction detected by pulmonary function studies, and a reduced diffusion capacity [",
"      <a class=\"abstract\" href=\"UTD.htm?27/23/28026/abstract/68\">",
"       68",
"      </a>",
"      ]. However, exercise capacity and gas exchange parameters were normal and these patients did not have any physical impairment and had a normal quality of life. In general, these patients did not have severe form of CDH as infants; only 50 percent were symptomatic in the first 6 hours of life, 2 of 12 required a patch, 5 of 12 had an intrathoracic stomach, 5 of 12 had an intrathoracic liver, 4 of 12 had gastroesophageal reflux disease (GERD), and the average number of days requiring mechanical ventilation was three.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Post-ECMO studies in survivors showed an improvement in ipsilateral ventilation, but a nearly fixed perfusion deficit of approximately 50 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?27/23/28026/abstract/69,70\">",
"     69,70",
"    </a>",
"    ]. There was an increased incidence of bronchopulmonary dysplasia, respiratory infections, rehospitalization [",
"    <a class=\"abstract\" href=\"UTD.htm?27/23/28026/abstract/71-73\">",
"     71-73",
"    </a>",
"    ], and chronic lung disease [",
"    <a class=\"abstract\" href=\"UTD.htm?27/23/28026/abstract/74\">",
"     74",
"    </a>",
"    ] in patients who had required ECMO therapy. There is a perception that lung function and pulmonary status tend to improve over time in infants who survive. In one report of 56 infants including 9 who required ECMO therapy, pulmonary function and growth normalized by 24 months of age [",
"    <a class=\"abstract\" href=\"UTD.htm?27/23/28026/abstract/75\">",
"     75",
"    </a>",
"    ]. However, other reports note that survivors have persistent pulmonary and nonpulmonary morbidities [",
"    <a class=\"abstract\" href=\"UTD.htm?27/23/28026/abstract/63,76-78\">",
"     63,76-78",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A follow-up study of adolescent survivors reported that almost half of the 23 patients had mild or moderate abnormalities of the chest wall or spinal column (eg, pectus excavatum, pectus carinatum, and scoliosis) [",
"    <a class=\"abstract\" href=\"UTD.htm?27/23/28026/abstract/76\">",
"     76",
"    </a>",
"    ]. Pulmonary function studies demonstrated mild to moderate airway obstruction that was responsive to bronchodilators. In a second report of the same cohort, CDH adolescent survivors compared to normal gender and age matched controls only had a mild decrease in exercise capacity [",
"    <a class=\"abstract\" href=\"UTD.htm?27/23/28026/abstract/79\">",
"     79",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    These patients who required ECMO, presumably, would not have survived in the pre-ECMO era and represent patients with more severe pulmonary disease. So it is not surprising that these patients may have pulmonary sequelae compared to survivors treated in the pre-ECMO era.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h3\">",
"     Recurrent hernia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Recurrent diaphragmatic hernia occurs in 2 to 22 percent of all CDH survivors. Recurrence is highest (27 to 57 percent) in patients requiring patch repairs and ECMO support [",
"    <a class=\"abstract\" href=\"UTD.htm?27/23/28026/abstract/73,80-83\">",
"     73,80-83",
"    </a>",
"    ]. The site of recurrence with a patch is typically medial. Recurrent diaphragmatic herniation is usually diagnosed by chest or contrast studies prompted by respiratory or gastrointestinal symptoms. (See",
"    <a class=\"local\" href=\"#H20\">",
"     'Patch-related'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    As a result of these findings, CDH survivors must have careful ongoing follow-up and chest radiographs in order to diagnose complications and initiate treatment expeditiously.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Nonpulmonary complications",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h3\">",
"     Patch-related",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patches may become chronically infected, requiring removal of the patch and diaphragmatic reconstruction, preferably with native tissue [",
"    <a class=\"abstract\" href=\"UTD.htm?27/23/28026/abstract/80\">",
"     80",
"    </a>",
"    ]. Although initial repair using a patch is generally associated with a high rate recurrence of hernia (up to 40 percent), a lower recurrence rate (4 percent) was reported from one tertiary center that used a composite patch of",
"    <span class=\"nowrap\">",
"     Gore-Tex/Marlex",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?27/23/28026/abstract/84\">",
"     84",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The need for patch repair has been associated with a higher rate of chest wall deformities such as pectus excavatum, pectus carinatum, and thoracic scoliosis. Chest wall deformities have been reported in up to 50 percent of patients who were initially repaired with a patch [",
"    <a class=\"abstract\" href=\"UTD.htm?27/23/28026/abstract/52,76,83,85\">",
"     52,76,83,85",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h3\">",
"     Gastrointestinal",
"    </span>",
"    &nbsp;&mdash;&nbsp;Gastroesophageal reflux disease (GERD) and foregut dysmotility are prominent chronic abnormalities in CDH patients. A review of nine reports showed an overall rate of symptomatic reflux of 50 percent and 18 percent of patients required an antireflux procedure [",
"    <a class=\"abstract\" href=\"UTD.htm?27/23/28026/abstract/86\">",
"     86",
"    </a>",
"    ]. There are several anatomic factors that may contribute to the development of reflux [",
"    <a class=\"abstract\" href=\"UTD.htm?27/23/28026/abstract/87-89\">",
"     87-89",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Disturbance of normal esophageal and gastroesophageal junction due to mediastinal shift and compression",
"     </li>",
"     <li>",
"      Shortened intraabdominal esophagus",
"     </li>",
"     <li>",
"      Obtuse angle of His (angle at which the esophagus intersects the stomach at the cardioesophageal juncture)",
"     </li>",
"     <li>",
"      Deformation of the diaphragmatic crus by closure",
"     </li>",
"     <li>",
"      Pressure changes related to increased work of breathing",
"     </li>",
"     <li>",
"      Potential neurologic defects",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    With the increased survival rate due to changes in management, there appears to be an associated increase in morbidity, presumably occurring in infants who would not have previously survived [",
"    <a class=\"abstract\" href=\"UTD.htm?27/23/28026/abstract/24\">",
"     24",
"    </a>",
"    ]. In survivors, there is a high risk of gastrointestinal reflux (GERD) and the need for surgical intervention [",
"    <a class=\"abstract\" href=\"UTD.htm?27/23/28026/abstract/24\">",
"     24",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    This was illustrated in the following case series [",
"    <a class=\"abstract\" href=\"UTD.htm?27/23/28026/abstract/90-92\">",
"     90-92",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In the first study, 13 of 86 patients required antireflux therapy (fundoplication in 10 cases and gastrojejunal tube in 3) [",
"      <a class=\"abstract\" href=\"UTD.htm?27/23/28026/abstract/90\">",
"       90",
"      </a>",
"      ]. Based upon multivariate analysis, the need for surgical intervention for GERD was associated with patch closure and the presence of the liver in the chest cavity.",
"     </li>",
"     <li>",
"      In the second study, 21 of 39 surviving infants developed GERD of which 9 required fundoplication [",
"      <a class=\"abstract\" href=\"UTD.htm?27/23/28026/abstract/91\">",
"       91",
"      </a>",
"      ]. Patch closure and the use of ECMO were associated with an increased risk of GERD and the need for fundoplication. However, the side of the defect had no impact on the likelihood of GERD.",
"     </li>",
"     <li>",
"      A third study reported that one year after primary closure, 11 of 26 survivors had significant GERD and four patients required surgical correction [",
"      <a class=\"abstract\" href=\"UTD.htm?27/23/28026/abstract/92\">",
"       92",
"      </a>",
"      ]. One additional patient was noted to have GERD one year after closure but did not require surgery.",
"     </li>",
"     <li>",
"      A retrospective study reported early documented GERD (within first two years after CDH repair) in 27 of 67 patients (45 percent), nine of whom underwent reflux surgery [",
"      <a class=\"abstract\" href=\"UTD.htm?27/23/28026/abstract/93\">",
"       93",
"      </a>",
"      ]. Long-term follow up of 58 patients (mean age 12.1 years &plusmn;3.4) showed that 9 patients (16 percent) had late GERD symptoms including seven patients in whom GERD was confirmed by diagnostic testing. None of the patients with late GERD had been diagnosed with GERD or were treated with antireflux therapy in the three years preceding the follow up evaluation. Patients generally responded well with resolution of symptoms with the administration of proton pump inhibitors. Multivariate analysis demonstrated that patch closure and an intrathoracic location of the stomach were independent risk factors for early GERD, but no risk factors were identified for late GERD.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Intestinal obstruction secondary to adhesions occurs in 10 percent of patients with CDH [",
"    <a class=\"abstract\" href=\"UTD.htm?27/23/28026/abstract/74,85,94\">",
"     74,85,94",
"    </a>",
"    ]. All patients with CDH have malrotation and, thus, a predisposition to development of volvulus. Rates of this potentially devastating complication vary from 3 to 9 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?27/23/28026/abstract/85,95\">",
"     85,95",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h3\">",
"     Failure to thrive",
"    </span>",
"    &nbsp;&mdash;&nbsp;Subsequent failure to thrive (FTT) has been reported in 30 to 86 percent of infants with CDH. Risk factors include prematurity, prolonged ventilation, and oxygen requirement at discharge [",
"    <a class=\"abstract\" href=\"UTD.htm?27/23/28026/abstract/77,96,97\">",
"     77,96,97",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Many patients will require gastrostomy tube feedings because of oral aversion to feeding due to reflux or need for supplementation. The incidence of gastrostomy tube feedings may be increasing with the increase in survival rate [",
"    <a class=\"abstract\" href=\"UTD.htm?27/23/28026/abstract/24\">",
"     24",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In one retrospective case series, fundoplication performed at the time of initial repair was associated with a decrease in growth impairment thought to be due to prevention of GERD [",
"    <a class=\"abstract\" href=\"UTD.htm?27/23/28026/abstract/98\">",
"     98",
"    </a>",
"    ]. Further studies are needed to confirm this observation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h3\">",
"     Neurologic",
"    </span>",
"    &nbsp;&mdash;&nbsp;Abnormalities detected by cranial imaging include intraventricular hemorrhage, infarction, periventricular leukomalacia, and extra-axial fluid collections. In addition, magnetic resonance imaging of survivors of severe CDH demonstrates delayed maturation and structural brain abnormalities including periventricular leukomalacia and varying degrees of intracranial hemorrhage [",
"    <a class=\"abstract\" href=\"UTD.htm?27/23/28026/abstract/99\">",
"     99",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    These abnormalities may in part lead to long-term neurologic complications. (See",
"    <a class=\"local\" href=\"#H28\">",
"     'Long-term outcome'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h1\">",
"     OUTCOME",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h2\">",
"     Survival",
"    </span>",
"    &nbsp;&mdash;&nbsp;The postnatal survival rate at tertiary centers has improved with reported rates of 70 to 92 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?27/23/28026/abstract/11,13-15,100,101\">",
"     11,13-15,100,101",
"    </a>",
"    ]. This increased survival rate appears to be a result of the shift from early surgical intervention to intensive preoperative supportive care aimed at avoiding lung injury followed by surgical correction.",
"   </p>",
"   <p>",
"    However, these data represent the survival rate of cases of congenital diaphragmatic hernia (CDH) that were full-term infants born or transferred to tertiary care centers with available skilled personnel and access to advanced technology (eg, extracorporeal membrane oxygenation [ECMO]). These survival rates do not account for the cases of CDH that are stillborn, died outside a tertiary center, or fetal loss due to spontaneous or therapeutic abortion [",
"    <a class=\"abstract\" href=\"UTD.htm?27/23/28026/abstract/101-105\">",
"     101-105",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In a population-based study from Western Australia, 35 percent of live-born infants died before reaching a tertiary center [",
"      <a class=\"abstract\" href=\"UTD.htm?27/23/28026/abstract/102\">",
"       102",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In a study from Great Britain, the survival rate of all cases of CDH was estimated to be 40 percent [",
"      <a class=\"abstract\" href=\"UTD.htm?27/23/28026/abstract/103\">",
"       103",
"      </a>",
"      ]. However, this study also included pregnancies that were electively terminated, which confounds the accurate assessment of the true outcome of CDH.",
"     </li>",
"     <li>",
"      In a population-based study from Eastern Australia between 1992 and 2001, 242 pregnancies with affected fetuses were identified [",
"      <a class=\"abstract\" href=\"UTD.htm?27/23/28026/abstract/104\">",
"       104",
"      </a>",
"      ]. Eight percent of pregnancies were electively terminated, and 10 percent of infants were stillborn and 82 percent liveborn. Of the liveborn infants, 56 percent survived. This results in an overall survival rate of 46 percent, which slightly rises to 48 percent, if electively terminated pregnancies are excluded.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Because of the continued mortality of CDH, in utero therapy to prevent or reverse pulmonary hypoplasia, thereby restoring adequate lung growth for neonatal survival, is currently under investigation. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/11/42169?source=see_link&amp;anchor=H22#H22\">",
"     \"Congenital diaphragmatic hernia: Prenatal diagnosis and management\", section on 'In utero therapy'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Survival also decreases with decreasing gestational age. A review from the Congenital Diaphragmatic Hernia Registry (CDHR) reported lower survival for preterm infants compared with term infants (54 versus 73 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?27/23/28026/abstract/106\">",
"     106",
"    </a>",
"    ]. Preterm infants were less likely to undergo surgical repair (69 versus 86 percent) and be treated with ECMO (26 versus 33 percent). Survival was higher in preterm infants who underwent surgical repair (77 percent), but this was still lower than term infants with surgical repair (85 percent). Preterm infants were more likely to have chromosomal abnormalities (8 versus 4 percent), and major cardiac defects (12 versus 6 percent). Data from the CDHR showed that patients with major complex cardiac defects (eg, single ventricle physiology, left heart obstructive lesions, and transposition of the great arteries) have a significantly lower survival rate (36 percent) compared with those with either minor heart defects (67 percent) or no heart defect (73 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?27/23/28026/abstract/107\">",
"     107",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Neonatal transport of infants with CDH is associated with poorer survival compared with infants who are inborn at a tertiary center with expertise in the management of CDH [",
"    <a class=\"abstract\" href=\"UTD.htm?27/23/28026/abstract/108,109\">",
"     108,109",
"    </a>",
"    ]. In addition, survival is poorer in infants whose highest recorded pre-ductal oxygen saturation is below 85 percent in the first 24 hours of life compared with those with higher levels [",
"    <a class=\"abstract\" href=\"UTD.htm?27/23/28026/abstract/110\">",
"     110",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Outcome is also dependent upon the size of the defect and is poorer in infants with a right versus left-sided lesion, as discussed below.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h3\">",
"     Defect size",
"    </span>",
"    &nbsp;&mdash;&nbsp;Infants with very large defects have a poorer outcome [",
"    <a class=\"abstract\" href=\"UTD.htm?27/23/28026/abstract/111-114\">",
"     111-114",
"    </a>",
"    ]. This was illustrated in a large multicenter study of the Congenital Diaphragmatic Hernia Group that included 3062 liveborn infants with CDH between 1995 and 2004. [",
"    <a class=\"abstract\" href=\"UTD.htm?27/23/28026/abstract/111\">",
"     111",
"    </a>",
"    ] There were 538 infants who did not undergo correction and subsequently died. Of the infants who underwent repair, a logistic regression analysis demonstrated that the defect size alone predicted survival. Infants with a completely absent (or near absent) diaphragm had a 57 percent survival rate compared to 79 percent of those without agenesis but required a patch for repair and 95 percent of patients who underwent primary repair without a patch.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h3\">",
"     Right versus left-sided lesion",
"    </span>",
"    &nbsp;&mdash;&nbsp;Disease severity appears to be greater in patients with right-sided lesions, resulting in a higher mortality rate [",
"    <a class=\"abstract\" href=\"UTD.htm?27/23/28026/abstract/115\">",
"     115",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In a series of 267 infants with CDH who underwent surgical repair from 1990 to 2006, the 40 infants with right-sided CDH had a lower survival rate compared to those with left-sided lesions (50 versus 75 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?27/23/28026/abstract/115\">",
"     115",
"    </a>",
"    ]. A greater proportion of infants with right compared to those with left-sided lesions required ECMO (40 versus 15 percent) and a diaphragmatic patch (76 versus 41 percent).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28\">",
"    <span class=\"h2\">",
"     Long-term outcome",
"    </span>",
"    &nbsp;&mdash;&nbsp;Neurodevelopmental disabilities and gastrointestinal and pulmonary complications are the most common long-term complications of CDH.",
"   </p>",
"   <p>",
"    In a case series of 53 of120 CDH survivors who were managed by a permissive hypercapnia regimen and had availability of ECMO, follow-up evaluation at 8 years of age was obtained using parental-reported written responses [",
"    <a class=\"abstract\" href=\"UTD.htm?27/23/28026/abstract/116\">",
"     116",
"    </a>",
"    ]. About one-half of the parents reported at least one or more of the following medical problems or functional impairment:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Learning difficulties (32 percent)",
"     </li>",
"     <li>",
"      Impaired gastrointestinal (25 percent) or pulmonary (18 percent) function",
"     </li>",
"     <li>",
"      Muscle weakness (23 percent)",
"     </li>",
"     <li>",
"      Speech (23 percent), hearing (16 percent), or vision (14 percent) problems",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In another case series with follow-up at a mean age of 8.6 years, 26 survivors without genetic comorbidity had normal cognitive outcome but had impaired fine and gross motor function [",
"    <a class=\"abstract\" href=\"UTD.htm?27/23/28026/abstract/117\">",
"     117",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Neurological impairment has been described in 30 to 80 percent of surviving patients [",
"    <a class=\"abstract\" href=\"UTD.htm?27/23/28026/abstract/86,116,118\">",
"     86,116,118",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      One observational study demonstrated a high incidence of motor and language impairment at one to three years of age [",
"      <a class=\"abstract\" href=\"UTD.htm?27/23/28026/abstract/118\">",
"       118",
"      </a>",
"      ]. Neurodevelopmental assessment at one year of age of 69 of the original cohort of 112 survivors demonstrated motor problems in 60 percent of the patients and language problems in 18 percent. At three years of age, evaluation of 30 patients demonstrated motor problems in 22 patients (73 percent), language problems in 18 (60 percent), and",
"      <span class=\"nowrap\">",
"       sensory/hearing",
"      </span>",
"      difficulties in three (10 percent). In this cohort, 30 percent of patients were treated with ECMO, 17 percent had cardiac anomalies, and 25 percent had other congenital anomalies.",
"     </li>",
"     <li>",
"      In a study of 41 CDH survivors from our institution (mean follow-up 24 months, range 6 to 62 months), neurocognitive and language skill scores were average, mixed, mildly delayed, and severely delayed in 49, 19, 17, and 15 percent of patients, respectively [",
"      <a class=\"abstract\" href=\"UTD.htm?27/23/28026/abstract/119\">",
"       119",
"      </a>",
"      ]. Psychomotor scores were normal, mildly delayed, and severely delayed in 46, 23, and 31 percent, respectively. Hypotonicity was noted in 49 percent of patients, and 1 patient had hypertonicity. The use of ECMO was the most significant risk factor for neurodevelopmental impairment.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    ECMO is associated with an increase risk of hearing loss among infants with CDH. Hearing loss requiring amplification has been reported in 30 to 49 percent of CDH survivors [",
"    <a class=\"abstract\" href=\"UTD.htm?27/23/28026/abstract/77,85,120\">",
"     77,85,120",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29\">",
"    <span class=\"h1\">",
"     POST-DISCHARGE MANAGEMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Because of the associated significant morbidities (ie, pulmonary complications, neurodevelopmental delay, gastroesophageal reflux, hearing loss, and poor growth), care of survivors with congenital diaphragmatic hernia (CDH) following discharge from the hospital is challenging. Structured follow-up, often involving a multidisciplinary team, facilitates recognition and treatment of these complications.",
"   </p>",
"   <p>",
"    In 2008, the American Academy of Pediatrics section on Surgery and the Committee on Fetus and Newborn published a comprehensive plan for the detection and management of the associated morbidities for clinicians who provide care for these patients (",
"    <a class=\"graphic graphic_table graphicRef59931 \" href=\"UTD.htm?30/52/31565\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?27/23/28026/abstract/121\">",
"     121",
"    </a>",
"    ]. This plan provides a recommended schedule that includes the following:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Growth parameters at each visit",
"     </li>",
"     <li>",
"      Chest radiography if a patch was used in repair of the defect",
"     </li>",
"     <li>",
"      Pulmonary function testing based upon clinical status",
"     </li>",
"     <li>",
"      Respiratory syncytial virus prophylaxis",
"     </li>",
"     <li>",
"      Echocardiography if previously abnormal or use of supplemental oxygen",
"     </li>",
"     <li>",
"      Brain imaging if previous abnormal head ultrasound, abnormal neurologic status, patch repair, or ECMO used",
"     </li>",
"     <li>",
"      Hearing evaluation",
"     </li>",
"     <li>",
"      Developmental screening",
"     </li>",
"     <li>",
"      Oral feeding assessment",
"     </li>",
"     <li>",
"      Upper gastrointestinal study based upon clinical status",
"     </li>",
"     <li>",
"      Scoliosis and chest wall deformity screening",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H48600457\">",
"    <span class=\"h1\">",
"     LATE CDH PRESENTATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Infrequently, CDH will present after the neonatal period. In one case series of 15 children, patients presented with respiratory symptoms (n = 6), gastrointestinal symptoms (n = 6), or both (n = 3) at a mean age of 1.5 years (range 3.8 days to 9.9 years) [",
"    <a class=\"abstract\" href=\"UTD.htm?27/23/28026/abstract/122\">",
"     122",
"    </a>",
"    ]. Five patients had failure to thrive. The diagnosis was made by chest radiography in six patients, and the other patients were diagnosed by gastrointestinal contrast series or computed tomography. Primary repair without a patch was successful in all patients with a 100 percent survival rate at a mean follow-up of two years.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?2/6/2146?source=see_link\">",
"       \"Patient information: Congenital hernia of the diaphragm (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H30\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Congenital diaphragmatic hernia (CDH) is a developmental defect in the diaphragm that allows abdominal viscera to herniate into the chest, thereby interfering with normal lung development. Compression of the developing lung by the herniated abdominal contents decreases bronchial and pulmonary arterial branching resulting in lung hypoplasia and pulmonary arterial muscle hyperplasia. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The morbidity and mortality of CDH is related to the severity of lung hypoplasia and pulmonary hypertension. In addition, associated anomalies (eg, cardiac defects and chromosomal abnormalities) increase the mortality rate. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?41/11/42169?source=see_link&amp;anchor=H11#H11\">",
"       \"Congenital diaphragmatic hernia: Prenatal diagnosis and management\", section on 'Prognostic factors'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?41/11/42169?source=see_link&amp;anchor=H7#H7\">",
"       \"Congenital diaphragmatic hernia: Prenatal diagnosis and management\", section on 'Associated anomalies'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Infants with CDH most often develop respiratory distress in the first few hours or days of life. The spectrum of presentation can vary from acute, severe respiratory distress at birth, which is common, to minimal to no symptoms, which is observed in a much smaller group of patients. Physical examination will reveal a barrel-shaped chest, a scaphoid appearing abdomen because of loss of the abdominal contents into the chest, and the absence of breath sounds on the ipsilateral side. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Clinical manifestations'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Diagnosis can be made prenatally with ultrasound examination. Among infants in whom CDH is not diagnosed in utero, the diagnosis is made by chest radiography showing herniation of abdominal contents. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?41/11/42169?source=see_link&amp;anchor=H5#H5\">",
"       \"Congenital diaphragmatic hernia: Prenatal diagnosis and management\", section on 'Prenatal diagnosis'",
"      </a>",
"      and",
"      <a class=\"local\" href=\"#H3\">",
"       'Diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H31\">",
"    <span class=\"h2\">",
"     Treatment",
"    </span>",
"    &nbsp;&mdash;&nbsp;The management of CDH has shifted from early surgical intervention to pre-operative management of pulmonary hypoplasia and pulmonary hypertension and delaying surgery until there is resolution of early pulmonary insufficiency and acute pulmonary hypertension. (See",
"    <a class=\"local\" href=\"#H5\">",
"     'Management'",
"    </a>",
"    above and",
"    <a class=\"local\" href=\"#H14\">",
"     'Timing'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Although there are no clinical trials showing the efficacy of the pre-operative stabilization followed by surgical repair approach, there has been an improvement of survival rate in centers that have adapted this approach. Based upon this improved survival rate, the guidelines that we utilize for the preoperative care of the infant with CDH are as follows:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In the initial management of all infants with CDH, we suggest immediate endotracheal intubation to prevent further dilation of abdominal contents. (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). We recommend NOT using blow-by oxygen",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      bag-masking because these lead to",
"      <span class=\"nowrap\">",
"       gastric/abdominal",
"      </span>",
"      distension and compression of the lung. (",
"      <a class=\"grade\" href=\"._grade_3?title=Grade 1C\">",
"       Grade 1C",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Initial treatment'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We suggest ventilatory support with minimal airway pressure to maintain preductal oxygen saturations above 80 percent and partial pressure of oxygen (PaO",
"      <sub>",
"       2",
"      </sub>",
"      ) above 60 mm Hg (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Ventilation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Other supportive measures include placement of a nasogastric tube to continuous suction for decompression of the stomach and intestine, and maintenance of the mean arterial blood pressure &gt;50 mm Hg with fluids and inotropic agents to prevent right to left shunting. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Initial treatment'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      If ventilation is needed, conventional ventilator management (CMV) is first used. High frequency ventilation and extracorporeal membrane oxygenation are reserved for patients who fail CMV, although the precise indications for these measures are not clear and likely to be center dependent. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Extracorporeal membrane oxygenation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The optimal clinical condition and timing of surgical repair remains unclear and is dependent on the severity of the respiratory distress. (See",
"      <a class=\"local\" href=\"#H14\">",
"       'Timing'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H32\">",
"    <span class=\"h2\">",
"     Complications and outcome",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Persistent pulmonary hypertension is the most serious postoperative complication following surgical repair of CDH. In some cases, patients may require extracorporeal membrane oxygenation (ECMO) therapy",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      inhaled nitric oxide. (See",
"      <a class=\"local\" href=\"#H16\">",
"       'Complications'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H10\">",
"       'Extracorporeal membrane oxygenation'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?26/37/27225?source=see_link&amp;anchor=H15#H15\">",
"       \"Persistent pulmonary hypertension of the newborn\", section on 'Management'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Other long-term complications in survivors of CDH include gastroesophageal reflux, failure to thrive, neurodevelopmental delay, and rarely intestinal obstruction due to adhesions. In infants who required ECMO, there is an increased risk for chronic pulmonary sequelae and hearing loss. Infants who were initially repaired with a patch are at increased risk for infection and recurrence of herniation. (See",
"      <a class=\"local\" href=\"#H16\">",
"       'Complications'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Although the survival rates in single tertiary centers with skilled personal and access to advanced technology (eg, ECMO) has improved to about 80 percent or above, this does not include cases who were stillborn or died prior to reaching a tertiary center. As a result, overall survival of all cases of CDH is lower than reported from case series from tertiary centers. (See",
"      <a class=\"local\" href=\"#H25\">",
"       'Survival'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Structured follow-up facilitates recognition and treatment of the associated morbidities associated with CDH as outlined by the American Academy of Pediatrics recommended schedule for follow-up of these patients (",
"      <a class=\"graphic graphic_table graphicRef59931 \" href=\"UTD.htm?30/52/31565\">",
"       table 1",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H29\">",
"       'Post-discharge management'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28026/abstract/1\">",
"      Bloss RS, Aranda JV, Beardmore HE. Congenital diaphragmatic hernia: pathophysiology and pharmacologic support. Surgery 1981; 89:518.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28026/abstract/2\">",
"      Lotze A, Knight GR, Anderson KD, et al. Surfactant (beractant) therapy for infants with congenital diaphragmatic hernia on ECMO: evidence of persistent surfactant deficiency. J Pediatr Surg 1994; 29:407.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28026/abstract/3\">",
"      Wilcox DT, Glick PL, Karamanoukian HL, Holm BA. Pathophysiology of congenital diaphragmatic hernia. IX: Correlation of surfactant maturation with fetal cortisol and triiodothyronine concentration. J Pediatr Surg 1994; 29:825.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28026/abstract/4\">",
"      Wilcox DT, Glick PL, Karamanoukian HL, et al. Pathophysiology of congenital diaphragmatic hernia. XII: Amniotic fluid lecithin/sphingomyelin ratio and phosphatidylglycerol concentrations do not predict surfactant status in congenital diaphragmatic hernia. J Pediatr Surg 1995; 30:410.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28026/abstract/5\">",
"      Hedrick HL, Crombleholme TM, Flake AW, et al. Right congenital diaphragmatic hernia: Prenatal assessment and outcome. J Pediatr Surg 2004; 39:319.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28026/abstract/6\">",
"      Kamath BD, Fashaw L, Kinsella JP. Adrenal insufficiency in newborns with congenital diaphragmatic hernia. J Pediatr 2010; 156:495.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28026/abstract/7\">",
"      Sakurai M, Donnelly LF, Klosterman LA, Strife JL. Congenital diaphragmatic hernia in neonates: variations in umbilical catheter and enteric tube position. Radiology 2000; 216:112.",
"     </a>",
"    </li>",
"    <li>",
"     Ladd W, Gross R. Abdominal Surgery of Infancy and Childhood, W.B. Saunders, Philadelphia 1941.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28026/abstract/9\">",
"      GROSS RE. Congenital hernia of the diaphragm. Am J Dis Child 1946; 71:579.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28026/abstract/10\">",
"      Wung JT, Sahni R, Moffitt ST, et al. Congenital diaphragmatic hernia: survival treated with very delayed surgery, spontaneous respiration, and no chest tube. J Pediatr Surg 1995; 30:406.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28026/abstract/11\">",
"      Frenckner B, Ehr&eacute;n H, Granholm T, et al. Improved results in patients who have congenital diaphragmatic hernia using preoperative stabilization, extracorporeal membrane oxygenation, and delayed surgery. J Pediatr Surg 1997; 32:1185.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28026/abstract/12\">",
"      Boloker J, Bateman DA, Wung JT, Stolar CJ. Congenital diaphragmatic hernia in 120 infants treated consecutively with permissive hypercapnea/spontaneous respiration/elective repair. J Pediatr Surg 2002; 37:357.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28026/abstract/13\">",
"      Reickert CA, Hirschl RB, Schumacher R, et al. Effect of very delayed repair of congenital diaphragmatic hernia on survival and extracorporeal life support use. Surgery 1996; 120:766.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28026/abstract/14\">",
"      Kays DW, Langham MR Jr, Ledbetter DJ, Talbert JL. Detrimental effects of standard medical therapy in congenital diaphragmatic hernia. Ann Surg 1999; 230:340.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28026/abstract/15\">",
"      Downard CD, Jaksic T, Garza JJ, et al. Analysis of an improved survival rate for congenital diaphragmatic hernia. J Pediatr Surg 2003; 38:729.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28026/abstract/16\">",
"      Logan JW, Rice HE, Goldberg RN, Cotten CM. Congenital diaphragmatic hernia: a systematic review and summary of best-evidence practice strategies. J Perinatol 2007; 27:535.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28026/abstract/17\">",
"      Glick PL, Leach CL, Besner GE, et al. Pathophysiology of congenital diaphragmatic hernia. III: Exogenous surfactant therapy for the high-risk neonate with CDH. J Pediatr Surg 1992; 27:866.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28026/abstract/18\">",
"      Van Meurs K, Congenital Diaphragmatic Hernia Study Group. Is surfactant therapy beneficial in the treatment of the term newborn infant with congenital diaphragmatic hernia? J Pediatr 2004; 145:312.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28026/abstract/19\">",
"      Wilson JM, Lund DP, Lillehei CW, Vacanti JP. Congenital diaphragmatic hernia--a tale of two cities: the Boston experience. J Pediatr Surg 1997; 32:401.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28026/abstract/20\">",
"      Kolobow T, Moretti MP, Fumagalli R, et al. Severe impairment in lung function induced by high peak airway pressure during mechanical ventilation. An experimental study. Am Rev Respir Dis 1987; 135:312.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28026/abstract/21\">",
"      Dreyfuss D, Soler P, Basset G, Saumon G. High inflation pressure pulmonary edema. Respective effects of high airway pressure, high tidal volume, and positive end-expiratory pressure. Am Rev Respir Dis 1988; 137:1159.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28026/abstract/22\">",
"      Drummond WH, Gregory GA, Heymann MA, Phibbs RA. The independent effects of hyperventilation, tolazoline, and dopamine on infants with persistent pulmonary hypertension. J Pediatr 1981; 98:603.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28026/abstract/23\">",
"      Reynolds M, Luck SR, Lappen R. The \"critical\" neonate with diaphragmatic hernia: a 21-year perspective. J Pediatr Surg 1984; 19:364.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28026/abstract/24\">",
"      Chiu PP, Sauer C, Mihailovic A, et al. The price of success in the management of congenital diaphragmatic hernia: is improved survival accompanied by an increase in long-term morbidity? J Pediatr Surg 2006; 41:888.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28026/abstract/25\">",
"      Datin-Dorriere V, Walter-Nicolet E, Rousseau V, et al. Experience in the management of eighty-two newborns with congenital diaphragmatic hernia treated with high-frequency oscillatory ventilation and delayed surgery without the use of extracorporeal membrane oxygenation. J Intensive Care Med 2008; 23:128.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28026/abstract/26\">",
"      Reyes C, Chang LK, Waffarn F, et al. Delayed repair of congenital diaphragmatic hernia with early high-frequency oscillatory ventilation during preoperative stabilization. J Pediatr Surg 1998; 33:1010.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28026/abstract/27\">",
"      Somaschini M, Locatelli G, Salvoni L, et al. Impact of new treatments for respiratory failure on outcome of infants with congenital diaphragmatic hernia. Eur J Pediatr 1999; 158:780.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28026/abstract/28\">",
"      Migliazza L, Bellan C, Alberti D, et al. Retrospective study of 111 cases of congenital diaphragmatic hernia treated with early high-frequency oscillatory ventilation and presurgical stabilization. J Pediatr Surg 2007; 42:1526.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28026/abstract/29\">",
"      Cohen MS, Rychik J, Bush DM, et al. Influence of congenital heart disease on survival in children with congenital diaphragmatic hernia. J Pediatr 2002; 141:25.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28026/abstract/30\">",
"      German JC, Gazzaniga AB, Amlie R, et al. Management of pulmonary insufficiency in diaphragmatic hernia using extracorporeal circulation with a membrane oxygenator (ECMO). J Pediatr Surg 1977; 12:905.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28026/abstract/31\">",
"      Van Meurs KP, Newman KD, Anderson KD, Short BL. Effect of extracorporeal membrane oxygenation on survival of infants with congenital diaphragmatic hernia. J Pediatr 1990; 117:954.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28026/abstract/32\">",
"      Langham MR Jr, Krummel TM, Bartlett RH, et al. Mortality with extracorporeal membrane oxygenation following repair of congenital diaphragmatic hernia in 93 infants. J Pediatr Surg 1987; 22:1150.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28026/abstract/33\">",
"      Bailey PV, Connors RH, Tracy TF Jr, et al. A critical analysis of extracorporeal membrane oxygenation for congenital diaphragmatic hernia. Surgery 1989; 106:611.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28026/abstract/34\">",
"      Rothenbach P, Lange P, Powell D. The use of extracorporeal membrane oxygenation in infants with congenital diaphragmatic hernia. Semin Perinatol 2005; 29:40.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28026/abstract/35\">",
"      Conrad SA, Rycus PT, Dalton H. Extracorporeal Life Support Registry Report 2004. ASAIO J 2005; 51:4.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28026/abstract/36\">",
"      Schumacher RE, Baumgart S. Extracorporeal membrane oxygenation 2001. The odyssey continues. Clin Perinatol 2001; 28:629.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28026/abstract/37\">",
"      Delius R, Anderson H 3rd, Schumacher R, et al. Venovenous compares favorably with venoarterial access for extracorporeal membrane oxygenation in neonatal respiratory failure. J Thorac Cardiovasc Surg 1993; 106:329.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28026/abstract/38\">",
"      Heiss KF, Clark RH, Cornish JD, et al. Preferential use of venovenous extracorporeal membrane oxygenation for congenital diaphragmatic hernia. J Pediatr Surg 1995; 30:416.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28026/abstract/39\">",
"      Hazebroek FW, Tibboel D, Bos AP, et al. Congenital diaphragmatic hernia: impact of preoperative stabilization. A prospective pilot study in 13 patients. J Pediatr Surg 1988; 23:1139.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28026/abstract/40\">",
"      Goh DW, Drake DP, Brereton RJ, et al. Delayed surgery for congenital diaphragmatic hernia. Br J Surg 1992; 79:644.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28026/abstract/41\">",
"      Langer JC, Filler RM, Bohn DJ, et al. Timing of surgery for congenital diaphragmatic hernia: is emergency operation necessary? J Pediatr Surg 1988; 23:731.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28026/abstract/42\">",
"      Nio M, Haase G, Kennaugh J, et al. A prospective randomized trial of delayed versus immediate repair of congenital diaphragmatic hernia. J Pediatr Surg 1994; 29:618.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28026/abstract/43\">",
"      Downard CD, Wilson JM. Current therapy of infants with congenital diaphragmatic hernia. Semin Neonatol 2003; 8:215.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28026/abstract/44\">",
"      Lally KP. Extracorporeal membrane oxygenation in patients with congenital diaphragmatic hernia. Semin Pediatr Surg 1996; 5:249.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28026/abstract/45\">",
"      Ryan CA, Perreault T, Johnston-Hodgson A, Finer NN. Extracorporeal membrane oxygenation in infants with congenital diaphragmatic hernia and cardiac malformations. J Pediatr Surg 1994; 29:878.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28026/abstract/46\">",
"      Breaux CW Jr, Rouse TM, Cain WS, Georgeson KE. Congenital diaphragmatic hernia in an era of delayed repair after medical and/or extracorporeal membrane oxygenation stabilization: a prognostic and management classification. J Pediatr Surg 1992; 27:1192.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28026/abstract/47\">",
"      Dillon PW, Cilley RE, Mauger D, et al. The relationship of pulmonary artery pressure and survival in congenital diaphragmatic hernia. J Pediatr Surg 2004; 39:307.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28026/abstract/48\">",
"      Seetharamaiah R, Younger JG, Bartlett RH, et al. Factors associated with survival in infants with congenital diaphragmatic hernia requiring extracorporeal membrane oxygenation: a report from the Congenital Diaphragmatic Hernia Study Group. J Pediatr Surg 2009; 44:1315.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28026/abstract/49\">",
"      Payne NR, Wright G, Kriesmer PJ, et al. Recurrent pulmonary arterial hypertension following neonatal treatment with extracorporeal membrane oxygenation. Crit Care Med 1991; 19:1210.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28026/abstract/50\">",
"      Lally KP, Breaux CW Jr. A second course of extracorporeal membrane oxygenation in the neonate--is there a benefit? Surgery 1995; 117:175.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28026/abstract/51\">",
"      Tsai J, Sulkowski J, Adzick NS, et al. Patch repair for congenital diaphragmatic hernia: is it really a problem? J Pediatr Surg 2012; 47:637.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28026/abstract/52\">",
"      Lally KP, Cheu HW, Vazquez WD. Prosthetic diaphragm reconstruction in the growing animal. J Pediatr Surg 1993; 28:45.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28026/abstract/53\">",
"      Schnitzer JJ, Kikiros CS, Short BL, et al. Experience with abdominal wall closure for patients with congenital diaphragmatic hernia repaired on ECMO. J Pediatr Surg 1995; 30:19.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28026/abstract/54\">",
"      Brant-Zawadzki PB, Fenton SJ, Nichol PF, et al. The split abdominal wall muscle flap repair for large congenital diaphragmatic hernias on extracorporeal membrane oxygenation. J Pediatr Surg 2007; 42:1047.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28026/abstract/55\">",
"      Rowe MI, Uribe FL. Diaphragmatic hernia in the newborn infant: blood gas and pH considerations. Surgery 1971; 70:758.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28026/abstract/56\">",
"      Greenholz SK. Congenital diaphragmatic hernia: an overview. Semin Pediatr Surg 1996; 5:216.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28026/abstract/57\">",
"      Dassinger MS, Copeland DR, Gossett J, et al. Early repair of congenital diaphragmatic hernia on extracorporeal membrane oxygenation. J Pediatr Surg 2010; 45:693.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28026/abstract/58\">",
"      Lally KP, Paranka MS, Roden J, et al. Congenital diaphragmatic hernia. Stabilization and repair on ECMO. Ann Surg 1992; 216:569.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28026/abstract/59\">",
"      Vazquez WD, Cheu HW. Hemorrhagic complications and repair of congenital diaphragmatic hernias: does timing of the repair make a difference? Data from the Extracorporeal Life Support Organization. J Pediatr Surg 1994; 29:1002.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28026/abstract/60\">",
"      Wilson JM, Bower LK, Lund DP. Evolution of the technique of congenital diaphragmatic hernia repair on ECMO. J Pediatr Surg 1994; 29:1109.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28026/abstract/61\">",
"      Cullen ML. Congenital diaphragmatic hernia: operative considerations. Semin Pediatr Surg 1996; 5:243.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28026/abstract/62\">",
"      Sigalet DL, Tierney A, Adolph V, et al. Timing of repair of congenital diaphragmatic hernia requiring extracorporeal membrane oxygenation support. J Pediatr Surg 1995; 30:1183.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28026/abstract/63\">",
"      Iocono JA, Cilley RE, Mauger DT, et al. Postnatal pulmonary hypertension after repair of congenital diaphragmatic hernia: predicting risk and outcome. J Pediatr Surg 1999; 34:349.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28026/abstract/64\">",
"      Reid IS, Hutcherson RJ. Long-term follow-up of patients with congenital diaphragmatic hernia. J Pediatr Surg 1976; 11:939.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28026/abstract/65\">",
"      Wohl ME, Griscom NT, Strieder DJ, et al. The lung following repair of congenital diaphragmatic hernia. J Pediatr 1977; 90:405.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28026/abstract/66\">",
"      Falconer AR, Brown RA, Helms P, et al. Pulmonary sequelae in survivors of congenital diaphragmatic hernia. Thorax 1990; 45:126.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28026/abstract/67\">",
"      Freyschuss U, L&auml;nnergren K, Frenckner B. Lung function after repair of congenital diaphragmatic hernia. Acta Paediatr Scand 1984; 73:589.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28026/abstract/68\">",
"      Peetsold MG, Vonk-Noordegraaf A, Heij HH, Gemke RJ. Pulmonary function and exercise testing in adult survivors of congenital diaphragmatic hernia. Pediatr Pulmonol 2007; 42:325.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28026/abstract/69\">",
"      Nagaya M, Akatsuka H, Kato J, et al. Development in lung function of the affected side after repair of congenital diaphragmatic hernia. J Pediatr Surg 1996; 31:349.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28026/abstract/70\">",
"      Nagaya M, Kato J, Niimi N, et al. Analysis of patients with congenital diaphragmatic hernia requiring pre-operative extracorporeal membrane oxygenation (ECMO). Pediatr Surg Int 1998; 14:25.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28026/abstract/71\">",
"      Hamutcu R, Nield TA, Garg M, et al. Long-term pulmonary sequelae in children who were treated with extracorporeal membrane oxygenation for neonatal respiratory failure. Pediatrics 2004; 114:1292.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28026/abstract/72\">",
"      Bernbaum J, Schwartz IP, Gerdes M, et al. Survivors of extracorporeal membrane oxygenation at 1 year of age: the relationship of primary diagnosis with health and neurodevelopmental sequelae. Pediatrics 1995; 96:907.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28026/abstract/73\">",
"      Van Meurs KP, Robbins ST, Reed VL, et al. Congenital diaphragmatic hernia: long-term outcome in neonates treated with extracorporeal membrane oxygenation. J Pediatr 1993; 122:893.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28026/abstract/74\">",
"      D'Agostino JA, Bernbaum JC, Gerdes M, et al. Outcome for infants with congenital diaphragmatic hernia requiring extracorporeal membrane oxygenation: the first year. J Pediatr Surg 1995; 30:10.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28026/abstract/75\">",
"      Koumbourlis AC, Wung JT, Stolar CJ. Lung function in infants after repair of congenital diaphragmatic hernia. J Pediatr Surg 2006; 41:1716.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28026/abstract/76\">",
"      Trachsel D, Selvadurai H, Bohn D, et al. Long-term pulmonary morbidity in survivors of congenital diaphragmatic hernia. Pediatr Pulmonol 2005; 39:433.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28026/abstract/77\">",
"      Cortes RA, Keller RL, Townsend T, et al. Survival of severe congenital diaphragmatic hernia has morbid consequences. J Pediatr Surg 2005; 40:36.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28026/abstract/78\">",
"      Muratore CS, Kharasch V, Lund DP, et al. Pulmonary morbidity in 100 survivors of congenital diaphragmatic hernia monitored in a multidisciplinary clinic. J Pediatr Surg 2001; 36:133.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28026/abstract/79\">",
"      Trachsel D, Selvadurai H, Adatia I, et al. Resting and exercise cardiorespiratory function in survivors of congenital diaphragmatic hernia. Pediatr Pulmonol 2006; 41:522.",
"     </a>",
"    </li>",
"    <li>",
"     Grethel E, Cortes R, Wagner A, et al. Prosthetic patches for congenital diaphragmatic hernia repair: surgisis versus gore-tex, American Pediatric Surgical Association, Phoenix, AZ 2005.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28026/abstract/81\">",
"      Rais-Bahrami K, Robbins ST, Reed VL, et al. Congenital diaphragmatic hernia. Outcome of preoperative extracorporeal membrane oxygenation. Clin Pediatr (Phila) 1995; 34:471.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28026/abstract/82\">",
"      Atkinson JB, Ford EG, Humphries B, et al. The impact of extracorporeal membrane support in the treatment of congenital diaphragmatic hernia. J Pediatr Surg 1991; 26:791.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28026/abstract/83\">",
"      Jancelewicz T, Vu LT, Keller RL, et al. Long-term surgical outcomes in congenital diaphragmatic hernia: observations from a single institution. J Pediatr Surg 2010; 45:155.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28026/abstract/84\">",
"      Riehle KJ, Magnuson DK, Waldhausen JH. Low recurrence rate after Gore-Tex/Marlex composite patch repair for posterolateral congenital diaphragmatic hernia. J Pediatr Surg 2007; 42:1841.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28026/abstract/85\">",
"      Lund DP, Mitchell J, Kharasch V, et al. Congenital diaphragmatic hernia: the hidden morbidity. J Pediatr Surg 1994; 29:258.",
"     </a>",
"    </li>",
"    <li>",
"     Reickert C, Hirschl R. Congenital diaphragmatic hernia. In: Pediatric Surgery and Urology: Long Term Outcomes, Stringer MD, Oldham KT, Mouriquand PDE, Howard RH (Eds), W. B. Saunders, London 1998. p.131.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28026/abstract/87\">",
"      Stolar CJ, Levy JP, Dillon PW, et al. Anatomic and functional abnormalities of the esophagus in infants surviving congenital diaphragmatic hernia. Am J Surg 1990; 159:204.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28026/abstract/88\">",
"      Koot VC, Bergmeijer JH, Bos AP, Molenaar JC. Incidence and management of gastroesophageal reflux after repair of congenital diaphragmatic hernia. J Pediatr Surg 1993; 28:48.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28026/abstract/89\">",
"      Kieffer J, Sapin E, Berg A, et al. Gastroesophageal reflux after repair of congenital diaphragmatic hernia. J Pediatr Surg 1995; 30:1330.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28026/abstract/90\">",
"      Diamond IR, Mah K, Kim PC, et al. Predicting the need for fundoplication at the time of congenital diaphragmatic hernia repair. J Pediatr Surg 2007; 42:1066.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28026/abstract/91\">",
"      Su W, Berry M, Puligandla PS, et al. Predictors of gastroesophageal reflux in neonates with congenital diaphragmatic hernia. J Pediatr Surg 2007; 42:1639.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28026/abstract/92\">",
"      Koivusalo AI, Pakarinen MP, Lindahl HG, Rintala RJ. The cumulative incidence of significant gastroesophageal reflux in patients with congenital diaphragmatic hernia-a systematic clinical, pH-metric, and endoscopic follow-up study. J Pediatr Surg 2008; 43:279.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28026/abstract/93\">",
"      Peetsold MG, Kneepkens CM, Heij HA, et al. Congenital diaphragmatic hernia: long-term risk of gastroesophageal reflux disease. J Pediatr Gastroenterol Nutr 2010; 51:448.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28026/abstract/94\">",
"      Vanamo K. A 45-year perspective of congenital diaphragmatic hernia. Br J Surg 1996; 83:1758.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28026/abstract/95\">",
"      Rescorla FJ, Shedd FJ, Grosfeld JL, et al. Anomalies of intestinal rotation in childhood: analysis of 447 cases. Surgery 1990; 108:710.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28026/abstract/96\">",
"      Stolar CJ, Crisafi MA, Driscoll YT. Neurocognitive outcome for neonates treated with extracorporeal membrane oxygenation: are infants with congenital diaphragmatic hernia different? J Pediatr Surg 1995; 30:366.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28026/abstract/97\">",
"      Muratore CS, Utter S, Jaksic T, et al. Nutritional morbidity in survivors of congenital diaphragmatic hernia. J Pediatr Surg 2001; 36:1171.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28026/abstract/98\">",
"      Dariel A, Roz&eacute; JC, Piloquet H, et al. Impact of prophylactic fundoplication on survival without growth disorder in left congenital diaphragmatic hernia requiring a patch repair. J Pediatr 2010; 157:688.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28026/abstract/99\">",
"      Danzer E, Zarnow D, Gerdes M, et al. Abnormal brain development and maturation on magnetic resonance imaging in survivors of severe congenital diaphragmatic hernia. J Pediatr Surg 2012; 47:453.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28026/abstract/100\">",
"      Fredly S, Aksnes G, Viddal KO, et al. The outcome in newborns with congenital diaphragmatic hernia in a Norwegian region. Acta Paediatr 2009; 98:107.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28026/abstract/101\">",
"      Mah VK, Zamakhshary M, Mah DY, et al. Absolute vs relative improvements in congenital diaphragmatic hernia survival: what happened to \"hidden mortality\". J Pediatr Surg 2009; 44:877.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28026/abstract/102\">",
"      Colvin J, Bower C, Dickinson JE, Sokol J. Outcomes of congenital diaphragmatic hernia: a population-based study in Western Australia. Pediatrics 2005; 116:e356.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28026/abstract/103\">",
"      Stege G, Fenton A, Jaffray B. Nihilism in the 1990s: the true mortality of congenital diaphragmatic hernia. Pediatrics 2003; 112:532.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28026/abstract/104\">",
"      Levison J, Halliday R, Holland AJ, et al. A population-based study of congenital diaphragmatic hernia outcome in New South Wales and the Australian Capital Territory, Australia, 1992-2001. J Pediatr Surg 2006; 41:1049.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28026/abstract/105\">",
"      Brownlee EM, Howatson AG, Davis CF, Sabharwal AJ. The hidden mortality of congenital diaphragmatic hernia: a 20-year review. J Pediatr Surg 2009; 44:317.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28026/abstract/106\">",
"      Tsao K, Allison ND, Harting MT, et al. Congenital diaphragmatic hernia in the preterm infant. Surgery 2010; 148:404.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28026/abstract/107\">",
"      Menon SC, Tani LY, Weng HY, et al. Clinical characteristics and outcomes of patients with cardiac defects and congenital diaphragmatic hernia. J Pediatr 2013; 162:114.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28026/abstract/108\">",
"      Aly H, Bianco-Batlles D, Mohamed MA, Hammad TA. Mortality in infants with congenital diaphragmatic hernia: a study of the United States National Database. J Perinatol 2010; 30:553.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28026/abstract/109\">",
"      Nasr A, Langer JC, Canadian Pediatric Surgery Network. Influence of location of delivery on outcome in neonates with congenital diaphragmatic hernia. J Pediatr Surg 2011; 46:814.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28026/abstract/110\">",
"      Yoder BA, Lally PA, Lally KP, Congenital Diaphragmatic Hernia Study Group. Does a highest pre-ductal O(2) saturation &lt;85% predict non-survival for congenital diaphragmatic hernia? J Perinatol 2012; 32:947.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28026/abstract/111\">",
"      Congenital Diaphragmatic Hernia Study Group, Lally KP, Lally PA, et al. Defect size determines survival in infants with congenital diaphragmatic hernia. Pediatrics 2007; 120:e651.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28026/abstract/112\">",
"      Singh SJ, Cummins GE, Cohen RC, et al. Adverse outcome of congenital diaphragmatic hernia is determined by diaphragmatic agenesis, not by antenatal diagnosis. J Pediatr Surg 1999; 34:1740.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28026/abstract/113\">",
"      Tsang TM, Tam PK, Dudley NE, Stevens J. Diaphragmatic agenesis as a distinct clinical entity. J Pediatr Surg 1994; 29:1439.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28026/abstract/114\">",
"      Lally KP, Lally PA, Van Meurs KP, et al. Treatment evolution in high-risk congenital diaphragmatic hernia: ten years' experience with diaphragmatic agenesis. Ann Surg 2006; 244:505.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28026/abstract/115\">",
"      Fisher JC, Jefferson RA, Arkovitz MS, Stolar CJ. Redefining outcomes in right congenital diaphragmatic hernia. J Pediatr Surg 2008; 43:373.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28026/abstract/116\">",
"      Chen C, Jeruss S, Chapman JS, et al. Long-term functional impact of congenital diaphragmatic hernia repair on children. J Pediatr Surg 2007; 42:657.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28026/abstract/117\">",
"      Tureczek I, Caflisch J, Moehrlen U, et al. Long-term motor and cognitive outcome in children with congenital diaphragmatic hernia. Acta Paediatr 2012; 101:507.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28026/abstract/118\">",
"      Friedman S, Chen C, Chapman JS, et al. Neurodevelopmental outcomes of congenital diaphragmatic hernia survivors followed in a multidisciplinary clinic at ages 1 and 3. J Pediatr Surg 2008; 43:1035.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28026/abstract/119\">",
"      Danzer E, Gerdes M, Bernbaum J, et al. Neurodevelopmental outcome of infants with congenital diaphragmatic hernia prospectively enrolled in an interdisciplinary follow-up program. J Pediatr Surg 2010; 45:1759.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28026/abstract/120\">",
"      Morini F, Capolupo I, Masi R, et al. Hearing impairment in congenital diaphragmatic hernia: the inaudible and noiseless foot of time. J Pediatr Surg 2008; 43:380.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28026/abstract/121\">",
"      American Academy of Pediatrics Section on Surgery, American Academy of Pediatrics Committee on Fetus and Newborn, Lally KP, Engle W. Postdischarge follow-up of infants with congenital diaphragmatic hernia. Pediatrics 2008; 121:627.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?27/23/28026/abstract/122\">",
"      Chao PH, Chuang JH, Lee SY, Huang HC. Late-presenting congenital diaphragmatic hernia in childhood. Acta Paediatr 2011; 100:425.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 4963 Version 20.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-221.10.40.232-7F6A7747C1-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f27_23_28026=[""].join("\n");
var outline_f27_23_28026=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H30\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      CLINICAL MANIFESTATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      DIFFERENTIAL DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      MANAGEMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Prenatal management",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Initial treatment",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Ventilation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Echocardiography",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Extracorporeal membrane oxygenation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      - Criteria",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      - Efficacy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Surgery",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      - Timing",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      COMPLICATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Pulmonary complications",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      - Recurrent hernia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Nonpulmonary complications",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      - Patch-related",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      - Gastrointestinal",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      - Failure to thrive",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      - Neurologic",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      OUTCOME",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      Survival",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      - Defect size",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      - Right versus left-sided lesion",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H28\">",
"      Long-term outcome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H29\">",
"      POST-DISCHARGE MANAGEMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H48600457\">",
"      LATE CDH PRESENTATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H30\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H31\">",
"      Treatment",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H32\">",
"      Complications and outcome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PEDS/4963\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/4963|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?14/37/14928\" title=\"diagnostic image 1\">",
"      Congenital diaphragmatic hernia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?38/40/39566\" title=\"diagnostic image 2A\">",
"      Echo assessment rt ventricle1",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?2/42/2720\" title=\"diagnostic image 2B\">",
"      Echo assessment rt ventricle2",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/4963|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?21/11/21684\" title=\"picture 1\">",
"      Intraoperative congenital diaphragmatic hernia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/4963|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?30/52/31565\" title=\"table 1\">",
"      AAP followup schedule CDH",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/11/42169?source=related_link\">",
"      Congenital diaphragmatic hernia: Prenatal diagnosis and management",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/12/19656?source=related_link\">",
"      Pathophysiology and clinical manifestations of respiratory distress syndrome in the newborn",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?2/6/2146?source=related_link\">",
"      Patient information: Congenital hernia of the diaphragm (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/37/27225?source=related_link\">",
"      Persistent pulmonary hypertension of the newborn",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f27_23_28027="Pharmacokinetics of insulin used in pregnant women";
var content_f27_23_28027=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F83634&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F83634&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Pharmacokinetics of insulin in pregnant women",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Insulin type",
"       </td>",
"       <td class=\"subtitle1\">",
"        Onset of action",
"       </td>",
"       <td class=\"subtitle1\">",
"        Peak effect",
"       </td>",
"       <td class=\"subtitle1\">",
"        Duration of action",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Lispro, aspart",
"       </td>",
"       <td>",
"        5 to 15 minutes",
"       </td>",
"       <td>",
"        45 to 75 minutes",
"       </td>",
"       <td>",
"        2 to 4 hours",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Regular",
"       </td>",
"       <td>",
"        About 30 minutes",
"       </td>",
"       <td>",
"        2 to 4 hours",
"       </td>",
"       <td>",
"        5 to 8 hours",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        NPH",
"       </td>",
"       <td>",
"        About 2 hours",
"       </td>",
"       <td>",
"        4 to 12 hours",
"       </td>",
"       <td>",
"        18 to 28 hours",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Insulin glargine",
"       </td>",
"       <td>",
"        About 2 hours",
"       </td>",
"       <td>",
"        No peak",
"       </td>",
"       <td>",
"        20 to &gt;24 hours",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Insulin detemir",
"       </td>",
"       <td>",
"        About 2 hours",
"       </td>",
"       <td>",
"        3 to 9 hours",
"       </td>",
"       <td>",
"        6 to 24 hours*",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * Duration of action is dose-dependent. At higher doses (&ge;0.8 units/kg), mean duration of action is longer and less variable (22 to 23 hours).",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f27_23_28027=[""].join("\n");
var outline_f27_23_28027=null;
var title_f27_23_28028="Unstable hand fractures";
var content_f27_23_28028=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=SURG%2F62550&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=SURG%2F62550&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Unstable hand fractures",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Bone",
"       </td>",
"       <td class=\"subtitle1\">",
"        Location",
"       </td>",
"       <td class=\"subtitle1\">",
"        Type",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Distal phalanx",
"       </td>",
"       <td>",
"        Base",
"       </td>",
"       <td>",
"        <ol>",
"         <li>",
"          Seymour fracture",
"         </li>",
"         <li>",
"          Transverse fracture between flexor and extensor tendon insertion",
"         </li>",
"         <li>",
"          FDP avulsion fracture",
"         </li>",
"         <li>",
"          Mallet fracture with DIPJ subluxation",
"         </li>",
"        </ol>",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td rowspan=\"3\">",
"        Middle and proximal phalanx",
"       </td>",
"       <td>",
"        Head",
"       </td>",
"       <td>",
"        <ol>",
"         <li>",
"          Displaced unicondylar/bicondylar fracture",
"         </li>",
"        </ol>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Shaft",
"       </td>",
"       <td>",
"        <ol>",
"         <li>",
"          Displaced oblique/spiral fractures with rotational deformity",
"         </li>",
"        </ol>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Base",
"       </td>",
"       <td>",
"        <ol>",
"         <li>",
"          Palmar lip fractures that need &gt;30&deg; of PIPJ flexion to maintain reduction",
"         </li>",
"         <li>",
"          Pilon fracture",
"         </li>",
"        </ol>",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td rowspan=\"3\">",
"        Metacarpal",
"       </td>",
"       <td>",
"        Head",
"       </td>",
"       <td>",
"        <ol>",
"         <li>",
"          &gt;25 percent articular surface involvement or 1 mm step-off",
"         </li>",
"        </ol>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Shaft",
"       </td>",
"       <td>",
"        <ol>",
"         <li>",
"          Displaced oblique/spiral fractures with rotational deformity",
"         </li>",
"        </ol>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Base",
"       </td>",
"       <td>",
"        <ol>",
"         <li>",
"          Displaced with CMCJ subluxation/dislocation",
"         </li>",
"         <li>",
"          Displaced Bennett fracture",
"         </li>",
"         <li>",
"          Displaced Rolando fracture",
"         </li>",
"        </ol>",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        Scaphoid",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        <ol>",
"         <li>",
"          Displacement &gt;1 mm",
"         </li>",
"         <li>",
"          Comminution",
"         </li>",
"         <li>",
"          Proximal pole",
"         </li>",
"         <li>",
"          Intrascaphoid angle &gt;45&deg;",
"         </li>",
"         <li>",
"          Height-to-length ratio &gt;0.65",
"         </li>",
"         <li>",
"          Associated DISI deformity",
"         </li>",
"         <li>",
"          Associated perilunate injury",
"         </li>",
"        </ol>",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     FDP: flexor digitorum profundus; DIPJ: distal interphalangeal joint; PIPJ: proximal interphalangeal joint; CMCJ: carpometacarpal joints; DISI: dorsal intercalated segment instability.",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f27_23_28028=[""].join("\n");
var outline_f27_23_28028=null;
var title_f27_23_28029="Na handling in nephrosis";
var content_f27_23_28029=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEPH%2F82649&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEPH%2F82649&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 523px\">",
"   <div class=\"ttl\">",
"    Increased collecting tubule sodium reabsorption in nephrotic syndrome",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 503px; height: 217px; background-image: url(data:image/gif;base64,R0lGODlh9wHZAOYAAP///4CAgAAAAEBAQMDAwP+AgP8AABAQEICA//+goHBwcP/AwKCgoNDQ0PDw/wAz/xAQ//8gIGBgYODg4CAgIPDw8MDA/zAwMLCwsFBQUEBm//9AQDAw/0BA//8QEJCQ/+Dg/yAg/5CQkP9gYP8wMP/Q0P/w8P+wsP/g4LCw/3Bw/9DQ/1BQ/2Bg//9wcP9QUICZ/wAA//+QkMDN/6Cg/yBN/3CN/7DA/xBA/1Bz//Dz/zBZ/9DZ/6Cz/2CA/++wwJCm/+Dm/zAg7tCw398QMG8Aj49gz49Ar58AX98AHwAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAACH5BAAAAAAALAAAAAD3AdkAAAf/gACCg4SFhoeIiYqLjI2Oj5CRkpOUlZaXmJmam5ydnp+goaKjpKWmp6ipqqusra6vsLGys7S1tre4ubq7vL2+v8DBwsPExcbHyMnKy8zNzs/Q0dLT1NXW19jZ2tvc3d7f4OHi4+Tl5ufo6err7O3u7/Dx8vP09fa8DQSEDQEBDfcAAwpMNIHBAQGDMAigQEEAhoEQI9oLIKDioAsCGjQQcEGix4/vLAoSKRKkyZPkSpJECIBAv5cB9KGcacolzJs4c+rcybOnz59Ag+KUWavkwQoVBBwQZPPlgAA0o44K8FSo1atYs2rN+bTWBAIVCUwAIEFAPwESEPWTyvbT2olQ/2lRrGgWQIUMFTNUUBu3rd9Mb+sFPjb4r+FJheUlJrb4sGNGjd9FDjb5seVCldll9rX5suXO6UBnqiDiJQNOoj0bTm2OtaUBdAUMQN1XtW1CrsnlpsSRgO9/m3bfnik8XPFIF2rTHs4cwHFNM2boAKBjRhBPNjR4ev5IAQXTy5vf5o7pwYMcAGY8gOFJw4PtykfBpjs7eHzxj8lfMv8g+npBQGiQww2CwNADD+z1AMMNGtiggw8a8CBIdhr4IKF78KGSj28EAKeJfvgF1JkFCJRo4okopmiiBYo8sAMONdzwnw0P2JDDAwQ+gIN5ALhXQw06+ihIDTDYAGOP73UCYv8iBFSw4W/hhXjZiCpWaSWLiTygQQ9a/ofDDtSdB4CLg2CoHnsYppfdjkhmWIoABMxXUX2X2NSVlFPet4qWSP7H55ja/dnmmW3KOOAO76UZ5VQFwXQaJnbqiWdbS1LCp3r/3XgDDA8AAWiZ7xGKIacLAtmmkpJSluqkUVU6yZ8+/KfDjTjYIIigZv6HoQ6I/phokouSQkAGAxSrQLCs+uXqNcsechB9yCbLVrPVUFvIAce6taq0J1k7jbeDMDAAhx4Cti23IIEbjbpkxUanuej+xe4z7HIEnn3xKnuuOuwOkK2b+Uo1rzPsSnBAsf5GG7BJAzfTr7sKL/xRw8xQDLD/xChZrIzGjTDQ0AGpcixICilg/O2+oaF8yQUM7AXJRhQQ0FC5mKkcSgohdACCydCITJjNlWB0gAQ0K7LRARgMcMBYfMniAAIxIOAAzw4DXY66DRi8kAguLzJXXYM01c+dsoDQQQglU72x1bqxXUkF4lYkAdOIEHBABgY5FPZNZM+CcwcrqI2Mz8ZQPIECBxB1CEXHKgD24m6L8nQMKkwtOGORG5c5Jl0fMsFBsC2dCOGHmA0BDZcPQzrmqDCA06MEldayIqsf8nfgqf9SuzAPxybbh5uTMnnlufeyu6qoZCCCb091CLwvpqNevC7HA1PvQ85lEPEtt0+PC+ELLGAC/wAmLICCIyVskEAlLmxgCbsUgIy49vgCM7zl3s9CuAEGvADAAgYogCMAKEBIGMB9AEhAASnBrgY86wBFe1/wVBG9/OlvgpjgnwHCF0BBJGADG5ABAFBQgBO07wT/M4AL2lfAAiSgBAI0QftGUIIEGiACBUCBAgWBgva9AIWOGJhvLhYMC+QMdxZ0RWcWUIAmOvGJCxAEE59IxSgmwgAk8EAETtBBF6jwBQaQAQBxSAIDlACAB/SAAdZnADUaAABZLEAWe9jGDaTvjSbwgAcKMAIENoJdFVDAABqQAew9zxgIgADxksiKJVKxilJ8JBQVccAEHLCDWmziAQkIAC4WgP+TngQAFgVRAhV2MoyiROAG3iiDNfLwEezCC5wkQL9DGgMELDgdI1exP/etsoM3dGICOElAYgITgcYU4AEFsUoAFGCDkqiXCMZFle0Bw4iA2yUqepnCDoLxkwoE4AgWUMYzdpCTyxSEFhcAxhre0HzNLCUJFpAA/wURg41wyLgGUEt4LSORi9TmVPBpiXSOoIMmGIEa9zjGNq4vmakcRAnKGIH1OZN/dxTECcrYwXuiwmAHaAjs/LkMXOpSoKKoHiI4eUFU3EUp/6rT2AgqC2xiCaVE3AVLZaFSR0QqGolsAf5wakt69G5O1jyGST9A1PoJhqaKEGSxhpZUZBiRAzf/bWolemo8qDZCAf3EBFc3EdShajUSY90FxRSQFqdSY6lnRYxXmTXXQ8gJWiS1xlWzGlfI1LVafy2EVBGWsLxeo6x9/WNgT7Y2bsA1sbRbrDTSqlhvWIADWIWsWqqylc569rOd7VvhJKuLD0BAqJothNhAy9rWujYnihttOBzQAggwNbUL61xRv3HZzOI2XjILgG7rJoFiRbYcpkXtb6U1gdAZEhEMWEgA2tq0ctDWtstF1xAVcQAINum45+gtX7N7GwkEgG6MAMuzKNC11YoWuRBgwc7IO5z54K0RYJkNXkSwN5i817q1RQB9h4MBrWELvYaYAEec8zhDUPYVlw3B/3gHfJgCQ0wRsEGc6KrbDtPKl8KPmQ/LChLTQwSSnxEcxINjcV0Bg9gwElAAgnfbjghP+MUoYcBIq3oOD88XxzQhFih8Rs/x2S/AQKaJx8jF41GwE4syON8vLHC2Gyd5IHd9l1hJywgTJEChJChADX1Bg/j++MoRcd29aByLEyg0Ai4Y8y4coAIIuBjNEcHAef3R5FWUwAUR8MAIgKiLFVQZzwNxHJwyQF3D4gKGWRxBAoyMizJ/GNH3GNoFXKLlS6wYBTIo4wuseAs62xnT9oDTuIrb51l4mdS4MLSEUT2PAVyAAvttNS6KfIsy64zW8HBgRS4wXAkmYwGrHLQt6P8cNbMCWx3O08RPlUHCCMBZzrKQddqenY4Yz9gS02ZGCcAsA0rHwtdn5jY5RDw7tzajnv2zKItV0Gx1mwMD3vmdu51hglALGtuu0La9yVHghnTa2NX4s7VzeG4I/Hrg3xAx13R9DDdvEhbMlhrEu+FtbW3j1dk+27Y3LpAVi4LXrPhbukkejUEOtrBs3gayDaDsVUxO4yyXhqovHHNuVPvaqzAb2nL+1HOM2wMkKLcqUhBfZxN9cK+j+DXg/QJ5m+K6t326MnyH1H2bo9+RBvgosLlyrQ+DQ2hPsSEq0JCQcfkYCsehlIVX56yb/Rh6ngCfGyFLt8vD4huAtSh6i8T/uw9D0cNqdCIUghe/zwPkp4DanQ0fDE1zmhEVABlFauPet0cD5aFYAWatTHlcqJoArPaabBpCAdh1XiAzr3koTBvQ0u/C1rgWAH8XYSfZxBY3npfGz+McCqGT3vayEDZHiq2WBjs4+NQ4etLNzYnkOh35tIj2I77ybRVD3xpUt/omHJDLkWM/FjnZsae/fw2w/9sTTGfB9c+vCq7ru+cSiTvDx19bu9OfFb5BAcsTJ/hkcskAeIJ3CWT3f6+gN85xcFvFft4AeeNXdwzYCvETAPMjdeJBeBeoCsoHQRyIH5L3gaqwXSMIEvSECaLnWyZYDAZYDeS0R3NHCbQ3fy+o/1YSqA4LcFDjZAnGl4O8s4PrQEJIJ36RYH1CqDtE2A4JEEc1CAnkBwHmt4SWIALPcn/gNlOs0oM0l4COEH84aIWOoBQIU2KUEG6TYoTzNAlYR4aW8B1D1oTzMEyVsIBwKAnB1Q/qh3DaZGr+l4eMgBF4hX9diISN4IGCmE8ZwGRexy3khEPU1wgluIiLwFZzyDPsJGhRyAgteHyCmGUpOBwooFCjloSKNIZw+HJo6IdUYwIFEAEkgIiJEISWeAoxCA9PKImPoIS3KAisOIpSsokj0ImIMIVVmIei+IiCU4oecIqNIIa/OAgU8FxbxkiwKItgaAhvOI0XAIGYcRAH0P+H3idQdugIeLiKxYIRYYUIGaAAitZ9zkGH+AGIykgXFKB2dgUno0OPh3ECtEgIijiNi6BgFEAIr6dVJ2BtATkIlfiCTfIk2leQFyCC/eUU/ugYCcCQi/CJL7hzhWg0IaWP8whZG1lRi3CDH3heasaH+RQbkpKLKHGSDWmLBCkIN/F75YhbNKkIvnh+9geOcpVdPXmM5Ud/U/WNSqN460dfRWk7TUd/iQOMTOmKRMmRh9CNyIcWdiFkzMiT1kZohZCOlKdoFVGAGYknCSCWhWCPtjdNA7B7XzlgAGkIA3mTwIdoC4mShfCQWvdS2IIqqPaUguCRWgcbtuZ8TUlrhAn/ACpJdA4oSMJoklgpCDZJciDTle1olYxZmY55WqqIaWbpgDJFFWnJM0+JjCw3TYUkbVy4cU8pjepWAWIBAHknmCxXlFoJbAGwNAqhFPI4lER3kkBElpg2AGmBFwbTihFodms5CG6Jal1xEA84mXh2l2gmASzzO5I5lyy3gn55ZWBREadBAczJQKfJSDPoAkMweogmLlARJzrZnNg3bv1zBKn4gjJ5Of0WAUlQBEIAioa3n7lzAmCEBEYQmlpHoMXTQx5ABD/AgAzqPQkQoSwHNwHQbhyGl4iGEbDREf3IoZjGeACAF9aYlyKKZ5vHYDGZnik6KSu6okzBN5z1WjZ6/6M4mqM6uqM8mqPzaTIiIACNo3sXOTY12qNIihXFkqRMqqRH2qRQyhP/xTMGKTMCII8T6p3YkKWGKDEesxDkiJMuqgpc6mjeUKb3gKaLKQ5qypko1ab0yaZjmgpwOg91Kpxy2jZxhYLhwKfg4KffAKgvOqiEWqiGeqiBinYnBgANMABhCgwSyXyD0KiPWgndGQkwNwpo96PhMkiJIJniQpJ2dZ7Y5zsE4DotURewEUT8SAt3xampClWoKglaKAq+Axmtuo8tcV6HUKuE4Kv/Fxa+gaGxaqUxoXcEgAEMMAHF5S8V0FxocRrMipyiKgqwMYDPGgD4dicVUFyNVwh6t/+tD4GsysqoxaUAe1Ea6SpcqBquxdUASZMtw1IsuwesnyCs+uASBTYA2ENIxZKrCcFPDbGrY5E1/KRj0jUB0+qsAGCvQGkWa7GqYJGhoMMA6uV7T1EWRNMQFyBjB5Ac3eUKsGFe8TknB3EaGMFWzgcW34ER+aAUsvE5INsRYCEB0cVfEjsnSsEQAnAa00UVPduwQskJZ5mhDHYwFaGw3QW0saUQyTGwFCEW9kJLjnMw+ZCxXOmwpRobAJCzULGqqfovDFBcvxO1ABCk5gUbsGqtXDuxtmkWG5EWEzueZuG2ChETQioIQfoQjvMPQXo3guC1XYsQbksaGYARUKG1RAv/LWbrOAQQpD4LJ18zLFc6uAzWIQuhABN3f2OLmEKbgyVhuW4Ltm4LAI6jAPl1uQxGsrzKCmobNnUxt7FrFrTpG18xu3gbF2ZrtgoWtKKrqoRbFxUpAkGauEO7CaG7u5LLj1H7FcMKtqtqtklzEB2hb6ebuopre6EruLCBAS8bF90bXbOxeZh7ARhAAApQraAwsv1wuyUrXCGFviuLFgTgsqW7EY0YP3ZRkUrzD9wbvIkbM45jvKZQtFChvL4hAI34urhhFhgAtXCCeucbsgshFuH7O9lbetsLwLZ5EMsDNsLmuRPQENqDAYR4AcEpH7GRwO8LAHkDG8rBskpxGqXrY8Ic+w9l0SQfWwH/G6surLME/CZci8CmqxQYEVs8vBAQLBYn/A9zoRGgg8HHi6jJUMNUTGtWfMVavMVc3MVe/MVgHMZiPMZkXMZmfMZonMZqvMZs3MZu/MZwHMdyPMd0nD+BAAA7);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Micropuncture studies (in which samples are taken via micropipettes from different nephron segments) of sodium handling in unilateral nephrotic syndrome in the rat. Although less sodium is filtered in the nephrotic kidney, less is reabsorbed so that the quantity of sodium remaining in the tubular lumen at the end of the distal tubule is the same in the two kidneys. Thus, sodium reabsorption must be increased in the collecting tubules to account for the two-thirds reduction in total sodium excretion in the nephrotic kidney when compared to the normal kidney.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from Ichikawa, I, Rennke, HG, Hoyer, JR, et al, J Clin Invest 1983; 71:91.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f27_23_28029=[""].join("\n");
var outline_f27_23_28029=null;
var title_f27_23_28030="Pre-HCT screening for infection";
var content_f27_23_28030=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F56453&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F56453&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Pretransplant screening to evaluate the risk of infection in hematopoietic cell transplant donors and candidates",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <colgroup width=\"50%\">",
"     </colgroup>",
"     <colgroup span=\"2\" width=\"25%\">",
"     </colgroup>",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Tests and evaluations",
"       </td>",
"       <td class=\"subtitle1\">",
"        Donor",
"       </td>",
"       <td class=\"subtitle1\">",
"        Candidate",
"        <br/>",
"        (allogeneic or autologous)",
"       </td>",
"      </tr>",
"      <tr class=\"divider_bottom\">",
"       <td>",
"        <strong>",
"         History, review of systems, physical examination",
"        </strong>",
"       </td>",
"       <td class=\"centered\">",
"        +",
"       </td>",
"       <td class=\"centered\">",
"        +",
"       </td>",
"      </tr>",
"      <tr class=\"divider_bottom\">",
"       <td>",
"        <strong>",
"         Dental evaluation",
"        </strong>",
"       </td>",
"       <td class=\"centered\">",
"        -",
"       </td>",
"       <td class=\"centered\">",
"        +",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist_other_start\" colspan=\"3\">",
"        <strong>",
"         Radiology",
"        </strong>",
"       </td>",
"      </tr>",
"      <tr class=\"divider_bottom\">",
"       <td class=\"indent1\">",
"        Chest radiograph",
"       </td>",
"       <td class=\"centered\">",
"        -",
"       </td>",
"       <td class=\"centered\">",
"        +",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist_other_start\" colspan=\"3\">",
"        <strong>",
"         Pathogen-specific testing",
"        </strong>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        CMV IgG",
"       </td>",
"       <td class=\"centered\">",
"        +",
"       </td>",
"       <td class=\"centered\">",
"        +",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Hepatitis B (HBsAg, anti-HBsAg, anti-HBc) +/- viral load*",
"       </td>",
"       <td class=\"centered\">",
"        +",
"       </td>",
"       <td class=\"centered\">",
"        +",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Hepatitis C (IgM, IgG) +/- viral load",
"        <sup>",
"         &bull;",
"        </sup>",
"       </td>",
"       <td class=\"centered\">",
"        +",
"       </td>",
"       <td class=\"centered\">",
"        +",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        VZV IgG",
"       </td>",
"       <td class=\"centered\">",
"        +",
"       </td>",
"       <td class=\"centered\">",
"        +",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        HSV IgG",
"       </td>",
"       <td class=\"centered\">",
"        -",
"       </td>",
"       <td class=\"centered\">",
"        +",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        EBV (VCA IgG)",
"       </td>",
"       <td class=\"centered\">",
"        +",
"       </td>",
"       <td class=\"centered\">",
"        +",
"        <br/>",
"        (especially allogeneic and T cell-depleted)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        HIV-1, -2 antibodies",
"        <sup>",
"         &Delta;",
"        </sup>",
"       </td>",
"       <td class=\"centered\">",
"        +",
"       </td>",
"       <td class=\"centered\">",
"        +",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        HTLV-1 antibodies",
"       </td>",
"       <td class=\"centered\">",
"        +",
"       </td>",
"       <td class=\"centered\">",
"        +",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        RPR or VDRL",
"       </td>",
"       <td class=\"centered\">",
"        +",
"       </td>",
"       <td class=\"centered\">",
"        +",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Serum Aspergillus galactomannan antigen",
"        <sup>",
"         &loz;",
"        </sup>",
"       </td>",
"       <td class=\"centered\">",
"        -",
"       </td>",
"       <td class=\"centered\">",
"        +/-",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Toxoplasma gondii IgG",
"       </td>",
"       <td class=\"centered\">",
"        +",
"       </td>",
"       <td class=\"centered\">",
"        +/-",
"        <br/>",
"        (allogeneic only, particularly T cell-depleted)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Screening for TB",
"        <sup>",
"         &sect;",
"        </sup>",
"       </td>",
"       <td class=\"centered\">",
"        -",
"       </td>",
"       <td class=\"centered\">",
"        +",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Staphylococcus aureus nasal culture",
"       </td>",
"       <td class=\"centered\">",
"        -",
"       </td>",
"       <td class=\"centered\">",
"        +",
"       </td>",
"      </tr>",
"      <tr class=\"divider_bottom\">",
"       <td class=\"indent1\">",
"        Vancomycin-resistant Enterococcus rectal culture",
"       </td>",
"       <td class=\"centered\">",
"        -",
"       </td>",
"       <td class=\"centered\">",
"        +",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist_other_start\" colspan=\"3\">",
"        <strong>",
"         Tests for individuals who have resided in or traveled to endemic areas",
"        </strong>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Strongyloides stercoralis serology",
"        <sup>",
"         &yen;",
"        </sup>",
"       </td>",
"       <td class=\"centered\">",
"        +",
"       </td>",
"       <td class=\"centered\">",
"        +",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Coccidioides spp serology",
"        <sup>",
"         ������",
"        </sup>",
"       </td>",
"       <td class=\"centered\">",
"        -",
"       </td>",
"       <td class=\"centered\">",
"        +/-",
"        <br/>",
"        (especially allogeneic and T cell-depleted)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Histoplasma capsulatum serology",
"        <sup>",
"         ������",
"        </sup>",
"       </td>",
"       <td class=\"centered\">",
"        -",
"       </td>",
"       <td class=\"centered\">",
"        +/-",
"        <br/>",
"        (especially allogeneic and T cell-depleted)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Trypanosoma cruzi serology",
"        <sup>",
"         ������",
"        </sup>",
"       </td>",
"       <td class=\"centered\">",
"        +",
"       </td>",
"       <td class=\"centered\">",
"        +/-",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Malaria blood smears, rapid tests, and/or PCR**",
"       </td>",
"       <td class=\"centered\">",
"        +",
"       </td>",
"       <td class=\"centered\">",
"        +",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    The recommendations in this table are generally in keeping with the 2009 international guidelines for preventing infectious complications after hematopoietic cell transplantation",
"    <sup>",
"     [1]",
"    </sup>",
"    ; some of our recommendations are not included in the guidelines. Complete donor evaluation may not be possible when transplantation from an unrelated donor is planned.",
"    <div class=\"footnotes\">",
"     CMV: cytomegalovirus; Ig: immunoglobulin; HBsAg: hepatitis B surface antigen; anti-HBsAg: antibodies to hepatitis B surface antigen; anti-HBc: antibodies to hepatitis B core antigen; RT-PCR: reverse transcriptase polymerase chain reaction; HIV: human immunodeficiency virus; VZV: varicella-zoster virus; HSV: herpes simplex virus; EBV: Epstein Barr virus; HTLV: human T lymphotrophic virus; VDRL: venereal disease research laboratory; TB: tuberculosis; VCA: viral capsid antigen; CBC: complete blood count; PCR: polymerase chain reaction.",
"     <br>",
"      * All HCT donors who are either anti-HBc positive or HBsAg positive and all HCT candidates who are anti-HBc positive but negative for HBsAg and anti-HBs should undergo viral load testing for hepatitis B virus. Additional recommendations for the evaluation and management of HCT candidates in the setting of positive serologic or viral load testing results from the donor or recipient can be found in the 2009 international guidelines",
"      <sup>",
"       [1]",
"      </sup>",
"      .",
"      <br>",
"       <font class=\"bullet\">",
"        &bull;",
"       </font>",
"       In addition to serologic testing for hepatitis C, all HCT candidates should undergo a careful history and physical examination for risk factors, signs, and symptoms of hepatitis C, as well as serum alanine aminotransferase (ALT) testing. Hepatitis C viral load testing should be performed in donors and recipients at increased risk for hepatitis C infection, including those who have received a transfusion with blood not tested for hepatitis C (eg, before 1992 in developed countries), history of IV or inhaled drug use, tattoos, or unexplained elevation of serum ALT. Viral load testing should also be performed in donors and recipients with positive hepatitis C serologic testing. Additional recommendations for the evaluation and management of HCT candidates in the setting of positive serologic or viral load testing results from the donor or recipient can be found in the 2009 international guidelines",
"       <sup>",
"        [1]",
"       </sup>",
"       .",
"       <br>",
"        &Delta; In addition to serologic testing, HIV viral load testing should be performed in potential donors who are considered to be at high risk for HIV infection.",
"        <br>",
"         <font class=\"lozenge\">",
"          &loz;",
"         </font>",
"         Serum Aspergillus galactomannan antigen testing should be performed in HCT candidates who have a past history of invasive aspergillosis and in others who are high-risk for invasive aspergillosis.",
"         <br>",
"          &sect; Screening for TB includes obtaining a history of prior active TB or exposures to individuals likely to have TB, as well as results of previous tuberculin skin tests or interferon-gamma release assays.",
"          <br>",
"           &yen; If Strongyloides antibody testing is not available or if active disease with strongyloidiasis is suspected in a seronegative HCT candidate, three stool samples should be sent for ova and parasites.",
"           <br>",
"            &Dagger; Reactivation of endemic mycoses following HCT is very rare, even in endemic regions.",
"            <br>",
"             &dagger; Donors or recipients who were born, received a blood transfusion, or ever lived for six months or longer in a region that is endemic for Chagas disease (eg, parts of South and Central America and Mexico) should undergo serologic testing for T. cruzi IgG. Individuals who have lived for less than six months in an endemic are but who had high-risk living conditions (eg, lived in dwellings with mud walls, unmilled logs and sticks, or a thatched roof), should also undergo serologic testing. Individuals whose mother was born in an endemic region or who has a suggestive history (eg, cardiomegaly and dysrhythmias) should be screened due to the risk of congenital transmission. Since there is no gold standard for serologic testing, screening should be performed with at least two serologic tests (enzyme immunoassay, indirect hemagglutination, indirect fluorescent antibody, or radioimmunoprecipitation assay).",
"             <br>",
"              ** Donors who have traveled to a malaria-endemic area should defer donation for one year following their return. Former or current residents of endemic areas should defer donation for three years. If this is not feasible, the donor should be treated empirically for malaria prior to donation.",
"             </br>",
"            </br>",
"           </br>",
"          </br>",
"         </br>",
"        </br>",
"       </br>",
"      </br>",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"     Adapted from:",
"     <br/>",
"     <ol>",
"      <li>",
"       Tomblyn M, Chiller T, Einsele H, et al. Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective. Biol Blood Marrow Transplant 2009; 15:1143.",
"      </li>",
"     </ol>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f27_23_28030=[""].join("\n");
var outline_f27_23_28030=null;
var title_f27_23_28031="Dental enamel defects in a child with celiac disease";
var content_f27_23_28031=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F56066&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F56066&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Dental enamel defects in a child with celiac disease",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 282px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Dental enamel defects associated with celiac disease may consist of cream-, yellow-, or brown-colored opacities, loss of enamel glaze, horizontal grooves, or shallow pits.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Lisa Papagiannoulis, DDS, MS, School of Dental Medicine, University of Athens, Greece.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f27_23_28031=[""].join("\n");
var outline_f27_23_28031=null;
